≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Wide developmental disorders

DOID Endpoint Browser

KRA_PSY_DEVWIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F84
  • Hospital discharge: ICD-9 — 299[0|8|9]
  • Cause of death: ICD-10 — F84
  • Cause of death: ICD-9 — 299[0|8|9]

2 out of 7 registries used, show all original rules.

1568

4. Check minimum number of events

None

1568

5. Include endpoints

None

1568

6. Filter based on genotype QC (FinnGen only)

1460

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F80-F89
Name in latin
Perturbationes formationales pervasivae (in pueritia)

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1460 743 717
Unadjusted period prevalence (%) 0.30 0.26 0.33
Median age at first event (years) 22.68 26.76 18.45

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1567
Matched controls
15602
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F90.0
ICD-10 Finland
Disturbance of activity and attention
8.7
307.7
678
1260
F84.5
ICD-10 Finland
Asperger syndrome
1282.6
307.7
1093
28
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
493.5
307.7
351
9
N06BA04
ATC
methylphenidate; oral
8.4
307.7
608
1089
N05AX08
ATC
risperidone; systemic
9.7
307.6
422
572
F84.8
ICD-10 Finland
Other pervasive developmental disorders
1556.1
276.0
261
*
N05AH04
ATC
quetiapine; oral
5.6
248.0
728
2087
N05AX12
ATC
aripiprazole; systemic
7.2
206.5
358
618
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
7.3
204.8
350
595
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.0
203.1
636
1876
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
7.9
188.6
287
428
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
9.0
182.4
244
312
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
6.5
174.8
329
612
N06AX12
ATC
bupropion; oral
5.5
174.5
419
977
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.2
173.3
290
478
N05AH03
ATC
olanzapine; systemic
5.9
165.5
348
718
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
13.9
163.7
157
124
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
7.2
162.6
269
437
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.4
161.1
579
1852
ZY010
NOMESCO Finland
Hospital outpatient
5.4
158.5
371
841
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
5.6
154.5
346
753
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
6.6
152.9
275
486
N06AB03
ATC
fluoxetine; oral
5.1
149.8
380
920
N06AX16
ATC
venlafaxine; oral
4.5
140.7
443
1269
N06AB06
ATC
sertraline; oral
4.3
137.8
466
1406
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.4
135.1
310
685
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.3
131.2
302
668
Z2445
NOMESCO Finland
Psychologist
5.0
130.7
330
790
F84.0
ICD-10 Finland
Childhood autism
356.3
130.4
130
*
N06BA12
ATC
lisdexamfetamine; oral
7.8
130.1
194
279
IGV01
NOMESCO Finland
Psychiatric network contact
8.3
129.2
181
242
ZYC01
NOMESCO Finland
Remote contact by phone
5.4
126.1
280
599
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.3
123.2
280
611
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.0
122.9
240
456
N03AX09
ATC
lamotrigine; oral
5.4
115.8
259
556
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.5
110.4
235
482
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.9
109.2
397
1241
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.4
107.6
551
2151
P29
ICPC
Psychological sympt/compl other
3.7
107.4
443
1507
F83
ICD-10 Finland
Mixed specific developmental disorders
7.4
107.0
164
242
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.9
104.7
261
612
Z2446
NOMESCO Finland
Social worker
4.0
101.1
339
997
P99
ICPC
Psychological disorders other
6.1
100.2
187
338
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
6.8
98.9
164
263
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.4
97.8
172
293
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.0
97.0
332
989
N05BA04
ATC
oxazepam; oral
3.3
96.8
496
1920
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.5
96.1
271
699
F34.1
ICD-10 Finland
Dysthymia
5.9
88.8
170
314
N06AB10
ATC
escitalopram; oral
2.9
85.1
580
2611
IGY02
NOMESCO Finland
Psychiatric monitoring contact
4.2
84.2
255
691
N03AG01
ATC
valproic acid; systemic, rectal
4.8
83.7
208
483
F93.89
ICD-10 Finland
Other childhood emotional disorders
6.3
82.9
148
255
N06AX26
ATC
vortioxetine; oral
3.6
81.2
312
997
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.7
79.0
156
296
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
4.7
77.8
194
451
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.6
76.5
197
470
IGP01
NOMESCO Finland
Psychiatric family contact
5.7
76.0
151
288
ICB06, ,
NOMESCO Finland
7.5
74.4
110
155
N06AB04
ATC
citalopram; systemic
3.4
74.3
313
1057
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
7.0
73.8
117
178
SPAT1240
SPAT
Therapeutic discussion
3.0
73.7
408
1621
N06AX11
ATC
mirtazapine; oral
2.7
73.6
575
2742
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.3
73.6
208
533
IEV99
NOMESCO Finland
Other psychiatric network intervention
7.5
72.3
107
151
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
14.8
69.8
63
44
F89
ICD-10 Finland
Unspecified disorder of psychological development
14.2
68.1
63
46
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.2
67.9
195
505
F61.0
ICD-10 Finland
Mixed personality disorders
7.9
67.6
95
126
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
6.0
66.6
124
222
N05AB03
ATC
perphenazine; systemic, rectal
6.8
66.2
107
166
F40.1
ICD-10 Finland
Social phobias
4.1
65.8
198
530
N06AX21
ATC
duloxetine; oral
3.6
64.9
241
747
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.5
64.5
109
177
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
6.8
63.5
102
157
SPAT1307
SPAT
Psychosocial counselling and guidance
3.0
63.0
352
1393
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
11.2
62.6
67
62
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
5.2
62.4
136
281
F88
ICD-10 Finland
Other disorders of psychological development
11.6
62.2
65
58
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.8
61.5
118
217
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.9
61.5
196
546
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
5.3
60.3
129
262
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.5
60.2
122
236
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
9.0
59.5
75
87
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.7
58.5
95
148
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.9
58.2
109
196
N06BA09
ATC
atomoxetine; oral
8.5
57.8
76
93
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
11.9
57.6
59
51
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.1
56.5
271
980
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
9.6
54.5
65
70
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.0
54.3
166
448
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
6.7
53.8
88
138
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.0
52.4
160
431
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.6
51.3
74
101
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
6.3
50.6
88
147
N05BA01
ATC
diazepam; systemic, rectal
3.3
50.5
208
684
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.4
50.3
132
317
SPAT1389
SPAT
Visit based on need for special support
3.1
49.5
238
858
IBZ08
NOMESCO Finland
Gender identity assessment
11.1
49.4
53
49
N05AD01
ATC
haloperidol; systemic
8.0
49.3
68
88
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
6.1
49.1
87
148
IEP99
NOMESCO Finland
Other psychiatric family intervention
6.4
48.6
83
136
P03
ICPC
Feeling depressed
2.4
48.1
420
2046
IER01
NOMESCO Finland
Psychoeducation, group
6.4
48.1
82
134
OAB43, ,
SPAT
0.4
47.7
293
5819
P85
ICPC
Mental retardation
9.2
47.2
58
65
P76
ICPC
Depressive disorder
2.9
47.2
258
998
P01
ICPC
Feeling anxious/nervous/tense
2.2
46.2
570
3206
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
11.2
45.0
48
44
XA800
NOMESCO Finland
Neuropsychological investigation
3.6
44.8
162
489
N05AN01
ATC
lithium; oral
5.4
44.5
91
177
Z3231
NOMESCO Finland
Registered nurse
2.2
44.2
533
2961
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.4
44.1
392
1916
N05AF03
ATC
chlorprothixene; systemic
6.3
43.8
75
123
N06AX22
ATC
agomelatine; oral
4.8
43.6
101
219
F21
ICD-10 Finland
Schizotypal disorder
12.5
43.5
43
35
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.6
42.8
150
443
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
8.9
41.3
52
60
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
5.6
41.3
80
148
IAB03
NOMESCO Finland
Neuropsychiatric consultation
68.8
41.2
47
7
ZY000
NOMESCO Finland
Hospital inpatient
5.4
40.8
82
157
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
13.2
40.7
39
30
ZYY01
NOMESCO Finland
Contact between professionals
8.6
40.3
52
62
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
7.0
40.2
62
91
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.5
40.2
102
238
N05AE04
ATC
ziprasidone; systemic
9.4
40.0
48
52
F33.8
ICD-10 Finland
Other recurrent depressive disorders
7.7
39.4
56
75
N06AB05
ATC
paroxetine; oral
4.1
39.4
113
290
R5599
NOMESCO Finland
Other rehabilitation service
4.9
39.1
88
186
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
7.7
39.0
55
73
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
14.8
39.0
35
24
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.6
38.7
138
412
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.4
38.6
78
150
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.6
38.4
135
399
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
7.7
38.1
54
72
N05BA06
ATC
lorazepam; systemic, sublingual
5.2
38.1
81
163
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.2
37.9
158
521
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.1
37.8
177
625
F80.2
ICD-10 Finland
Receptive language disorder
5.5
37.6
74
139
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
37.6
357
1782
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.2
37.5
161
540
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
7.7
36.9
52
69
F60.5
ICD-10 Finland
Anankastic personality disorder
7.0
36.8
57
84
Z07
ICPC
Education problem
4.6
36.8
89
200
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
6.0
36.5
65
111
IEP03
NOMESCO Finland
Focused parental counselling
5.2
36.1
75
148
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
6.1
35.9
63
106
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.1
35.8
102
260
P74
ICPC
Anxiety disorder/anxiety state
2.7
35.7
212
850
IAZ98
NOMESCO Finland
Other internal psychiatric consultation
7.2
35.1
53
76
R4110, ,
SPAT
3.0
35.0
170
612
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
9.7
35.0
41
43
SPAT1243
SPAT
Psychiatric/psychological examination
3.3
34.8
141
456
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.4
34.6
58
93
F20.9
ICD-10 Finland
Schizophrenia, unspecified
5.2
34.4
72
143
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.0
34.1
166
598
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
8.1
34.0
46
58
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.8
34.0
181
685
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
3.5
33.9
121
361
N05AH02
ATC
clozapine; systemic
4.7
33.7
79
173
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.7
33.6
196
778
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
8.0
33.6
46
59
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.4
33.3
125
385
P81
ICPC
Hyperkinetic disorder
3.8
32.7
104
287
C07AA05
ATC
propranolol; systemic
2.1
32.6
376
2017
N05BE01
ATC
buspirone; oral
4.8
31.8
74
161
SPAT1234
SPAT
Support of social functional capacity
4.3
31.6
83
199
F84.10
ICD-10 Finland
Autism in atypical age
+∞
31.3
30
*
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
6.0
31.3
56
96
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.4
31.2
241
1093
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
8.1
31.0
42
53
N05AA02
ATC
levomepromazine; systemic
4.3
30.9
81
194
IEY01
NOMESCO Finland
Psychoeducation, individual
5.5
30.8
61
115
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.9
30.5
93
249
R62.0
ICD-10 Finland
Delayed milestone
3.8
30.1
94
256
F82
ICD-10 Finland
Specific developmental disorder of motor function
4.5
30.0
75
173
N06AG02
ATC
moclobemide; oral
5.1
29.8
63
126
F64.0
ICD-10 Finland
Transsexualism
9.0
29.7
37
42
ZXY03
NOMESCO Finland
Occupational therapist
9.1
29.4
36
40
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
5.7
29.2
55
99
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
4.6
29.2
70
156
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
3.9
29.1
88
234
N03AE01
ATC
clonazepam; systemic
4.1
29.0
83
212
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
6.1
29.0
51
86
F50.8
ICD-10 Finland
Other eating disorders
8.1
28.9
39
49
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
5.8
28.9
53
93
N06BA02
ATC
dexamfetamine; oral
9.6
28.8
34
36
Z3226
NOMESCO Finland
Physiotherapist
2.1
28.7
312
1628
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
6.4
28.6
48
77
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.5
28.6
100
294
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.7
28.5
93
261
IGY02, ,
SPAT
4.3
28.5
75
180
IHZ04, ,
SPAT
4.0
28.1
83
217
N05AX16
ATC
brexpiprazole; oral
8.9
28.0
35
40
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
6.2
27.9
48
79
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
7.0
27.9
43
63
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
7.5
27.9
40
54
N06AA04
ATC
clomipramine; systemic
7.3
27.9
41
57
F32.1
ICD-10 Finland
Moderate depressive episode
2.4
27.4
203
900
M79.7
ICD-10 Finland
Fibromyalgia
4.4
27.4
69
160
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
4.3
27.3
72
173
N04AA02
ATC
biperiden; systemic
6.5
27.3
45
71
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.7
26.9
158
627
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
26.3
330
1809
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
5.8
26.3
48
84
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
7.7
26.2
37
49
Z72.8
ICD-10 Finland
Other problems related to lifestyle
7.4
26.2
38
52
N06AX03
ATC
mianserin; oral
4.6
26.1
63
141
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
25.8
196
878
N03AX11
ATC
topiramate; oral
4.0
25.8
75
194
ZXY60
NOMESCO Finland
2-person team, nurses
6.2
25.7
44
72
F84.11
ICD-10 Finland
Autism with atypical symptoms
263.7
25.7
26
*
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
7.0
25.4
39
57
SPAT1284
SPAT
Extensive health certificate
3.5
25.4
92
277
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.3
25.1
97
304
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.9
24.9
120
428
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
7.5
24.9
36
49
G47.3
ICD-10 Finland
Sleep apnoea
2.2
24.9
235
1154
F31
ICD-10 Finland
Bipolar affective disorder
5.3
24.5
50
97
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
24.5
121
438
ZXY49
NOMESCO Finland
Other health care provider
6.8
24.1
38
57
N05AX15
ATC
cariprazine; oral
7.0
24.1
37
54
N05AE05
ATC
lurasidone; oral
7.4
24.1
35
48
AA400
NOMESCO Finland
Electroconvulsive therapy
7.2
24.1
36
51
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
4.7
23.8
55
119
P06
ICPC
Sleep disturbance
2.1
23.5
271
1437
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
5.9
23.5
42
72
ZYC02
NOMESCO Finland
Remote contact by video link
7.6
23.3
33
44
F32
ICD-10 Finland
Depressive episode
2.6
23.2
149
617
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.5
23.1
57
130
P27
ICPC
Fear of mental disorder
3.9
23.1
69
182
SPAT1229
SPAT
Assessment of need for aid
4.4
22.9
58
135
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.8
22.9
70
188
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.4
22.8
163
710
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
5.4
22.7
45
85
M35.7
ICD-10 Finland
Hypermobility syndrome
4.5
22.6
55
124
SPAT1310
SPAT
Counselling related to known health issue
1.7
22.5
555
3744
N05BA12
ATC
alprazolam; oral
2.8
22.3
115
426
F50.9
ICD-10 Finland
Eating disorder, unspecified
3.8
22.2
69
187
SPAT1139
SPAT
Nutrition survey
4.3
22.0
57
135
F32.8
ICD-10 Finland
Other depressive episodes
3.8
22.0
67
179
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
5.2
21.9
45
88
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.3
21.6
186
878
F33
ICD-10 Finland
Recurrent depressive disorder
3.3
21.5
85
270
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.7
21.4
118
453
W78
ICPC
Pregnancy
0.4
21.3
123
2713
N06AX05
ATC
trazodone; oral
4.4
21.3
53
122
N02BF02
ATC
pregabalin; oral
3.0
21.2
99
347
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.8
21.2
48
102
F60.8
ICD-10 Finland
Other specific personality disorders
7.0
21.1
32
46
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
7.3
21.1
31
43
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
9.1
21.1
26
29
N05CF01
ATC
zopiclone; oral
2.0
20.8
262
1430
ZXY61
NOMESCO Finland
2-person team, special workers
8.8
20.6
26
30
P72
ICPC
Schizophrenia
4.2
20.5
55
134
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
20.2
315
1843
OAA80, ,
SPAT
0.3
20.2
47
1624
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.2
20.2
81
260
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.5
20.2
131
545
A01
ICPC
Pain general/multiple sites
2.4
20.1
149
658
T82
ICPC
Obesity
2.9
20.1
95
335
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
20.0
172
811
N03AX16
ATC
[U] pregabalin
2.1
19.9
195
968
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
7.3
19.9
29
40
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
4.8
19.8
45
96
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
5.3
19.8
40
77
RT420, ,
NOMESCO Finland
8.2
19.6
26
32
IAZ99
NOMESCO Finland
Other psychiatric consultation
6.0
19.4
34
57
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.6
19.3
46
102
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
4.7
19.1
44
95
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
3.7
19.0
62
174
A28
ICPC
Limited function/disability NOS
2.6
19.0
114
456
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.2
19.0
77
249
R5140
NOMESCO Finland
Monitoring the use of the aid
2.7
18.8
107
417
Z50.5
ICD-10 Finland
Speech therapy
3.2
18.7
77
251
RS140, ,
NOMESCO Finland
6.1
18.5
32
53
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
30.3
18.3
24
8
IHZ07, ,
SPAT
6.5
18.3
30
47
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
4.9
18.2
40
83
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.5
18.2
44
99
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
6.0
18.2
32
54
P86
ICPC
Anorexia nervosa/bulimia
6.0
18.2
32
54
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.7
18.1
99
378
R1250, ,
SPAT
2.8
17.9
94
351
OAA68, ,
SPAT
4.0
17.9
51
130
183
Kela drug reimbursment
Lamotrigin and topiramate
4.7
17.9
41
88
Z29
ICPC
Social problem NOS
3.1
17.9
75
247
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
4.0
17.9
50
126
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
7.6
17.8
25
33
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
4.9
17.7
39
81
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
5.5
17.5
34
63
R4120
NOMESCO Finland
Occupational therapy
2.5
17.4
115
482
F22.0
ICD-10 Finland
Delusional disorder
6.6
17.4
28
43
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
17.4
200
3467
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.5
17.3
59
171
F50.0
ICD-10 Finland
Anorexia nervosa
4.1
17.3
47
116
IHZ05, ,
SPAT
2.0
17.2
194
1014
Z02.7
ICD-10 Finland
Issue of medical certificate
2.3
17.1
141
652
Z08
ICPC
Social welfare problem
4.8
17.0
38
80
N06AB08
ATC
fluvoxamine; oral
6.0
16.9
30
51
OAA43, ,
SPAT
2.4
16.8
120
521
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
16.8
214
1167
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
4.5
16.8
41
93
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
16.7
254
1468
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.5
16.6
156
2899
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.2
16.6
68
221
P28
ICPC
Limited function/disability (P)
5.1
16.6
35
70
K03.66
ICD-10 Finland
Tooth plaque
1.9
16.6
216
1187
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
16.4
16.5
26
16
F84.12
ICD-10 Finland
Autism both in atypical age and with atypical symptoms
171.0
16.5
17
*
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.4
16.5
71
1799
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
7.3
16.5
24
33
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
7.3
16.5
24
33
R1250
NOMESCO Finland
Evaluation of functional capability
3.9
16.1
47
122
SPAT1395
SPAT
Health check-up of persons outside student and working life
3.9
16.1
47
122
K59.09
ICD-10 Finland
Constipation, unspecified
2.6
16.1
95
377
Z2221
NOMESCO Finland
Medical doctor
1.7
16.1
390
2576
IEP01
NOMESCO Finland
Psychoeducation, family
4.8
16.1
36
76
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
6.0
16.0
28
47
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.4
15.9
40
93
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
12.3
15.8
28
23
N05CF02
ATC
zolpidem; oral
2.0
15.7
176
917
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
15.6
229
1308
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.2
15.5
141
678
XA820, ,
NOMESCO Finland
6.5
15.3
25
39
SPAT1301
SPAT
No procedures
1.6
15.2
455
3160
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.6
15.1
50
142
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
5.3
15.1
30
57
T05
ICPC
Feeding problem of adult
3.8
15.1
45
119
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.5
15.0
97
403
R4130
NOMESCO Finland
Speech therapy
3.2
15.0
61
198
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
14.9
425
2916
F50.1
ICD-10 Finland
Atypical anorexia nervosa
4.6
14.9
35
77
IGY99, ,
SPAT
2.2
14.8
126
590
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
3.9
14.8
44
116
IBA01, ,
SPAT
2.6
14.8
85
333
N06AX18
ATC
reboxetine; oral
11.4
14.7
27
24
F84.4
ICD-10 Finland
Overactive disorder associated with mental retardation and stereotyped movements
+∞
14.6
14
*
SPAT1260
SPAT
Consultation of another employee
1.8
14.5
250
1498
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.1
14.5
135
656
F80.1
ICD-10 Finland
Expressive language disorder
3.0
14.5
64
218
P79
ICPC
Phobia/compulsive disorder
4.1
14.4
39
96
IHZ04
NOMESCO Finland
Psychosocial counselling and guidance
12.6
14.4
25
20
R53
ICD-10 Finland
Malaise and fatigue
1.6
14.2
384
2596
P22
ICPC
Child behaviour symptom/complaint
2.5
14.0
89
367
X78
ICD-10 Finland
Intentional self-harm by sharp object
4.0
13.8
39
99
N03AF02
ATC
oxcarbazepine; oral
2.7
13.8
75
286
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
5.6
13.8
26
47
IAA01, ,
SPAT
3.5
13.7
47
137
C07AB07
ATC
bisoprolol; oral
1.7
13.6
260
1602
OAB48, ,
SPAT
0.5
13.6
142
2570
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.5
13.6
103
2081
WZC00, ,
SPAT
1.7
13.6
301
1933
F84.2
ICD-10 Finland
Rett syndrome
+∞
13.5
13
*
L28
ICPC
Limited function/disability (L)
2.1
13.5
136
680
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.9
13.5
39
101
F84.1
ICD-10 Finland
Atypical autism
140.6
13.4
14
*
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
18.3
13.3
20
11
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.6
13.2
78
310
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.0
13.2
58
197
N05BA09
ATC
clobazam; oral
3.8
13.1
39
103
N06AA12
ATC
doxepin; systemic
3.8
13.1
39
103
N06AX17
ATC
milnacipran; oral
12.2
13.1
23
19
OAA11, ,
SPAT
0.3
13.1
43
1246
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
4.4
13.0
32
73
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.1
13.0
53
172
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
4.5
13.0
31
69
IEY02
NOMESCO Finland
Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)
5.5
13.0
25
46
F60.1
ICD-10 Finland
Schizoid personality disorder
16.8
13.0
20
12
WZA10, ,
SPAT
2.4
12.9
94
412
F95.9
ICD-10 Finland
Tic disorder, unspecified
6.2
12.9
22
36
C02AC02
ATC
guanfacine; oral
22.6
12.9
18
8
ICB07, ,
NOMESCO Finland
11.6
12.8
23
20
SPAT1197
SPAT
Extensive health check-up of expecting family
0.5
12.8
102
2025
IBC98
NOMESCO Finland
Other child protection assessment
5.8
12.7
23
40
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
12.6
286
1843
SPAT1051
SPAT
Guidance regarding sleep disorders
3.6
12.6
42
120
Z06
ICPC
Unemployment problem
4.0
12.6
35
88
R4140
NOMESCO Finland
Psychotherapy
4.5
12.5
30
67
SPAT1312
SPAT
General health counselling
1.5
12.5
617
4740
2999A
ICD-9 Finland
Psychoses with origin specific to childhood, Unspecified[LAPSUUDEN LAAJA-AL.KEHITYSHÄIR,NUD,TÄYDEL OIREYHTYM]
+∞
12.5
12
*
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
20.1
12.4
18
9
F81.0
ICD-10 Finland
Specific reading disorder
3.3
12.4
46
141
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.3
12.3
99
453
IEP02
NOMESCO Finland
Child-centred family therapy
3.2
12.3
49
157
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
12.2
167
2794
RT150, ,
NOMESCO Finland
4.0
12.1
34
86
P98
ICPC
Psychosis NOS/other
4.4
12.1
30
69
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
12.4
12.1
21
17
OAB95, ,
SPAT
0.4
12.1
49
1286
R4120, ,
SPAT
4.8
12.1
27
57
ICB01, ,
SPAT
3.7
12.1
37
100
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
5.3
12.0
24
46
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
11.9
153
835
N06AA06
ATC
trimipramine; systemic
4.7
11.8
27
58
ZYA02
NOMESCO Finland
Contact at day ward in specialised medical care or in other intensive outpatient care setting
11.8
11.8
21
18
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
11.8
11.8
21
18
A04
ICPC
Weakness/tiredness general
1.6
11.8
311
2081
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.3
11.7
37
1098
N05AL01
ATC
sulpiride; systemic
5.9
11.7
21
36
OAA12, ,
SPAT
0.2
11.7
22
871
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
3.6
11.7
38
107
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.5
11.6
87
1772
N05AE03
ATC
sertindole; oral
12.6
11.6
20
16
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.7
11.6
62
235
P23
ICPC
Adolescent behaviour sympt/compl
3.1
11.5
48
158
Z00.0
ICD-10 Finland
General medical examination
1.6
11.5
331
2258
N05CD07
ATC
temazepam; oral
3.1
11.5
47
153
Z91.5
ICD-10 Finland
Personal history of self-harm
8.6
11.5
24
28
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
5.3
11.5
23
44
T07
ICPC
Weight gain
2.9
11.5
52
180
MA3AE
NOMESCO Finland
Combined first trimester screening
0.3
11.4
36
1065
F50.2
ICD-10 Finland
Bulimia nervosa
4.2
11.3
30
73
N03AX12
ATC
[U] gabapentin; oral
2.0
11.2
126
656
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.1
11.1
103
499
SPAT1379
SPAT
Health check-up of pregnant person
0.5
11.1
92
1809
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.5
11.1
119
2146
ZXY53
NOMESCO Finland
2-person team, doctor-social worker
10.1
11.0
21
21
ZYB05
NOMESCO Finland
Outreach service at patient’s workplace, school or occupational/school health care
10.1
11.0
21
21
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
4.8
10.9
24
50
OAA62, ,
SPAT
0.5
10.8
89
1755
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
10.8
96
458
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.9
10.8
49
170
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.0
10.8
128
680
ICB03, ,
SPAT
5.2
10.7
22
43
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.9
10.7
51
182
A06AD11
ATC
lactulose; oral
2.1
10.7
101
494
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.1
10.6
29
72
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.7
10.6
209
1295
H13
ICPC
Plugged feeling ear
1.7
10.5
192
1165
OAA67, ,
SPAT
0.5
10.5
126
2200
F91.3
ICD-10 Finland
Oppositional defiant disorder
8.5
10.5
22
26
IAB01, ,
SPAT
5.0
10.5
22
44
IEY03
NOMESCO Finland
Vocational rehabilitation
4.7
10.4
24
52
2998A
ICD-9 Finland
Psychoses with origin specific to childhood, Other specified early childhood psychoses[LAPSUUDEN LAAJA-ALAIN KEHITYSHÄIR,TÄYDEL OIREYHTYMÄ]
+∞
10.4
10
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
10.4
717
5809
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.7
10.4
32
87
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.1
10.3
43
142
F64.8
ICD-10 Finland
Other gender identity disorders
18.8
10.2
15
8
Z71.8
ICD-10 Finland
Other specified counselling
1.4
10.2
578
4513
Z10.0
ICD-10 Finland
Occupational health examination
0.4
10.1
65
1407
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
10.1
142
2370
A02BC02
ATC
pantoprazole; systemic
1.4
10.0
629
5000
Z03
ICPC
Housing/neighbourhood problem
8.5
10.0
21
25
R32
ICD-10 Finland
Unspecified urinary incontinence
3.6
9.9
32
90
N05AL05
ATC
amisulpride; oral
12.2
9.8
17
14
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
8.1
9.8
21
26
R02
ICPC
Shortness of breath/dyspnoea
1.8
9.8
160
940
ZXY02
NOMESCO Finland
Neuropsychologist
5.2
9.8
20
39
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
10.7
9.8
18
17
N27
ICPC
Fear of neurological disease other
4.9
9.7
21
43
SPAT1058
SPAT
PEF monitoring instruction
2.1
9.7
97
484
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
3.8
9.7
29
77
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
9.7
121
653
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
4.7
9.7
22
47
H03AA01
ATC
levothyroxine sodium; systemic
1.7
9.6
193
1201
R42
ICD-10 Finland
Dizziness and giddiness
1.7
9.6
202
1273
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
3.9
9.5
27
69
N05AF05
ATC
zuclopenthixol; systemic
8.4
9.5
20
24
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
5.0
9.5
20
40
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
4.8
9.5
21
44
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
9.4
1057
11663
R06.0
ICD-10 Finland
Dyspnoea
1.6
9.4
250
1669
Z72.9
ICD-10 Finland
Problem related to lifestyle, unspecified
30.1
9.4
12
*
F84.3
ICD-10 Finland
Other childhood disintegrative disorder
+∞
9.4
9
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.9
9.3
44
156
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.9
9.3
20
41
F28
ICD-10 Finland
Other nonorganic psychotic disorders
7.3
9.2
21
29
OAA10, ,
SPAT
0.3
9.2
34
932
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
9.1
162
976
F90.8
ICD-10 Finland
Other hyperkinetic disorders
5.0
9.0
19
38
G47.9
ICD-10 Finland
Sleep disorder, unspecified
2.5
9.0
56
229
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
4.8
9.0
20
42
IEY17
NOMESCO Finland
Neuropsychiatric coaching
36.7
9.0
11
*
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
10.1
9.0
17
17
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.5
9.0
91
1679
IBA03
NOMESCO Finland
Psychotherapy evaluation
2.9
8.9
42
149
K59.0
ICD-10 Finland
Constipation
2.1
8.9
79
377
IAB05
NOMESCO Finland
Psychiatric consultation for gender identity assessment
24.0
8.9
12
5
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.5
8.9
63
1314
A29
ICPC
General symptom/complaint other
1.7
8.9
167
1021
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
8.8
75
352
RT490, ,
NOMESCO Finland
6.8
8.8
21
31
R96
ICPC
Asthma
1.9
8.8
121
675
IAA02, ,
SPAT
4.7
8.8
20
43
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
1.8
8.7
141
827
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
8.7
244
1649
OAA65, ,
SPAT
0.6
8.7
200
2955
OAB72, ,
SPAT
2.8
8.7
41
146
F41.00
ICD-10 Finland
Moderate panic disorder
2.6
8.7
47
180
OAB38, ,
SPAT
1.8
8.7
132
760
L17
ICPC
Foot/toe symptom/complaint
1.4
8.7
417
3144
SPAT1262
SPAT
Handing over of treatment supplies
1.8
8.6
130
746
C09CA06
ATC
candesartan; oral
1.7
8.6
177
1108
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
8.6
64
285
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
11.6
8.5
15
13
ZYC01, ,
SPAT
1.5
8.5
264
1822
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
8.5
561
4465
IHZ02, ,
SPAT
2.0
8.5
87
439
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
8.5
117
653
SPAT1053
SPAT
Memory test
4.1
8.5
23
57
A13
ICPC
Concern/fear medical treatment
3.5
8.5
28
80
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
8.5
856
9716
Z61.8
ICD-10 Finland
Other negative life events in childhood
4.2
8.4
22
53
P20
ICPC
Memory disturbance
3.7
8.4
26
71
H52.1
ICD-10 Finland
Myopia
1.9
8.4
100
533
G40.89
ICD-10 Finland
Other epilepsy
6.7
8.3
20
30
F20
ICD-10 Finland
Schizophrenia
4.9
8.3
18
37
IFB02
NOMESCO Finland
Transcranial magnetic stimulation (TMS)
4.9
8.3
18
37
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
4.9
8.3
18
37
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
8.3
1288
11789
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
8.3
287
2027
N02BF01
ATC
gabapentin; oral
2.0
8.3
90
464
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
8.3
69
322
SPAT1216
SPAT
Assessment of functional ability
1.9
8.2
110
608
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
3.1
8.2
33
107
XG466
NOMESCO Finland
Sleep oxymetry
3.8
8.2
24
63
ZXY54
NOMESCO Finland
2-person team, doctor-occupational therapist
14.5
8.2
13
9
R1260
NOMESCO Finland
Evaluation of communicative skills
3.2
8.2
31
97
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.3
8.2
62
278
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
6.5
8.2
20
31
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
7.5
8.1
18
24
D12
ICPC
Constipation
2.5
8.1
48
192
IEY19, ,
SPAT
4.4
8.1
20
46
WZA00, ,
SPAT
2.0
8.1
85
433
T90
ICPC
Diabetes non-insulin dependent
1.9
8.1
108
597
AA1AD
NOMESCO Finland
CT of head and brain
1.6
8.1
187
1206
G03DC03
ATC
lynestrenol; oral
2.8
8.1
38
135
F84
ICD-10 Finland
Pervasive developmental disorders
33.4
8.1
10
*
F45.0
ICD-10 Finland
Somatization disorder
8.1
8.1
17
21
GD1AA, ,
SPAT
0.5
8.0
98
1710
N88
ICPC
Epilepsy
4.0
8.0
22
55
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
4.0
8.0
22
55
F61
ICD-10 Finland
Mixed and other personality disorders
10.0
8.0
15
15
U04
ICPC
Incontinence urine
2.8
8.0
38
136
SPAT1281
SPAT
Other administrative function
1.8
7.9
123
712
R45.8
ICD-10 Finland
Other symptoms and signs involving emotional state
3.5
7.9
26
74
G04BD08
ATC
solifenacin; oral
3.2
7.9
30
94
R63.4
ICD-10 Finland
Abnormal weight loss
2.6
7.9
44
171
P11
ICPC
Eating problem in child
4.0
7.8
22
56
G50.1
ICD-10 Finland
Atypical facial pain
4.0
7.8
22
56
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
4.6
7.8
18
39
N06BA07
ATC
modafinil; oral
4.6
7.8
18
39
SPAT1380
SPAT
Postpartum check-up
0.5
7.8
79
1459
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
8.5
7.8
16
19
IHZ05
NOMESCO Finland
Therapeutic conversation
3.8
7.8
23
61
SPAT1097
SPAT
Recording of ECG
2.0
7.7
85
441
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
15.0
7.7
12
8
N05CD08
ATC
midazolam; nasal, systemic
2.7
7.7
41
156
E66.00
ICD-10 Finland
Metabolic syndrome
2.4
7.7
52
222
SPAT1377
SPAT
Polysomnography
2.9
7.7
34
117
UKC02
NOMESCO Finland
Cystoscopy
2.0
7.7
82
421
H81
ICPC
Excessive ear wax
1.7
7.6
139
842
N03AX14
ATC
levetiracetam; systemic
2.4
7.6
49
204
R4190, ,
SPAT
4.3
7.6
19
44
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.4
7.6
50
1074
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
3.3
7.6
28
86
OAA64, ,
SPAT
0.5
7.6
77
1423
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
7.6
91
486
RL720, ,
NOMESCO Finland
25.0
7.6
10
*
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
11.9
7.6
13
11
R55
ICD-10 Finland
Syncope and collapse
1.8
7.6
105
588
XKD00
NOMESCO Finland
Uroflowmetry
2.0
7.5
80
411
T83
ICPC
Overweight
2.6
7.4
42
165
F34.9
ICD-10 Finland
Persistent mood [affective] disorder, unspecified
4.4
7.4
18
41
F91.9
ICD-10 Finland
Conduct disorder, unspecified
4.4
7.4
18
41
G93.3
ICD-10 Finland
Postviral fatigue syndrome
4.4
7.4
18
41
ZYB01
NOMESCO Finland
Outreach service at unit of same specialty
13.4
7.4
12
9
ZYC03
NOMESCO Finland
Remote contact, text-based
7.7
7.4
16
21
N17
ICPC
Vertigo/dizziness
1.7
7.3
145
899
T08
ICPC
Weight loss
2.5
7.3
45
184
F94.0
ICD-10 Finland
Elective mutism
8.4
7.3
15
18
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
8.4
7.3
15
18
ZXY84
NOMESCO Finland
Occupational therapist in multidisciplinary team
8.4
7.3
15
18
F40.2
ICD-10 Finland
Specific (isolated) phobias
3.1
7.3
30
99
N07BB01
ATC
disulfiram; oral
2.3
7.2
52
228
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
7.2
602
4941
ZXY85
NOMESCO Finland
Other special worker in multidisciplinary team
15.8
7.2
11
7
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.2
7.2
27
84
IFA99, ,
SPAT
4.3
7.2
18
42
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
4.3
7.2
18
42
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
4.3
7.2
18
42
RS214, ,
NOMESCO Finland
4.3
7.2
18
42
H50.30
ICD-10 Finland
Intermittent esotropy
3.0
7.2
30
100
3138X
ICD-9 Finland
Disturbance of emotions specific to childhood and adolescence, Other or mixed emotional disturbances of childhood or adolescence[MUU MÄÄRITTELTY EMOTIONAALISENA OIREENA ILM. HÄIRIÖ]
30.0
7.1
9
*
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
30.0
7.1
9
*
Z00.8
ICD-10 Finland
Other general examinations
1.7
7.1
141
874
Z01.2
ICD-10 Finland
Dental examination
1.3
7.1
874
7586
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
6.6
7.1
17
26
IEV99, ,
SPAT
6.6
7.1
17
26
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.1
7.1
63
302
F44.88
ICD-10 Finland
Other definite dissociation disorder
12.0
7.1
12
10
-1, ,
ICPC
2.5
7.1
41
163
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.7
7.0
130
791
F42
ICD-10 Finland
Obsessive-compulsive disorder
4.1
7.0
19
47
F50.3
ICD-10 Finland
Atypical bulimia nervosa
4.1
7.0
19
47
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
8.8
7.0
14
16
S22
ICPC
Nail symptom/complaint
1.8
7.0
103
587
R11
ICD-10 Finland
Nausea and vomiting
1.6
7.0
163
1053
188
Kela drug reimbursment
Psychosis requiring demanding treatment
7.0
7.0
16
23
3007
Kela drug reimbursment
Erenumab and fremanezumab
2.9
7.0
31
107
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
6.9
87
472
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
6.9
91
501
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
3.0
6.9
30
102
L20
ICPC
Joint symptom/complaint NOS
2.3
6.9
51
227
P73
ICPC
Affective psychosis
7.5
6.9
15
20
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
6.9
230
1610
IFA98, ,
NOMESCO Finland
8.3
6.8
14
17
IER02, ,
SPAT
8.3
6.8
14
17
F23.8
ICD-10 Finland
Other acute and transient psychotic disorders
6.7
6.8
16
24
OAB76, ,
SPAT
2.2
6.8
58
274
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
5.7
6.7
18
32
IEY17, ,
SPAT
22.5
6.7
9
*
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
0.4
6.7
35
820
R44.0
ICD-10 Finland
Auditory hallucinations
5.5
6.6
18
33
R35
ICD-10 Finland
Polyuria
2.1
6.6
57
271
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.2
6.6
55
258
R04
ICPC
Breathing problem other
2.2
6.5
51
232
N03AF01
ATC
carbamazepine; oral, rectal
2.7
6.5
34
128
G04BD12
ATC
mirabegron; oral
2.4
6.5
44
188
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
10.0
6.5
12
12
SPAT1370
SPAT
Other health check-up
2.1
6.5
57
272
K30
ICD-10 Finland
Functional dyspepsia
1.7
6.5
126
777
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.5
6.5
69
1256
R2130, ,
SPAT
1.9
6.5
77
411
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
0.4
6.5
29
726
F20.8
ICD-10 Finland
Other schizophrenia
6.2
6.4
16
26
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
6.2
6.4
16
26
L01
ICPC
Neck symptom/complaint
1.5
6.4
232
1648
N05AF01
ATC
flupentixol; systemic
6.5
6.3
15
23
G43.9
ICD-10 Finland
Migraine, unspecified
1.6
6.3
135
854
MAX99
NOMESCO Finland
Assistance to normal delivery
0.5
6.3
61
1144
R06.5
ICD-10 Finland
Mouth breathing
1.7
6.3
124
768
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
5.2
6.3
18
35
SPAT1153
SPAT
Removal of sutures
1.5
6.3
233
1664
F20.0
ICD-10 Finland
Paranoid schizophrenia
6.0
6.3
16
27
R1430, ,
SPAT
2.1
6.3
54
256
N02CD01
ATC
erenumab; parenteral
3.6
6.3
20
56
S29
ICPC
Skin symptom/complaint other
1.4
6.3
279
2062
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
18.0
6.2
9
5
F95.8
ICD-10 Finland
Other tic disorders
18.0
6.2
9
5
IER06
NOMESCO Finland
Rehabilitative psychiatric group intervention, Social Cognition and Interaction Training (SCIT)
18.0
6.2
9
5
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.5
6.2
21
61
2999B
ICD-9 Finland
Psychoses with origin specific to childhood, Unspecified[LAPSUUDEN LAAJA-ALAINEN KEHITYSHÄIRIÖ NUD,JÄLKITILA]
+∞
6.2
6
*
2990A
ICD-9 Finland
Psychoses with origin specific to childhood, Infantile autism[AUTISMUS INFANTILIS,TÄYDELLINEN OIREYHTYMÄ]
+∞
6.2
6
*
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
3.3
6.2
23
71
F51.2
ICD-10 Finland
Nonorganic disorder of the sleep-wake schedule
3.3
6.2
23
71
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
7.0
6.2
14
20
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.6
6.2
156
1027
F45.8
ICD-10 Finland
Other somatoform disorders
1.6
6.2
126
788
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.6
6.2
139
891
L68.0
ICD-10 Finland
Hirsutism
3.7
6.2
19
52
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
5.3
6.1
17
32
P80
ICPC
Personality disorder
4.0
6.1
17
43
R4170
NOMESCO Finland
Therapy forms involving educational rehabilitation
7.7
6.1
13
17
R40.0
ICD-10 Finland
Somnolence
7.7
6.1
13
17
W90
ICPC
Uncompl labour/delivery livebirth
0.4
6.1
34
777
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.4
6.1
38
157
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
6.1
231
1658
K08.3
ICD-10 Finland
Retained dental root
2.0
6.0
59
294
IFA37
NOMESCO Finland
Ketamine treatment
6.7
6.0
14
21
S51.7
ICD-10 Finland
Multiple open wounds of forearm
3.6
6.0
19
53

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Psychiatry
26 [38004469]
1.9e+00
2.7e+00
2.9e+00
7.1e+00
3.1e+00
3.1e+00
2.4e+00
cases:36.27%
controls:7.86%
cases:41.47%
controls:4.45%
cases:25.81%
controls:1.85%
cases:56.18%
controls:0.10%
cases:29.72%
controls:1.92%
cases:49.06%
controls:4.35%
cases:48.52%
controls:8.00%
535
1143
940
13408
617
653
871
14018
384
271
1104
14400
836
15
652
14656
442
281
1045
14347
703
615
730
13526
541
885
574
10178
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
1.6e+00
2.5e+00
2.9e+00
6.2e+00
3.1e+00
2.8e+00
2.5e+00
cases:19.12%
controls:4.47%
cases:20.50%
controls:2.06%
cases:13.64%
controls:0.90%
cases:21.64%
controls:0.05%
cases:16.27%
controls:0.87%
cases:25.54%
controls:1.97%
cases:30.22%
controls:3.56%
282
650
1193
13901
305
302
1183
14369
203
132
1285
14539
322
8
1166
14663
242
127
1245
14501
366
279
1067
13862
337
394
778
10669
Other disorders of psychological development
F88 [45538087]
2.8e+00
3.0e+00
3.5e+00
1.0e+50
3.0e+00
2.6e+00
2.4e+00
cases:1.97%
controls:0.12%
cases:2.42%
controls:0.12%
cases:1.61%
controls:0.05%
cases:0.74%
controls:0.00%
cases:0.67%
controls:0.03%
cases:1.12%
controls:0.08%
cases:1.17%
controls:0.11%
29
17
1446
14534
36
18
1452
14653
24
7
1464
14664
11
0
1477
14671
10
5
1477
14623
16
12
1417
14129
13
12
1102
11051
Unspecified nonorganic psychosis
F29 [45533099]
1.5e+00
1.8e+00
1.8e+00
4.3e+00
2.2e+00
2.3e+00
2.5e+00
cases:4.14%
controls:0.97%
cases:3.29%
controls:0.55%
cases:1.61%
controls:0.26%
cases:2.55%
controls:0.03%
cases:1.82%
controls:0.21%
cases:4.68%
controls:0.49%
cases:8.88%
controls:0.77%
61
141
1414
14410
49
81
1439
14590
24
38
1464
14633
38
5
1450
14666
27
31
1460
14597
67
69
1366
14072
99
85
1016
10978
Disturbance of activity and attention
F90.0 [45542870]
1.9e+00
2.5e+00
3.0e+00
—
3.5e+00
3.0e+00
2.4e+00
cases:11.46%
controls:1.84%
cases:17.27%
controls:1.62%
cases:9.48%
controls:0.52%
—
—
cases:15.00%
controls:0.53%
cases:27.98%
controls:1.83%
cases:27.53%
controls:3.18%
169
268
1306
14283
257
238
1231
14433
141
76
1347
14595
—
223
77
1264
14551
401
259
1032
13882
307
352
808
10711
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
2.4e+00
2.6e+00
2.8e+00
1.0e+50
2.9e+00
2.9e+00
2.6e+00
cases:6.10%
controls:0.61%
cases:4.70%
controls:0.38%
cases:1.88%
controls:0.12%
cases:3.09%
controls:0.00%
cases:2.42%
controls:0.13%
cases:5.23%
controls:0.29%
cases:7.17%
controls:0.60%
90
89
1385
14462
70
56
1418
14615
28
17
1460
14654
46
0
1442
14671
36
19
1451
14609
75
41
1358
14100
80
66
1035
10997
lisdexamfetamine; oral
N06BA12 [40252237]
2.0e+00
2.5e+00
2.7e+00
—
2.9e+00
3.0e+00
2.7e+00
cases:2.85%
controls:0.41%
cases:4.23%
controls:0.35%
cases:2.28%
controls:0.16%
—
—
cases:3.03%
controls:0.17%
cases:7.75%
controls:0.41%
cases:8.43%
controls:0.64%
42
59
1433
14492
63
52
1425
14619
34
23
1454
14648
—
45
25
1442
14603
111
58
1322
14083
94
71
1021
10992
Recurrent depressive disorder, unspecified
F33.9 [45581458]
2.2e+00
2.7e+00
2.8e+00
1.0e+50
3.2e+00
2.6e+00
2.0e+00
cases:5.08%
controls:0.57%
cases:3.90%
controls:0.26%
cases:1.28%
controls:0.07%
cases:1.75%
controls:0.00%
cases:1.21%
controls:0.05%
cases:3.91%
controls:0.30%
cases:5.38%
controls:0.79%
75
83
1400
14468
58
38
1430
14633
19
11
1469
14660
26
0
1462
14671
18
7
1469
14621
56
42
1377
14099
60
87
1055
10976
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
1.8e+00
2.7e+00
3.7e+00
1.0e+50
2.9e+00
2.4e+00
2.1e+00
cases:4.07%
controls:0.70%
cases:4.91%
controls:0.35%
cases:1.81%
controls:0.05%
cases:0.54%
controls:0.00%
cases:1.01%
controls:0.05%
cases:3.77%
controls:0.36%
cases:6.73%
controls:0.87%
60
102
1415
14449
73
51
1415
14620
27
7
1461
14664
8
0
1480
14671
15
8
1472
14620
54
51
1379
14090
75
96
1040
10967
Evaluation concerning developmental neuropsychiatry
IBZ06 [2001304080]
1.7e+00
3.7e+00
4.1e+00
1.0e+50
—
3.2e+00
2.6e+00
cases:1.15%
controls:0.21%
cases:4.77%
controls:0.12%
cases:1.95%
controls:0.03%
cases:2.62%
controls:0.00%
—
—
cases:2.65%
controls:0.11%
cases:1.61%
controls:0.13%
17
31
1458
14520
71
18
1417
14653
29
5
1459
14666
39
0
1449
14671
—
38
15
1395
14126
18
14
1097
11049
Dysthymia
F34.1 [45586238]
2.4e+00
2.6e+00
2.8e+00
1.0e+50
2.6e+00
2.7e+00
2.1e+00
cases:4.07%
controls:0.37%
cases:2.55%
controls:0.19%
cases:0.67%
controls:0.04%
cases:1.14%
controls:0.00%
cases:0.74%
controls:0.05%
cases:2.79%
controls:0.20%
cases:3.41%
controls:0.43%
60
54
1415
14497
38
28
1450
14643
10
6
1478
14665
17
0
1471
14671
11
8
1476
14620
40
28
1393
14113
38
48
1077
11015
Psychiatric family contact
IGP01 [2001304317]
1.7e+00
2.3e+00
3.2e+00
1.0e+50
3.2e+00
2.4e+00
2.2e+00
cases:3.12%
controls:0.60%
cases:3.43%
controls:0.34%
cases:1.28%
controls:0.05%
cases:0.34%
controls:0.00%
cases:1.01%
controls:0.04%
cases:3.07%
controls:0.30%
cases:4.30%
controls:0.52%
46
87
1429
14464
51
50
1437
14621
19
8
1469
14663
5
0
1483
14671
15
6
1472
14622
44
42
1389
14099
48
57
1067
11006
Other childhood emotional disorders
F93.89 [2000502046]
1.9e+00
2.6e+00
2.5e+00
—
2.8e+00
2.5e+00
2.4e+00
cases:2.51%
controls:0.38%
cases:2.76%
controls:0.20%
cases:1.14%
controls:0.10%
—
—
cases:1.48%
controls:0.09%
cases:2.79%
controls:0.23%
cases:4.22%
controls:0.39%
37
55
1438
14496
41
30
1447
14641
17
14
1471
14657
—
22
13
1465
14615
40
32
1393
14109
47
43
1068
11020
Social worker
Z2446 [2001311559]
1.1e+00
2.0e+00
2.5e+00
1.0e+50
3.3e+00
2.9e+00
2.7e+00
cases:6.10%
controls:2.12%
cases:3.09%
controls:0.44%
cases:0.67%
controls:0.05%
cases:1.08%
controls:0.00%
cases:1.82%
controls:0.07%
cases:3.98%
controls:0.22%
cases:6.64%
controls:0.48%
90
309
1385
14242
46
64
1442
14607
10
8
1478
14663
16
0
1472
14671
27
10
1460
14618
57
31
1376
14110
74
53
1041
11010
methylphenidate; oral
N06BA04 [21604757]
2.0e+00
2.4e+00
2.4e+00
—
2.8e+00
2.6e+00
2.2e+00
cases:11.66%
controls:1.77%
cases:13.10%
controls:1.40%
cases:5.78%
controls:0.55%
—
—
cases:8.81%
controls:0.60%
cases:18.42%
controls:1.58%
cases:20.36%
controls:2.73%
172
258
1303
14293
195
205
1293
14466
86
80
1402
14591
—
131
88
1356
14540
264
224
1169
13917
227
302
888
10761
risperidone; oral, parenteral
N05AX08 [21604559]
1.9e+00
2.2e+00
2.4e+00
—
2.4e+00
2.8e+00
2.6e+00
cases:6.10%
controls:0.99%
cases:4.23%
controls:0.47%
cases:1.55%
controls:0.14%
—
—
cases:1.75%
controls:0.16%
cases:6.84%
controls:0.44%
cases:12.65%
controls:1.02%
90
144
1385
14407
63
69
1425
14602
23
20
1465
14651
—
26
24
1461
14604
98
62
1335
14079
141
113
974
10950
Psychologist
Z2445 [2001311558]
1.4e+00
2.2e+00
3.1e+00
1.0e+50
2.5e+00
2.4e+00
2.7e+00
cases:6.17%
controls:1.55%
cases:3.83%
controls:0.46%
cases:2.02%
controls:0.10%
cases:1.28%
controls:0.00%
cases:1.55%
controls:0.12%
cases:3.49%
controls:0.31%
cases:6.82%
controls:0.48%
91
226
1384
14325
57
67
1431
14604
30
14
1458
14657
19
0
1469
14671
23
18
1464
14610
50
44
1383
14097
76
53
1039
11010
Social phobias
F40.1 [45595907]
2.2e+00
2.4e+00
2.8e+00
—
2.8e+00
2.2e+00
2.0e+00
cases:5.36%
controls:0.63%
cases:3.97%
controls:0.37%
cases:2.15%
controls:0.14%
—
—
cases:2.15%
controls:0.14%
cases:3.84%
controls:0.44%
cases:5.20%
controls:0.73%
79
91
1396
14460
59
55
1429
14616
32
20
1456
14651
—
32
20
1455
14608
55
62
1378
14079
58
81
1057
10982
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
331 [2001600292]
2.0e+00
3.0e+00
1.0e+50
—
3.1e+00
3.8e+00
2.4e+00
cases:2.78%
controls:0.39%
cases:2.35%
controls:0.12%
cases:0.34%
controls:0.00%
—
—
cases:0.74%
controls:0.03%
cases:4.05%
controls:0.09%
cases:4.57%
controls:0.45%
41
57
1434
14494
35
17
1453
14654
5
0
1483
14671
—
11
5
1476
14623
58
13
1375
14128
51
50
1064
11013
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
2.1e+00
2.4e+00
2.5e+00
—
2.5e+00
2.5e+00
2.3e+00
cases:6.17%
controls:0.83%
cases:5.85%
controls:0.55%
cases:2.55%
controls:0.21%
—
—
cases:2.49%
controls:0.21%
cases:6.63%
controls:0.58%
cases:7.98%
controls:0.88%
91
121
1384
14430
87
81
1401
14590
38
31
1450
14640
—
37
31
1450
14597
95
82
1338
14059
89
97
1026
10966
Predominantly compulsive acts [obsessional rituals]
F42.1 [45591138]
2.4e+00
3.4e+00
2.9e+00
—
—
3.2e+00
2.4e+00
cases:1.02%
controls:0.10%
cases:1.34%
controls:0.05%
cases:0.60%
controls:0.03%
—
—
—
—
cases:1.47%
controls:0.06%
cases:1.52%
controls:0.14%
15
14
1460
14537
20
7
1468
14664
9
5
1479
14666
—
—
21
9
1412
14132
17
16
1098
11047
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
2.0e+00
2.5e+00
2.6e+00
—
2.5e+00
2.5e+00
1.8e+00
cases:7.86%
controls:1.13%
cases:5.44%
controls:0.49%
cases:2.89%
controls:0.22%
—
—
cases:2.22%
controls:0.19%
cases:5.44%
controls:0.48%
cases:6.73%
controls:1.14%
116
165
1359
14386
81
72
1407
14599
43
33
1445
14638
—
33
28
1454
14600
78
68
1355
14073
75
126
1040
10937
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
1.6e+00
2.7e+00
3.4e+00
—
2.3e+00
2.0e+00
1.3e+00
cases:13.08%
controls:3.09%
cases:13.78%
controls:1.10%
cases:5.91%
controls:0.22%
—
—
cases:2.82%
controls:0.29%
cases:8.03%
controls:1.13%
cases:10.31%
controls:2.91%
193
449
1282
14102
205
162
1283
14509
88
32
1400
14639
—
42
42
1445
14586
115
160
1318
13981
115
322
1000
10741
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
1.2e+00
2.1e+00
2.9e+00
1.0e+50
2.0e+00
2.3e+00
2.6e+00
cases:4.47%
controls:1.33%
cases:3.36%
controls:0.42%
cases:0.87%
controls:0.05%
cases:0.87%
controls:0.00%
cases:0.67%
controls:0.09%
cases:2.44%
controls:0.26%
cases:4.75%
controls:0.35%
66
194
1409
14357
50
62
1438
14609
13
7
1475
14664
13
0
1475
14671
10
13
1477
14615
35
37
1398
14104
53
39
1062
11024
Mixed obsessional thoughts and acts
F42.2 [45542850]
1.9e+00
2.1e+00
1.9e+00
—
2.7e+00
2.4e+00
2.3e+00
cases:1.36%
controls:0.21%
cases:1.48%
controls:0.18%
cases:0.60%
controls:0.10%
—
—
cases:1.01%
controls:0.07%
cases:2.02%
controls:0.19%
cases:2.69%
controls:0.28%
20
31
1455
14520
22
27
1466
14644
9
14
1479
14657
—
15
10
1472
14618
29
27
1404
14114
30
31
1085
11032
Diagnostic and symptom-mapping evaluation
IBA01 [2001304043]
1.4e+00
2.7e+00
3.5e+00
—
2.2e+00
1.7e+00
1.5e+00
cases:3.05%
controls:0.76%
cases:3.83%
controls:0.28%
cases:1.34%
controls:0.04%
—
—
cases:0.47%
controls:0.05%
cases:1.40%
controls:0.25%
cases:2.87%
controls:0.66%
45
111
1430
14440
57
41
1431
14630
20
6
1468
14665
—
7
8
1480
14620
20
35
1413
14106
32
73
1083
10990
Recurrent depressive disorder, currently in remission
F33.4 [45533100]
1.6e+00
2.0e+00
2.8e+00
1.0e+50
2.5e+00
2.3e+00
1.6e+00
cases:2.10%
controls:0.43%
cases:1.34%
controls:0.19%
cases:0.87%
controls:0.05%
cases:1.61%
controls:0.00%
cases:0.74%
controls:0.06%
cases:2.30%
controls:0.23%
cases:2.87%
controls:0.59%
31
62
1444
14489
20
28
1468
14643
13
8
1475
14663
24
0
1464
14671
11
9
1476
14619
33
33
1400
14108
32
65
1083
10998
atomoxetine; oral
N06BA09 [21604762]
1.8e+00
2.3e+00
2.0e+00
—
2.7e+00
2.9e+00
2.9e+00
cases:1.22%
controls:0.21%
cases:1.41%
controls:0.14%
cases:0.34%
controls:0.05%
—
—
cases:0.61%
controls:0.04%
cases:2.16%
controls:0.12%
cases:3.50%
controls:0.20%
18
31
1457
14520
21
20
1467
14651
5
7
1483
14664
—
9
6
1478
14622
31
17
1402
14124
39
22
1076
11041
Remote contact by phone
ZYC01 [2001311579]
1.6e+00
2.0e+00
2.4e+00
—
2.3e+00
2.1e+00
2.0e+00
cases:4.27%
controls:0.90%
cases:2.89%
controls:0.39%
cases:0.94%
controls:0.09%
—
—
cases:0.74%
controls:0.08%
cases:3.49%
controls:0.46%
cases:5.38%
controls:0.77%
63
131
1412
14420
43
57
1445
14614
14
13
1474
14658
—
11
11
1476
14617
50
65
1383
14076
60
85
1055
10978
bupropion; oral
N06AX12 [21604741]
2.1e+00
2.2e+00
1.8e+00
1.0e+50
2.2e+00
2.1e+00
1.9e+00
cases:10.10%
controls:1.36%
cases:7.26%
controls:0.85%
cases:1.75%
controls:0.29%
cases:0.47%
controls:0.00%
cases:2.22%
controls:0.24%
cases:7.68%
controls:1.03%
cases:10.49%
controls:1.80%
149
198
1326
14353
108
125
1380
14546
26
43
1462
14628
7
0
1481
14671
33
35
1454
14593
110
145
1323
13996
117
199
998
10864
Anorexia nervosa
F50.0 [45562053]
1.6e+00
2.3e+00
1.8e+00
1.0e+50
2.3e+00
2.3e+00
1.8e+00
cases:1.02%
controls:0.20%
cases:0.87%
controls:0.09%
cases:0.47%
controls:0.07%
cases:0.34%
controls:0.00%
cases:0.54%
controls:0.05%
cases:0.84%
controls:0.08%
cases:0.90%
controls:0.14%
15
29
1460
14522
13
13
1475
14658
7
11
1481
14660
5
0
1483
14671
8
8
1479
14620
12
12
1421
14129
10
16
1105
11047
Hospital outpatient
ZY010 [2001311599]
1.3e+00
2.0e+00
2.3e+00
—
1.6e+00
2.4e+00
2.6e+00
cases:6.58%
controls:1.97%
cases:4.84%
controls:0.65%
cases:2.22%
controls:0.23%
—
—
cases:1.41%
controls:0.28%
cases:5.23%
controls:0.49%
cases:8.79%
controls:0.74%
97
287
1378
14264
72
96
1416
14575
33
34
1455
14637
—
21
41
1466
14587
75
69
1358
14072
98
82
1017
10981
fluoxetine; oral
N06AB03 [21604711]
1.8e+00
2.0e+00
2.0e+00
—
2.5e+00
1.9e+00
1.9e+00
cases:8.07%
controls:1.39%
cases:4.77%
controls:0.70%
cases:1.68%
controls:0.24%
—
—
cases:2.02%
controls:0.17%
cases:5.02%
controls:0.76%
cases:8.16%
controls:1.36%
119
202
1356
14349
71
102
1417
14569
25
35
1463
14636
—
30
25
1457
14603
72
107
1361
14034
91
151
1024
10912
Other psychiatric treatment contact
IGY99 [2001304323]
1.5e+00
1.9e+00
2.4e+00
—
2.2e+00
2.2e+00
1.9e+00
cases:4.07%
controls:0.96%
cases:3.49%
controls:0.53%
cases:1.21%
controls:0.12%
—
—
cases:1.14%
controls:0.13%
cases:3.84%
controls:0.44%
cases:5.38%
controls:0.86%
60
139
1415
14412
52
78
1436
14593
18
17
1470
14654
—
17
19
1470
14609
55
62
1378
14079
60
95
1055
10968
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.6e+00
2.0e+00
2.4e+00
—
2.5e+00
2.1e+00
1.4e+00
cases:7.32%
controls:1.57%
cases:5.78%
controls:0.81%
cases:3.16%
controls:0.29%
—
—
cases:3.50%
controls:0.30%
cases:6.63%
controls:0.83%
cases:7.26%
controls:1.94%
108
229
1367
14322
86
119
1402
14552
47
43
1441
14628
—
52
44
1435
14584
95
118
1338
14023
81
215
1034
10848
Psychiatric network contact
IGV01 [2001304319]
2.3e+00
2.4e+00
2.6e+00
—
—
2.7e+00
2.0e+00
cases:2.64%
controls:0.26%
cases:2.02%
controls:0.19%
cases:0.47%
controls:0.03%
—
—
—
—
cases:2.72%
controls:0.19%
cases:3.86%
controls:0.56%
39
38
1436
14513
30
28
1458
14643
7
5
1481
14666
—
—
39
27
1394
14114
43
62
1072
11001
Unspecified disorder of psychological development
F89 [45557220]
2.7e+00
3.5e+00
—
1.0e+50
—
2.7e+00
3.0e+00
cases:1.15%
controls:0.08%
cases:1.61%
controls:0.05%
—
—
cases:0.47%
controls:0.00%
—
—
cases:0.63%
controls:0.04%
cases:1.08%
controls:0.05%
17
11
1458
14540
24
7
1464
14664
—
7
0
1481
14671
—
9
6
1424
14135
12
6
1103
11057
agomelatine; oral
N06AX22 [21604750]
1.9e+00
1.8e+00
2.0e+00
—
2.5e+00
1.8e+00
1.9e+00
cases:2.64%
controls:0.39%
cases:1.28%
controls:0.22%
cases:0.47%
controls:0.06%
—
—
cases:0.67%
controls:0.05%
cases:1.33%
controls:0.23%
cases:2.60%
controls:0.39%
39
57
1436
14494
19
32
1469
14639
7
9
1481
14662
—
10
8
1477
14620
19
32
1414
14109
29
43
1086
11020
Gender identity disorder, unspecified
F64.9 [45542862]
2.2e+00
2.7e+00
—
1.0e+50
—
3.6e+00
3.6e+00
cases:1.02%
controls:0.12%
cases:0.67%
controls:0.05%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.26%
controls:0.04%
cases:2.78%
controls:0.08%
15
17
1460
14534
10
7
1478
14664
—
5
0
1483
14671
—
18
5
1415
14136
31
9
1084
11054
Generalized anxiety disorder
F41.1 [45571764]
1.6e+00
1.9e+00
2.6e+00
—
2.5e+00
1.8e+00
1.4e+00
cases:6.58%
controls:1.35%
cases:5.24%
controls:0.81%
cases:2.69%
controls:0.20%
—
—
cases:2.69%
controls:0.23%
cases:4.95%
controls:0.85%
cases:6.55%
controls:1.71%
97
197
1378
14354
78
119
1410
14552
40
29
1448
14642
—
40
33
1447
14595
71
120
1362
14021
73
189
1042
10874
Accelerated psychiatric treatment contact
IGY01 [2001304321]
1.3e+00
1.9e+00
2.3e+00
—
2.1e+00
2.2e+00
1.9e+00
cases:2.85%
controls:0.76%
cases:2.62%
controls:0.41%
cases:0.74%
controls:0.07%
—
—
cases:0.74%
controls:0.09%
cases:4.12%
controls:0.46%
cases:5.83%
controls:0.94%
42
110
1433
14441
39
60
1449
14611
11
11
1477
14660
—
11
13
1476
14615
59
65
1374
14076
65
104
1050
10959
Anxious [avoidant] personality disorder
F60.6 [45557213]
2.7e+00
3.1e+00
—
1.0e+50
—
2.9e+00
3.1e+00
cases:1.22%
controls:0.08%
cases:1.14%
controls:0.05%
—
—
cases:0.74%
controls:0.00%
—
—
cases:0.91%
controls:0.05%
cases:1.52%
controls:0.07%
18
12
1457
14539
17
8
1471
14663
—
11
0
1477
14671
—
13
7
1420
14134
17
8
1098
11055
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
F98.8 [45605524]
1.7e+00
2.5e+00
2.0e+00
1.0e+50
2.5e+00
2.4e+00
2.5e+00
cases:0.95%
controls:0.18%
cases:1.01%
controls:0.08%
cases:0.34%
controls:0.05%
cases:0.67%
controls:0.00%
cases:0.74%
controls:0.06%
cases:1.12%
controls:0.10%
cases:1.70%
controls:0.14%
14
26
1461
14525
15
12
1473
14659
5
7
1483
14664
10
0
1478
14671
11
9
1476
14619
16
14
1417
14127
19
15
1096
11048
Depressive episode, unspecified
F32.9 [45571760]
1.7e+00
2.1e+00
2.4e+00
—
2.0e+00
1.8e+00
1.5e+00
cases:12.14%
controls:2.58%
cases:8.00%
controls:1.05%
cases:2.62%
controls:0.25%
—
—
cases:2.15%
controls:0.31%
cases:6.14%
controls:1.07%
cases:11.48%
controls:2.69%
179
375
1296
14176
119
154
1369
14517
39
36
1449
14635
—
32
45
1455
14583
88
151
1345
13990
128
298
987
10765
Mixed personality disorders
F61.0 [2000502024]
2.6e+00
2.8e+00
—
—
—
2.9e+00
2.8e+00
cases:2.44%
controls:0.19%
cases:1.61%
controls:0.10%
—
—
—
—
—
—
cases:1.95%
controls:0.11%
cases:2.87%
controls:0.17%
36
28
1439
14523
24
14
1464
14657
—
—
—
28
15
1405
14126
32
19
1083
11044
duloxetine; oral
N06AX21 [21604749]
1.6e+00
1.6e+00
2.3e+00
—
2.1e+00
1.8e+00
1.8e+00
cases:5.42%
controls:1.13%
cases:2.96%
controls:0.63%
cases:1.41%
controls:0.15%
—
—
cases:1.48%
controls:0.19%
cases:3.42%
controls:0.57%
cases:5.02%
controls:0.87%
80
164
1395
14387
44
93
1444
14578
21
22
1467
14649
—
22
28
1465
14600
49
81
1384
14060
56
96
1059
10967
Obsessive-compulsive disorder, unspecified
F42.9 [45600745]
2.3e+00
2.9e+00
—
1.0e+50
—
3.6e+00
2.3e+00
cases:0.81%
controls:0.08%
cases:0.87%
controls:0.05%
—
—
cases:0.47%
controls:0.00%
—
—
cases:1.26%
controls:0.04%
cases:0.99%
controls:0.10%
12
12
1463
14539
13
7
1475
14664
—
7
0
1481
14671
—
18
5
1415
14136
11
11
1104
11052
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
1.3e+00
1.6e+00
2.3e+00
—
2.0e+00
2.0e+00
1.9e+00
cases:4.14%
controls:1.21%
cases:4.30%
controls:0.89%
cases:2.49%
controls:0.27%
—
—
cases:2.02%
controls:0.28%
cases:5.51%
controls:0.75%
cases:7.89%
controls:1.32%
61
176
1414
14375
64
130
1424
14541
37
39
1451
14632
—
30
41
1457
14587
79
106
1354
14035
88
146
1027
10917
Specific developmental disorder of motor function
F82 [45605516]
1.6e+00
1.9e+00
2.0e+00
1.0e+50
2.2e+00
1.6e+00
1.7e+00
cases:1.76%
controls:0.37%
cases:1.48%
controls:0.22%
cases:0.47%
controls:0.06%
cases:0.54%
controls:0.00%
cases:0.47%
controls:0.05%
cases:1.12%
controls:0.22%
cases:1.88%
controls:0.35%
26
54
1449
14497
22
32
1466
14639
7
9
1481
14662
8
0
1480
14671
7
8
1480
14620
16
31
1417
14110
21
39
1094
11024
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
1.7e+00
1.8e+00
1.7e+00
—
2.0e+00
1.8e+00
1.9e+00
cases:2.64%
controls:0.52%
cases:1.95%
controls:0.33%
cases:0.87%
controls:0.16%
—
—
cases:1.08%
controls:0.14%
cases:2.23%
controls:0.36%
cases:3.23%
controls:0.51%
39
75
1436
14476
29
48
1459
14623
13
23
1475
14648
—
16
21
1471
14607
32
51
1401
14090
36
56
1079
11007
Anxiety disorder, unspecified
F41.9 [45542849]
1.4e+00
1.8e+00
2.5e+00
—
2.4e+00
1.5e+00
1.3e+00
cases:10.98%
controls:2.85%
cases:8.94%
controls:1.55%
cases:3.23%
controls:0.28%
—
—
cases:2.96%
controls:0.29%
cases:6.84%
controls:1.57%
cases:11.57%
controls:3.46%
162
415
1313
14136
133
227
1355
14444
48
41
1440
14630
—
44
42
1443
14586
98
222
1335
13919
129
383
986
10680
alprazolam; oral
N05BA12 [21604577]
1.8e+00
2.0e+00
2.2e+00
—
1.8e+00
1.8e+00
1.2e+00
cases:2.37%
controls:0.42%
cases:1.41%
controls:0.18%
cases:0.54%
controls:0.06%
—
—
cases:0.47%
controls:0.08%
cases:1.47%
controls:0.24%
cases:2.06%
controls:0.61%
35
61
1440
14490
21
27
1467
14644
8
9
1480
14662
—
7
11
1480
14617
21
34
1412
14107
23
67
1092
10996
Mixed specific developmental disorders
F83 [45595922]
9.9e-01
1.7e+00
2.4e+00
1.0e+50
2.2e+00
1.8e+00
1.7e+00
cases:2.85%
controls:1.07%
cases:2.55%
controls:0.46%
cases:1.14%
controls:0.10%
cases:1.41%
controls:0.00%
cases:1.21%
controls:0.13%
cases:2.86%
controls:0.50%
cases:4.39%
controls:0.84%
42
156
1433
14395
38
68
1450
14603
17
15
1471
14656
21
0
1467
14671
18
19
1469
14609
41
70
1392
14071
49
93
1066
10970
Transsexualism
F64.0 [45542861]
2.2e+00
2.3e+00
—
1.0e+50
—
2.8e+00
3.5e+00
cases:0.75%
controls:0.08%
cases:0.60%
controls:0.06%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.91%
controls:0.06%
cases:2.06%
controls:0.06%
11
12
1464
14539
9
9
1479
14662
—
6
0
1482
14671
—
13
8
1420
14133
23
7
1092
11056
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
1.0e+00
1.5e+00
1.8e+00
1.0e+50
1.6e+00
2.3e+00
2.4e+00
cases:6.44%
controls:2.37%
cases:2.96%
controls:0.66%
cases:0.87%
controls:0.14%
cases:1.21%
controls:0.00%
cases:0.87%
controls:0.17%
cases:4.19%
controls:0.44%
cases:6.37%
controls:0.60%
95
345
1380
14206
44
97
1444
14574
13
21
1475
14650
18
0
1470
14671
13
25
1474
14603
60
62
1373
14079
71
66
1044
10997
Psychiatric pharmacotherapy plan, not specified
IFA01 [2001304251]
1.2e+00
2.0e+00
—
1.0e+50
3.1e+00
2.7e+00
1.6e+00
cases:1.97%
controls:0.58%
cases:2.08%
controls:0.29%
—
—
cases:0.34%
controls:0.00%
cases:0.94%
controls:0.04%
cases:3.42%
controls:0.23%
cases:2.96%
controls:0.64%
29
85
1446
14466
31
42
1457
14629
—
5
0
1483
14671
14
6
1473
14622
49
32
1384
14109
33
71
1082
10992
Mixed disorder of conduct and emotions, unspecified
F92.9 [45586263]
2.4e+00
3.2e+00
—
—
—
2.3e+00
2.7e+00
cases:1.15%
controls:0.11%
cases:1.34%
controls:0.05%
—
—
—
—
—
—
cases:0.70%
controls:0.07%
cases:1.52%
controls:0.10%
17
16
1458
14535
20
8
1468
14663
—
—
—
10
10
1423
14131
17
11
1098
11052
Psychiatric treatment plan, standard
ICB01 [2001304098]
1.3e+00
1.9e+00
1.8e+00
1.0e+50
2.0e+00
2.0e+00
1.6e+00
cases:4.07%
controls:1.20%
cases:4.17%
controls:0.65%
cases:0.47%
controls:0.07%
cases:2.69%
controls:0.00%
cases:0.54%
controls:0.08%
cases:5.09%
controls:0.76%
cases:6.64%
controls:1.36%
60
174
1415
14377
62
95
1426
14576
7
11
1481
14660
40
0
1448
14671
8
11
1479
14617
73
107
1360
14034
74
150
1041
10913
Observation for suspected mental and behavioural disorders
Z03.2 [45552060]
1.7e+00
4.1e+00
1.0e+50
1.0e+50
—
2.6e+00
2.1e+00
cases:2.31%
controls:0.42%
cases:4.97%
controls:0.09%
cases:2.49%
controls:0.00%
cases:1.14%
controls:0.00%
—
—
cases:1.81%
controls:0.13%
cases:1.79%
controls:0.22%
34
61
1441
14490
74
13
1414
14658
37
0
1451
14671
17
0
1471
14671
—
26
19
1407
14122
20
24
1095
11039
Physiotherapist
Z3226 [2001311560]
5.6e-01
1.3e+00
1.7e+00
1.0e+50
3.0e+00
2.1e+00
2.0e+00
cases:5.02%
controls:2.93%
cases:2.69%
controls:0.74%
cases:0.60%
controls:0.12%
cases:0.94%
controls:0.00%
cases:1.55%
controls:0.08%
cases:3.42%
controls:0.43%
cases:6.37%
controls:0.96%
74
427
1401
14124
40
108
1448
14563
9
17
1479
14654
14
0
1474
14671
23
12
1464
14616
49
61
1384
14080
71
106
1044
10957
Combined vocal and multiple motor tic disorder [de la Tourette]
F95.2 [45571782]
1.8e+00
2.1e+00
—
—
—
2.6e+00
3.9e+00
cases:0.47%
controls:0.08%
cases:0.54%
controls:0.07%
—
—
—
—
—
—
cases:1.05%
controls:0.08%
cases:2.24%
controls:0.05%
7
11
1468
14540
8
10
1480
14661
—
—
—
15
11
1418
14130
25
5
1090
11058
Focused parental counselling
IEP03 [2001304195]
1.8e+00
2.6e+00
—
—
2.3e+00
1.8e+00
1.9e+00
cases:1.90%
controls:0.31%
cases:1.28%
controls:0.10%
—
—
—
—
cases:0.40%
controls:0.04%
cases:0.98%
controls:0.17%
cases:1.70%
controls:0.27%
28
45
1447
14506
19
14
1469
14657
—
—
6
6
1481
14622
14
24
1419
14117
19
30
1096
11033
Other specified anxiety disorders
F41.8 [45595908]
1.7e+00
1.9e+00
1.8e+00
1.0e+50
1.7e+00
1.8e+00
1.4e+00
cases:3.05%
controls:0.56%
cases:2.15%
controls:0.33%
cases:0.67%
controls:0.11%
cases:1.14%
controls:0.00%
cases:0.54%
controls:0.10%
cases:2.16%
controls:0.35%
cases:2.69%
controls:0.67%
45
82
1430
14469
32
49
1456
14622
10
16
1478
14655
17
0
1471
14671
8
15
1479
14613
31
50
1402
14091
30
74
1085
10989
Post-traumatic stress disorder
F43.1 [45595909]
1.5e+00
2.0e+00
2.0e+00
—
1.4e+00
1.8e+00
1.6e+00
cases:2.64%
controls:0.59%
cases:3.09%
controls:0.44%
cases:1.14%
controls:0.16%
—
—
cases:0.81%
controls:0.20%
cases:2.72%
controls:0.46%
cases:3.32%
controls:0.71%
39
86
1436
14465
46
64
1442
14607
17
23
1471
14648
—
12
29
1475
14599
39
65
1394
14076
37
78
1078
10985
quetiapine; oral
N05AH04 [21604544]
1.6e+00
1.7e+00
1.6e+00
—
1.8e+00
1.8e+00
1.9e+00
cases:17.83%
controls:4.38%
cases:12.16%
controls:2.52%
cases:3.43%
controls:0.74%
—
—
cases:4.10%
controls:0.71%
cases:13.12%
controls:2.53%
cases:22.15%
controls:4.05%
263
638
1212
13913
181
369
1307
14302
51
108
1437
14563
—
61
104
1426
14524
188
358
1245
13783
247
448
868
10615
Neurology
13 [38004458]
9.1e-01
9.3e-01
1.0e+00
3.9e+00
1.6e+00
1.0e+00
8.2e-01
cases:12.34%
controls:5.34%
cases:6.45%
controls:2.64%
cases:1.48%
controls:0.54%
cases:1.68%
controls:0.03%
cases:2.56%
controls:0.51%
cases:7.19%
controls:2.77%
cases:12.83%
controls:6.11%
182
777
1293
13774
96
388
1392
14283
22
79
1466
14592
25
5
1463
14666
38
74
1449
14554
103
391
1330
13750
143
676
972
10387
Anankastic personality disorder
F60.5 [45591150]
2.4e+00
2.6e+00
—
1.0e+50
—
3.2e+00
2.0e+00
cases:1.49%
controls:0.14%
cases:1.08%
controls:0.08%
—
—
cases:1.28%
controls:0.00%
—
—
cases:1.47%
controls:0.06%
cases:1.26%
controls:0.17%
22
20
1453
14531
16
12
1472
14659
—
19
0
1469
14671
—
21
9
1412
14132
14
19
1101
11044
Hyperkinetic disorders
F90 [45581476]
2.1e+00
2.4e+00
—
—
—
3.3e+00
2.2e+00
cases:1.02%
controls:0.13%
cases:0.54%
controls:0.05%
—
—
—
—
—
—
cases:1.19%
controls:0.04%
cases:1.52%
controls:0.17%
15
19
1460
14532
8
7
1480
14664
—
—
—
17
6
1416
14135
17
19
1098
11044
Severe psychotic and other severe mental disorders
112 [2001600112]
1.5e+00
2.1e+00
—
—
—
3.3e+00
3.0e+00
cases:3.53%
controls:0.77%
cases:1.75%
controls:0.21%
—
—
—
—
—
—
cases:2.79%
controls:0.11%
cases:8.25%
controls:0.42%
52
112
1423
14439
26
31
1462
14640
—
—
—
40
15
1393
14126
92
47
1023
11016
Nurse in multidisciplinary team
ZXY82 [2001311551]
1.9e+00
2.3e+00
—
1.0e+50
—
3.0e+00
2.8e+00
cases:1.22%
controls:0.19%
cases:0.54%
controls:0.05%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.70%
controls:0.04%
cases:1.08%
controls:0.06%
18
28
1457
14523
8
8
1480
14663
—
5
0
1483
14671
—
10
5
1423
14136
12
7
1103
11056
Outpatient Visit
OP [9202]
5.1e-01
6.6e-01
1.1e+00
4.7e+00
1.4e+00
8.3e-01
7.1e-01
cases:82.98%
controls:74.51%
cases:65.12%
controls:49.07%
cases:25.87%
controls:10.48%
cases:38.71%
controls:0.55%
cases:31.94%
controls:10.29%
cases:66.57%
controls:46.57%
cases:84.66%
controls:73.14%
1224
10842
251
3709
969
7199
519
7472
385
1537
1103
13134
576
80
912
14591
475
1505
1012
13123
954
6586
479
7555
944
8092
171
2971
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
9.7e-01
1.8e+00
2.3e+00
1.0e+50
—
2.4e+00
2.5e+00
cases:2.44%
controls:0.94%
cases:1.61%
controls:0.27%
cases:0.54%
controls:0.05%
cases:0.40%
controls:0.00%
—
—
cases:2.65%
controls:0.25%
cases:3.86%
controls:0.33%
36
137
1439
14414
24
40
1464
14631
8
8
1480
14663
6
0
1482
14671
—
38
36
1395
14105
43
36
1072
11027
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
1.2e+00
2.0e+00
2.3e+00
—
2.0e+00
8.8e-01
1.4e+00
cases:4.47%
controls:1.37%
cases:4.57%
controls:0.62%
cases:0.81%
controls:0.08%
—
—
cases:0.47%
controls:0.06%
cases:1.54%
controls:0.64%
cases:5.56%
controls:1.48%
66
199
1409
14352
68
91
1420
14580
12
12
1476
14659
—
7
9
1480
14619
22
91
1411
14050
62
164
1053
10899
Other rehabilitation service
R5599 [2001310270]
1.7e+00
2.4e+00
—
—
—
3.0e+00
2.7e+00
cases:1.29%
controls:0.23%
cases:0.81%
controls:0.07%
—
—
—
—
—
—
cases:0.98%
controls:0.05%
cases:2.24%
controls:0.15%
19
33
1456
14518
12
11
1476
14660
—
—
—
14
7
1419
14134
25
17
1090
11046
Doctor in multidisciplinary team
ZXY80 [2001311549]
1.7e+00
2.7e+00
—
—
—
2.9e+00
2.4e+00
cases:0.88%
controls:0.16%
cases:0.67%
controls:0.05%
—
—
—
—
—
—
cases:0.63%
controls:0.04%
cases:0.72%
controls:0.06%
13
23
1462
14528
10
7
1478
14664
—
—
—
9
5
1424
14136
8
7
1107
11056
escitalopram; oral
N06AB10 [21604718]
1.3e+00
1.2e+00
1.4e+00
2.6e+00
1.1e+00
1.0e+00
1.0e+00
cases:14.37%
controls:4.27%
cases:7.93%
controls:2.49%
cases:2.28%
controls:0.56%
cases:0.54%
controls:0.04%
cases:1.82%
controls:0.61%
cases:6.98%
controls:2.68%
cases:10.94%
controls:4.21%
212
621
1263
13930
118
365
1370
14306
34
82
1454
14589
8
6
1480
14665
27
89
1460
14539
100
379
1333
13762
122
466
993
10597
Other mixed anxiety disorders
F41.3 [45605492]
1.6e+00
2.2e+00
—
—
2.5e+00
1.8e+00
1.6e+00
cases:1.56%
controls:0.31%
cases:1.41%
controls:0.16%
—
—
—
—
cases:0.40%
controls:0.03%
cases:1.26%
controls:0.22%
cases:1.88%
controls:0.39%
23
45
1452
14506
21
23
1467
14648
—
—
6
5
1481
14623
18
31
1415
14110
21
43
1094
11020
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
2.1e+00
1.9e+00
1.8e+00
1.0e+50
—
1.9e+00
1.9e+00
cases:1.76%
controls:0.23%
cases:1.08%
controls:0.16%
cases:0.47%
controls:0.07%
cases:0.47%
controls:0.00%
—
—
cases:1.33%
controls:0.21%
cases:1.88%
controls:0.28%
26
33
1449
14518
16
24
1472
14647
7
11
1481
14660
7
0
1481
14671
—
19
29
1414
14112
21
31
1094
11032
Counselling and guidance which enhance independent living
R2130 [2001310196]
7.7e-01
8.8e-01
2.2e+00
1.0e+50
2.7e+00
1.5e+00
1.5e+00
cases:4.07%
controls:1.93%
cases:1.41%
controls:0.59%
cases:0.81%
controls:0.09%
cases:1.01%
controls:0.00%
cases:1.34%
controls:0.10%
cases:2.51%
controls:0.56%
cases:5.20%
controls:1.18%
60
281
1415
14270
21
87
1467
14584
12
13
1476
14658
15
0
1473
14671
20
14
1467
14614
36
79
1397
14062
58
131
1057
10932
Mental disorder, not otherwise specified
F99 [45605525]
1.7e+00
3.2e+00
—
—
—
2.7e+00
1.9e+00
cases:1.36%
controls:0.25%
cases:1.34%
controls:0.05%
—
—
—
—
—
—
cases:0.84%
controls:0.06%
cases:1.43%
controls:0.21%
20
37
1455
14514
20
8
1468
14663
—
—
—
12
8
1421
14133
16
23
1099
11040
Other psychiatric family intervention
IEP99 [2001304203]
1.7e+00
2.5e+00
—
—
2.0e+00
2.4e+00
2.9e+00
cases:1.69%
controls:0.32%
cases:1.55%
controls:0.13%
—
—
—
—
cases:0.34%
controls:0.05%
cases:1.26%
controls:0.11%
cases:2.24%
controls:0.13%
25
47
1450
14504
23
19
1465
14652
—
—
5
7
1482
14621
18
16
1415
14125
25
14
1090
11049
Hyperkinetic disorder, unspecified
F90.9 [45533124]
2.0e+00
2.1e+00
2.3e+00
1.0e+50
—
1.7e+00
1.4e+00
cases:1.69%
controls:0.23%
cases:1.21%
controls:0.14%
cases:0.40%
controls:0.04%
cases:0.34%
controls:0.00%
—
—
cases:0.70%
controls:0.13%
cases:1.08%
controls:0.27%
25
34
1450
14517
18
21
1470
14650
6
6
1482
14665
5
0
1483
14671
—
10
19
1423
14122
12
30
1103
11033
buspirone; oral
N05BE01 [21604601]
2.5e+00
2.4e+00
—
—
—
2.7e+00
1.8e+00
cases:1.76%
controls:0.14%
cases:0.54%
controls:0.05%
—
—
—
—
—
—
cases:0.70%
controls:0.05%
cases:1.08%
controls:0.17%
26
21
1449
14530
8
7
1480
14664
—
—
—
10
7
1423
14134
12
19
1103
11044
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
1.7e+00
1.7e+00
2.5e+00
1.0e+50
2.1e+00
1.9e+00
1.6e+00
cases:1.08%
controls:0.20%
cases:0.67%
controls:0.12%
cases:0.40%
controls:0.03%
cases:0.34%
controls:0.00%
cases:0.34%
controls:0.04%
cases:0.63%
controls:0.09%
cases:0.99%
controls:0.20%
16
29
1459
14522
10
18
1478
14653
6
5
1482
14666
5
0
1483
14671
5
6
1482
14622
9
13
1424
14128
11
22
1104
11041
venlafaxine; oral
N06AX16 [21604745]
1.7e+00
1.6e+00
1.5e+00
—
1.3e+00
1.6e+00
1.6e+00
cases:11.12%
controls:2.25%
cases:6.45%
controls:1.37%
cases:1.81%
controls:0.40%
—
—
cases:1.61%
controls:0.42%
cases:6.56%
controls:1.36%
cases:9.96%
controls:2.17%
164
327
1311
14224
96
201
1392
14470
27
59
1461
14612
—
24
62
1463
14566
94
193
1339
13948
111
240
1004
10823
Dissociative [conversion] disorder, unspecified
F44.9 [45605495]
2.2e+00
2.5e+00
—
1.0e+50
—
2.3e+00
2.4e+00
cases:0.81%
controls:0.09%
cases:0.81%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.70%
controls:0.07%
cases:1.35%
controls:0.13%
12
13
1463
14538
12
10
1476
14661
—
5
0
1483
14671
—
10
10
1423
14131
15
14
1100
11049
Dedicated profession-specific psychiatric intervention, group
IER02 [2001304206]
1.5e+00
1.9e+00
2.3e+00
—
—
1.8e+00
1.9e+00
cases:0.95%
controls:0.22%
cases:0.60%
controls:0.10%
cases:0.40%
controls:0.04%
—
—
—
—
cases:0.56%
controls:0.09%
cases:1.61%
controls:0.24%
14
32
1461
14519
9
14
1479
14657
6
6
1482
14665
—
—
8
13
1425
14128
18
26
1097
11037
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
2.1e+00
2.4e+00
—
1.0e+50
—
2.4e+00
2.5e+00
cases:2.31%
controls:0.28%
cases:1.28%
controls:0.12%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.98%
controls:0.09%
cases:2.06%
controls:0.18%
34
41
1441
14510
19
17
1469
14654
—
5
0
1483
14671
—
14
13
1419
14128
23
20
1092
11043
Specific reading disorder
F81.0 [45542866]
1.7e+00
2.2e+00
—
1.0e+50
—
2.6e+00
2.7e+00
cases:0.81%
controls:0.14%
cases:1.01%
controls:0.11%
—
—
cases:0.67%
controls:0.00%
—
—
cases:1.33%
controls:0.10%
cases:1.61%
controls:0.11%
12
21
1463
14530
15
16
1473
14655
—
10
0
1478
14671
—
19
14
1414
14127
18
12
1097
11051
Ehlers-Danlos syndrome
Q79.6 [45587483]
1.9e+00
2.4e+00
—
—
—
2.4e+00
2.6e+00
cases:0.68%
controls:0.10%
cases:0.67%
controls:0.06%
—
—
—
—
—
—
cases:0.70%
controls:0.06%
cases:1.08%
controls:0.08%
10
15
1465
14536
10
9
1478
14662
—
—
—
10
9
1423
14132
12
9
1103
11054
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
1.3e+00
2.0e+00
—
1.0e+50
2.2e+00
1.9e+00
1.9e+00
cases:5.22%
controls:1.44%
cases:4.84%
controls:0.70%
—
—
cases:2.55%
controls:0.00%
cases:0.61%
controls:0.07%
cases:4.54%
controls:0.72%
cases:6.91%
controls:1.11%
77
209
1398
14342
72
102
1416
14569
—
38
0
1450
14671
9
10
1478
14618
65
102
1368
14039
77
123
1038
10940
Recurrent depression, moderate episode of somatic syndrome
F33.11 [2000501985]
2.1e+00
2.5e+00
—
1.0e+50
—
2.6e+00
2.1e+00
cases:1.49%
controls:0.19%
cases:0.81%
controls:0.07%
—
—
cases:0.67%
controls:0.00%
—
—
cases:1.19%
controls:0.09%
cases:1.97%
controls:0.24%
22
28
1453
14523
12
10
1476
14661
—
10
0
1478
14671
—
17
13
1416
14128
22
26
1093
11037
Inpatient Hospital
21 [8717]
6.4e-02
2.1e-01
7.7e-01
5.6e+00
1.6e+00
7.1e-01
5.4e-01
cases:27.53%
controls:26.27%
cases:9.88%
controls:8.15%
cases:2.08%
controls:0.97%
cases:9.95%
controls:0.04%
cases:3.90%
controls:0.84%
cases:12.42%
controls:6.55%
cases:26.10%
controls:17.09%
406
3823
1069
10728
147
1196
1341
13475
31
143
1457
14528
148
6
1340
14665
58
123
1429
14505
178
926
1255
13215
291
1891
824
9172
vortioxetine; oral
N06AX26 [44819158]
1.8e+00
1.8e+00
1.7e+00
—
1.4e+00
1.4e+00
1.1e+00
cases:7.12%
controls:1.30%
cases:4.77%
controls:0.82%
cases:1.48%
controls:0.29%
—
—
cases:1.28%
controls:0.31%
cases:3.98%
controls:0.98%
cases:5.02%
controls:1.70%
105
189
1370
14362
71
121
1417
14550
22
42
1466
14629
—
19
46
1468
14582
57
138
1376
14003
56
188
1059
10875
Developmental disorder of speech and language, unspecified
F80.9 [45581473]
1.8e+00
2.8e+00
—
1.0e+50
—
2.9e+00
1.7e+00
cases:1.69%
controls:0.29%
cases:1.21%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.05%
controls:0.06%
cases:0.81%
controls:0.15%
25
42
1450
14509
18
11
1470
14660
—
5
0
1483
14671
—
15
8
1418
14133
9
17
1106
11046
Other eating disorders
F50.8 [45581465]
2.0e+00
2.4e+00
—
1.0e+50
—
2.6e+00
2.1e+00
cases:0.81%
controls:0.11%
cases:0.47%
controls:0.04%
—
—
cases:0.67%
controls:0.00%
—
—
cases:0.56%
controls:0.04%
cases:0.81%
controls:0.10%
12
16
1463
14535
7
6
1481
14665
—
10
0
1478
14671
—
8
6
1425
14135
9
11
1106
11052
olanzapine; oral, parenteral
N05AH03 [21604543]
1.3e+00
1.5e+00
1.4e+00
—
1.2e+00
1.6e+00
2.1e+00
cases:5.22%
controls:1.47%
cases:3.90%
controls:0.89%
cases:1.28%
controls:0.32%
—
—
cases:1.21%
controls:0.36%
cases:4.54%
controls:0.94%
cases:9.96%
controls:1.38%
77
214
1398
14337
58
131
1430
14540
19
47
1469
14624
—
18
53
1469
14575
65
133
1368
14008
111
153
1004
10910
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
1.2e+00
1.7e+00
—
—
2.6e+00
2.4e+00
1.2e+00
cases:1.83%
controls:0.58%
cases:1.08%
controls:0.20%
—
—
—
—
cases:0.67%
controls:0.05%
cases:1.33%
controls:0.13%
cases:1.61%
controls:0.49%
27
84
1448
14467
16
30
1472
14641
—
—
10
7
1477
14621
19
18
1414
14123
18
54
1097
11009
sertraline; oral
N06AB06 [21604714]
1.5e+00
1.4e+00
1.4e+00
—
1.7e+00
1.6e+00
1.4e+00
cases:8.68%
controls:2.08%
cases:5.24%
controls:1.37%
cases:1.55%
controls:0.37%
—
—
cases:2.08%
controls:0.38%
cases:6.84%
controls:1.46%
cases:9.78%
controls:2.61%
128
303
1347
14248
78
201
1410
14470
23
55
1465
14616
—
31
55
1456
14573
98
207
1335
13934
109
289
1006
10774
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
1.5e+00
2.3e+00
—
—
—
2.2e+00
2.9e+00
cases:2.98%
controls:0.67%
cases:2.15%
controls:0.22%
—
—
—
—
—
—
cases:1.33%
controls:0.14%
cases:2.78%
controls:0.15%
44
98
1431
14453
32
32
1456
14639
—
—
—
19
20
1414
14121
31
17
1084
11046
pH of Specimen
17433-4 [3019225]
1.5e+00
2.0e+00
—
—
2.5e+00
1.4e+00
1.6e+00
cases:3.93%
controls:0.88%
cases:2.89%
controls:0.42%
—
—
—
—
cases:0.74%
controls:0.06%
cases:1.47%
controls:0.35%
cases:4.04%
controls:0.87%
58
128
1417
14423
43
61
1445
14610
—
—
11
9
1476
14619
21
50
1412
14091
45
96
1070
10967
Fibromyalgia
M79.7 [45553272]
1.9e+00
1.9e+00
—
—
2.0e+00
1.6e+00
1.5e+00
cases:1.56%
controls:0.24%
cases:1.08%
controls:0.16%
—
—
—
—
cases:0.40%
controls:0.05%
cases:1.05%
controls:0.21%
cases:1.52%
controls:0.33%
23
35
1452
14516
16
24
1472
14647
—
—
6
8
1481
14620
15
29
1418
14112
17
37
1098
11026
Recurrent depression, mild episode without somatic syndrome
F33.00 [2000501982]
2.0e+00
2.4e+00
—
1.0e+50
—
2.3e+00
2.2e+00
cases:1.69%
controls:0.24%
cases:1.21%
controls:0.12%
—
—
cases:0.81%
controls:0.00%
—
—
cases:1.54%
controls:0.15%
cases:2.69%
controls:0.31%
25
35
1450
14516
18
17
1470
14654
—
12
0
1476
14671
—
22
21
1411
14120
30
34
1085
11029
Procedure duration 150 to 179 minutes
ZXE17 [2001311407]
2.0e+00
2.2e+00
—
—
—
2.1e+00
2.6e+00
cases:2.10%
controls:0.29%
cases:0.87%
controls:0.10%
—
—
—
—
—
—
cases:0.77%
controls:0.09%
cases:1.52%
controls:0.12%
31
42
1444
14509
13
15
1475
14656
—
—
—
11
13
1422
14128
17
13
1098
11050
erenumab; parenteral
N02CD01 [715930]
2.4e+00
2.2e+00
2.2e+00
—
—
2.1e+00
1.5e+00
cases:0.88%
controls:0.08%
cases:0.67%
controls:0.07%
cases:0.47%
controls:0.05%
—
—
—
—
cases:0.56%
controls:0.07%
cases:0.63%
controls:0.14%
13
12
1462
14539
10
11
1478
14660
7
8
1481
14663
—
—
8
10
1425
14131
7
15
1108
11048
oxazepam; oral
N05BA04 [21604569]
1.3e+00
1.4e+00
1.4e+00
—
1.7e+00
1.6e+00
1.4e+00
cases:12.41%
controls:3.72%
cases:7.86%
controls:2.00%
cases:1.81%
controls:0.45%
—
—
cases:2.08%
controls:0.40%
cases:8.65%
controls:1.84%
cases:12.65%
controls:3.58%
183
541
1292
14010
117
294
1371
14377
27
66
1461
14605
—
31
58
1456
14570
124
260
1309
13881
141
396
974
10667
melatonin; oral
N05CH01 [21604659]
1.3e+00
1.4e+00
1.3e+00
—
2.0e+00
1.5e+00
1.2e+00
cases:8.61%
controls:2.62%
cases:6.38%
controls:1.62%
cases:1.68%
controls:0.45%
—
—
cases:2.29%
controls:0.31%
cases:7.47%
controls:1.77%
cases:11.93%
controls:3.75%
127
381
1348
14170
95
238
1393
14433
25
66
1463
14605
—
34
46
1453
14582
107
250
1326
13891
133
415
982
10648
Hypermobility syndrome
M35.7 [45601437]
1.9e+00
2.7e+00
—
—
—
2.0e+00
2.0e+00
cases:1.49%
controls:0.22%
cases:1.01%
controls:0.07%
—
—
—
—
—
—
cases:0.70%
controls:0.09%
cases:1.08%
controls:0.15%
22
32
1453
14519
15
10
1473
14661
—
—
—
10
13
1423
14128
12
17
1103
11046
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
1.1e+00
1.9e+00
2.0e+00
—
2.0e+00
9.1e-01
7.9e-01
cases:5.76%
controls:1.98%
cases:5.44%
controls:0.89%
cases:0.67%
controls:0.10%
—
—
cases:0.67%
controls:0.10%
cases:2.16%
controls:0.88%
cases:5.56%
controls:2.61%
85
288
1390
14263
81
131
1407
14540
10
14
1478
14657
—
10
14
1477
14614
31
125
1402
14016
62
289
1053
10774
Other psychiatric pharmacotherapy service
IFA99 [2001304299]
1.5e+00
2.0e+00
—
—
—
3.1e+00
2.0e+00
cases:1.08%
controls:0.25%
cases:0.74%
controls:0.10%
—
—
—
—
—
—
cases:1.95%
controls:0.09%
cases:1.88%
controls:0.25%
16
36
1459
14515
11
15
1477
14656
—
—
—
28
13
1405
14128
21
28
1094
11035
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
1.2e+00
1.9e+00
1.6e+00
—
2.2e+00
6.6e-01
9.5e-01
cases:10.51%
controls:3.57%
cases:8.13%
controls:1.35%
cases:0.81%
controls:0.16%
—
—
cases:0.87%
controls:0.10%
cases:2.51%
controls:1.31%
cases:9.87%
controls:4.07%
155
520
1320
14031
121
198
1367
14473
12
24
1476
14647
—
13
14
1474
14614
36
185
1397
13956
110
450
1005
10613
Gender identity assessment
IBZ08 [2001304082]
2.1e+00
3.0e+00
—
—
—
—
3.4e+00
cases:0.61%
controls:0.08%
cases:0.67%
controls:0.03%
—
—
—
—
—
—
—
—
cases:2.06%
controls:0.07%
9
11
1466
14540
10
5
1478
14666
—
—
—
—
23
8
1092
11055
mirtazapine; oral
N06AX11 [21604740]
1.1e+00
1.5e+00
1.9e+00
—
1.7e+00
1.2e+00
1.1e+00
cases:11.46%
controls:4.12%
cases:7.26%
controls:1.80%
cases:2.28%
controls:0.35%
—
—
cases:1.95%
controls:0.37%
cases:6.63%
controls:1.99%
cases:12.38%
controls:4.66%
169
600
1306
13951
108
264
1380
14407
34
51
1454
14620
—
29
54
1458
14574
95
282
1338
13859
138
515
977
10548
mianserin; oral
N06AX03 [21604732]
2.3e+00
2.5e+00
—
—
—
1.9e+00
1.7e+00
cases:1.15%
controls:0.12%
cases:0.67%
controls:0.05%
—
—
—
—
—
—
cases:0.56%
controls:0.08%
cases:1.17%
controls:0.21%
17
17
1458
14534
10
8
1478
14663
—
—
—
8
12
1425
14129
13
23
1102
11040
Mixed anxiety and depressive disorder
F41.2 [45566845]
1.3e+00
1.5e+00
1.9e+00
—
1.5e+00
1.2e+00
8.5e-01
cases:8.75%
controls:2.55%
cases:4.97%
controls:1.12%
cases:1.28%
controls:0.20%
—
—
cases:1.21%
controls:0.27%
cases:4.54%
controls:1.39%
cases:6.37%
controls:2.81%
129
371
1346
14180
74
164
1414
14507
19
29
1469
14642
—
18
39
1469
14589
65
197
1368
13944
71
311
1044
10752
Emergency Room Visit
ER [9203]
2.0e-01
3.7e-01
1.1e+00
4.3e+00
1.2e+00
6.3e-01
4.8e-01
cases:38.03%
controls:33.43%
cases:13.78%
controls:9.92%
cases:3.02%
controls:1.07%
cases:3.70%
controls:0.05%
cases:2.89%
controls:0.85%
cases:14.10%
controls:8.01%
cases:33.54%
controls:23.74%
561
4864
914
9687
205
1456
1283
13215
45
157
1443
14514
55
8
1433
14663
43
125
1444
14503
202
1132
1231
13009
374
2626
741
8437
Predominantly obsessional thoughts or ruminations
F42.0 [45605493]
1.7e+00
2.0e+00
—
1.0e+50
—
2.4e+00
2.1e+00
cases:0.81%
controls:0.15%
cases:0.67%
controls:0.09%
—
—
cases:0.74%
controls:0.00%
—
—
cases:0.91%
controls:0.08%
cases:1.35%
controls:0.16%
12
22
1463
14529
10
13
1478
14658
—
11
0
1477
14671
—
13
12
1420
14129
15
18
1100
11045
Other psychiatric network intervention
IEV99 [2001304218]
1.9e+00
1.9e+00
—
—
—
2.2e+00
2.1e+00
cases:1.83%
controls:0.27%
cases:1.01%
controls:0.15%
—
—
—
—
—
—
cases:1.61%
controls:0.18%
cases:1.97%
controls:0.24%
27
40
1448
14511
15
22
1473
14649
—
—
—
23
25
1410
14116
22
26
1093
11037
Contact between professionals
ZYY01 [2001311592]
2.8e+00
—
—
—
—
2.7e+00
2.7e+00
cases:0.81%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.91%
controls:0.06%
cases:1.17%
controls:0.08%
12
7
1463
14544
—
—
—
—
13
9
1420
14132
13
9
1102
11054
Paediatric neurology
421 [44777781]
8.1e-01
9.6e-01
1.3e+00
—
2.2e+00
1.5e+00
1.4e+00
cases:11.46%
controls:5.46%
cases:7.66%
controls:3.09%
cases:2.49%
controls:0.67%
—
—
cases:5.38%
controls:0.64%
cases:10.54%
controls:2.56%
cases:13.36%
controls:3.68%
169
795
1306
13756
114
453
1374
14218
37
99
1451
14572
—
80
94
1407
14534
151
362
1282
13779
149
407
966
10656
hydroxyzine; oral, parenteral
N05BB01 [21604590]
8.7e-01
1.2e+00
1.8e+00
—
1.7e+00
1.4e+00
1.2e+00
cases:6.44%
controls:2.80%
cases:2.89%
controls:0.92%
cases:0.94%
controls:0.16%
—
—
cases:0.81%
controls:0.15%
cases:3.63%
controls:0.93%
cases:6.82%
controls:2.11%
95
407
1380
14144
43
135
1445
14536
14
24
1474
14647
—
12
22
1475
14606
52
131
1381
14010
76
233
1039
10830
Neuropsychological investigation
XA800 [2001300412]
1.2e+00
1.0e+00
2.7e+00
—
—
2.3e+00
1.9e+00
cases:3.12%
controls:0.95%
cases:0.74%
controls:0.27%
cases:0.60%
controls:0.04%
—
—
—
—
cases:1.47%
controls:0.16%
cases:3.77%
controls:0.57%
46
138
1429
14413
11
40
1477
14631
9
6
1479
14665
—
—
21
22
1412
14119
42
63
1073
11000
Other indirect service without contact with patient
ZYY79 [2001311594]
2.4e+00
3.3e+00
1.0e+50
—
—
—
2.3e+00
cases:0.68%
controls:0.06%
cases:0.94%
controls:0.03%
cases:0.60%
controls:0.00%
—
—
—
—
—
—
cases:0.99%
controls:0.10%
10
9
1465
14542
14
5
1474
14666
9
0
1479
14671
—
—
—
11
11
1104
11052
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.0e+00
1.4e+00
2.5e+00
—
—
1.9e+00
1.2e+00
cases:2.17%
controls:0.80%
cases:1.08%
controls:0.27%
cases:0.40%
controls:0.03%
—
—
—
—
cases:1.12%
controls:0.17%
cases:1.70%
controls:0.51%
32
117
1443
14434
16
39
1472
14632
6
5
1482
14666
—
—
16
24
1417
14117
19
56
1096
11007
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]
1.2e+00
1.7e+00
—
—
2.1e+00
1.5e+00
1.5e+00
cases:4.34%
controls:1.35%
cases:3.29%
controls:0.65%
—
—
—
—
cases:0.40%
controls:0.05%
cases:2.58%
controls:0.57%
cases:5.65%
controls:1.33%
64
197
1411
14354
49
95
1439
14576
—
—
6
7
1481
14621
37
81
1396
14060
63
147
1052
10916
Other therapy enhancing rehabilitation
R4160 [2001310240]
1.0e+00
2.0e+00
—
—
—
2.6e+00
2.2e+00
cases:1.42%
controls:0.52%
cases:0.67%
controls:0.10%
—
—
—
—
—
—
cases:1.19%
controls:0.08%
cases:2.60%
controls:0.29%
21
75
1454
14476
10
14
1478
14657
—
—
—
17
12
1416
14129
29
32
1086
11031
Personality disorder, unspecified
F60.9 [45538076]
2.1e+00
—
—
1.0e+50
1.0e+50
3.3e+00
2.5e+00
cases:1.15%
controls:0.14%
—
—
—
—
cases:0.47%
controls:0.00%
cases:0.34%
controls:0.00%
cases:0.91%
controls:0.04%
cases:1.26%
controls:0.11%
17
20
1458
14531
—
—
7
0
1481
14671
5
0
1482
14628
13
5
1420
14136
14
12
1101
11051
General evaluation of the need for rehabilitation
R1100 [2001310172]
1.7e+00
2.2e+00
—
—
—
1.8e+00
2.2e+00
cases:1.90%
controls:0.35%
cases:0.67%
controls:0.07%
—
—
—
—
—
—
cases:0.63%
controls:0.11%
cases:1.61%
controls:0.19%
28
51
1447
14500
10
11
1478
14660
—
—
—
9
15
1424
14126
18
21
1097
11042
chlorprothixene; oral, parenteral
N05AF03 [21604533]
1.9e+00
2.1e+00
—
—
—
1.9e+00
1.9e+00
cases:1.63%
controls:0.25%
cases:0.94%
controls:0.12%
—
—
—
—
—
—
cases:0.84%
controls:0.12%
cases:1.70%
controls:0.26%
24
36
1451
14515
14
17
1474
14654
—
—
—
12
17
1421
14124
19
29
1096
11034
Receptive language disorder
F80.2 [45576561]
1.7e+00
2.2e+00
—
—
—
1.8e+00
2.0e+00
cases:1.42%
controls:0.26%
cases:1.08%
controls:0.12%
—
—
—
—
—
—
cases:0.84%
controls:0.13%
cases:1.79%
controls:0.24%
21
38
1454
14513
16
17
1472
14654
—
—
—
12
19
1421
14122
20
26
1095
11037
lamotrigine; oral
N03AX09 [21604431]
1.4e+00
1.3e+00
1.2e+00
—
1.5e+00
1.7e+00
1.9e+00
cases:4.75%
controls:1.18%
cases:2.35%
controls:0.64%
cases:0.60%
controls:0.18%
—
—
cases:0.94%
controls:0.22%
cases:3.56%
controls:0.68%
cases:6.55%
controls:1.08%
70
172
1405
14379
35
94
1453
14577
9
26
1479
14645
—
14
32
1473
14596
51
96
1382
14045
73
120
1042
10943
Asperger syndrome
F84.5 [45576562]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
7.7e+00
—
—
cases:4.70%
controls:0.00%
cases:1.75%
controls:0.00%
cases:63.10%
controls:0.00%
cases:27.24%
controls:0.00%
—
—
cases:51.39%
controls:0.05%
—
70
0
1418
14671
26
0
1462
14671
939
0
549
14671
405
0
1082
14628
—
573
5
542
11058
trazodone; oral
N06AX05 [21604734]
1.8e+00
2.2e+00
2.3e+00
—
—
2.0e+00
1.7e+00
cases:1.42%
controls:0.23%
cases:1.01%
controls:0.12%
cases:0.34%
controls:0.03%
—
—
—
—
cases:1.19%
controls:0.16%
cases:1.70%
controls:0.32%
21
33
1454
14518
15
17
1473
14654
5
5
1483
14666
—
—
17
23
1416
14118
19
35
1096
11028
Disruption of family by separation and divorce
Z63.5 [45561643]
1.5e+00
2.4e+00
—
—
—
2.6e+00
2.6e+00
cases:0.47%
controls:0.10%
cases:0.54%
controls:0.05%
—
—
—
—
—
—
cases:0.49%
controls:0.04%
cases:0.81%
controls:0.06%
7
15
1468
14536
8
7
1480
14664
—
—
—
7
5
1426
14136
9
7
1106
11056
Other developmental disorders of scholastic skills
F81.8 [45542868]
1.9e+00
2.0e+00
—
1.0e+50
—
1.9e+00
1.8e+00
cases:1.02%
controls:0.16%
cases:0.67%
controls:0.10%
—
—
cases:0.60%
controls:0.00%
—
—
cases:0.63%
controls:0.09%
cases:1.17%
controls:0.19%
15
23
1460
14528
10
14
1478
14657
—
9
0
1479
14671
—
9
13
1424
14128
13
21
1102
11042
2-person team, doctor-nurse
ZXY51 [2001311525]
1.4e+00
2.0e+00
—
1.0e+50
—
1.8e+00
2.4e+00
cases:2.10%
controls:0.54%
cases:0.81%
controls:0.11%
—
—
cases:0.54%
controls:0.00%
—
—
cases:0.84%
controls:0.14%
cases:1.88%
controls:0.17%
31
79
1444
14472
12
16
1476
14655
—
8
0
1480
14671
—
12
20
1421
14121
21
19
1094
11044
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
1.6e+00
1.5e+00
—
—
—
1.7e+00
2.6e+00
cases:1.29%
controls:0.27%
cases:0.67%
controls:0.15%
—
—
—
—
—
—
cases:0.63%
controls:0.11%
cases:1.79%
controls:0.14%
19
40
1456
14511
10
22
1478
14649
—
—
—
9
16
1424
14125
20
15
1095
11048
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
1.0e+00
1.7e+00
1.7e+00
—
—
2.1e+00
2.5e+00
cases:4.27%
controls:1.54%
cases:2.69%
controls:0.50%
cases:0.40%
controls:0.07%
—
—
—
—
cases:2.58%
controls:0.32%
cases:5.11%
controls:0.44%
63
224
1412
14327
40
73
1448
14598
6
11
1482
14660
—
—
37
45
1396
14096
57
49
1058
11014
Procedure duration 0 to 9 minutes
ZXE01 [2001311395]
1.4e+00
1.9e+00
—
—
—
1.8e+00
2.2e+00
cases:1.15%
controls:0.30%
cases:0.54%
controls:0.08%
—
—
—
—
—
—
cases:0.49%
controls:0.08%
cases:1.26%
controls:0.14%
17
43
1458
14508
8
12
1480
14659
—
—
—
7
11
1426
14130
14
15
1101
11048
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
9.4e-01
1.8e+00
1.9e+00
—
1.7e+00
5.3e-01
7.8e-01
cases:5.76%
controls:2.33%
cases:5.31%
controls:0.89%
cases:0.81%
controls:0.12%
—
—
cases:0.54%
controls:0.10%
cases:1.81%
controls:1.07%
cases:6.28%
controls:2.97%
85
339
1390
14212
79
130
1409
14541
12
17
1476
14654
—
8
14
1479
14614
26
152
1407
13989
70
329
1045
10734
Psychiatric treatment plan, monitoring
ICB03 [2001304100]
1.6e+00
1.8e+00
—
1.0e+50
—
2.1e+00
1.7e+00
cases:2.24%
controls:0.46%
cases:1.14%
controls:0.18%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.54%
controls:0.20%
cases:2.51%
controls:0.49%
33
67
1442
14484
17
27
1471
14644
—
5
0
1483
14671
—
22
28
1411
14113
28
54
1087
11009
aripiprazole; oral, parenteral
N05AX12 [21604562]
1.3e+00
1.2e+00
8.3e-01
—
1.1e+00
1.3e+00
2.2e+00
cases:5.08%
controls:1.42%
cases:3.09%
controls:0.98%
cases:0.81%
controls:0.35%
—
—
cases:1.28%
controls:0.41%
cases:3.98%
controls:1.10%
cases:10.13%
controls:1.23%
75
207
1400
14344
46
144
1442
14527
12
52
1476
14619
—
19
60
1468
14568
57
156
1376
13985
113
136
1002
10927
Medical assessment of need and possibilities to rehabilitation
R1210 [2001310174]
1.3e+00
2.4e+00
—
—
—
2.5e+00
2.1e+00
cases:0.47%
controls:0.13%
cases:0.47%
controls:0.04%
—
—
—
—
—
—
cases:0.70%
controls:0.06%
cases:1.08%
controls:0.13%
7
19
1468
14532
7
6
1481
14665
—
—
—
10
8
1423
14133
12
14
1103
11049
Eating disorder, unspecified
F50.9 [45547713]
1.6e+00
1.8e+00
2.2e+00
—
2.3e+00
1.5e+00
1.5e+00
cases:1.63%
controls:0.34%
cases:0.94%
controls:0.16%
cases:0.54%
controls:0.06%
—
—
cases:0.34%
controls:0.03%
cases:0.70%
controls:0.16%
cases:0.72%
controls:0.16%
24
49
1451
14502
14
23
1474
14648
8
9
1480
14662
—
5
5
1482
14623
10
22
1423
14119
8
18
1107
11045
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
1.1e+00
1.9e+00
2.3e+00
—
—
3.7e-01
1.6e+00
cases:5.49%
controls:1.81%
cases:2.49%
controls:0.37%
cases:0.40%
controls:0.04%
—
—
—
—
cases:0.42%
controls:0.29%
cases:4.22%
controls:0.86%
81
263
1394
14288
37
55
1451
14616
6
6
1482
14665
—
—
6
41
1427
14100
47
95
1068
10968
Cocaine [Presence] in Urine
3397-7 [3016879]
8.9e-01
1.7e+00
1.9e+00
—
1.7e+00
3.9e-01
6.9e-01
cases:6.17%
controls:2.64%
cases:5.44%
controls:1.02%
cases:0.81%
controls:0.12%
—
—
cases:0.54%
controls:0.10%
cases:1.81%
controls:1.24%
cases:6.55%
controls:3.41%
91
384
1384
14167
81
150
1407
14521
12
17
1476
14654
—
8
14
1479
14614
26
175
1407
13966
73
377
1042
10686
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
8.5e-01
1.7e+00
1.9e+00
—
1.8e+00
3.8e-01
6.5e-01
cases:6.37%
controls:2.82%
cases:5.51%
controls:1.09%
cases:0.81%
controls:0.12%
—
—
cases:0.61%
controls:0.10%
cases:1.88%
controls:1.30%
cases:6.91%
controls:3.72%
94
411
1381
14140
82
160
1406
14511
12
17
1476
14654
—
9
14
1478
14614
27
184
1406
13957
77
412
1038
10651
EKG study
11524-6 [3013512]
1.1e+00
1.6e+00
1.9e+00
—
1.3e+00
1.3e+00
1.0e+00
cases:8.81%
controls:3.03%
cases:5.98%
controls:1.27%
cases:1.21%
controls:0.18%
—
—
cases:0.61%
controls:0.16%
cases:3.98%
controls:1.14%
cases:9.06%
controls:3.48%
130
441
1345
14110
89
186
1399
14485
18
27
1470
14644
—
9
24
1478
14604
57
161
1376
13980
101
385
1014
10678
Childhood emotional disorder, unspecified
F93.9 [45538091]
2.2e+00
2.9e+00
—
1.0e+50
—
1.4e+00
1.8e+00
cases:1.22%
controls:0.14%
cases:1.14%
controls:0.06%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.35%
controls:0.08%
cases:0.90%
controls:0.15%
18
20
1457
14531
17
9
1471
14662
—
5
0
1483
14671
—
5
12
1428
14129
10
17
1105
11046
Psychological disorders other
P99 [2002000880]
1.3e+00
1.7e+00
—
—
—
2.0e+00
1.9e+00
cases:1.76%
controls:0.48%
cases:1.28%
controls:0.23%
—
—
—
—
—
—
cases:1.47%
controls:0.21%
cases:3.95%
controls:0.63%
26
70
1449
14481
19
34
1469
14637
—
—
—
21
29
1412
14112
44
70
1071
10993
Psychiatric monitoring contact
IGY02 [2001304322]
8.4e-01
1.5e+00
1.1e+00
1.0e+50
1.6e+00
1.5e+00
1.4e+00
cases:2.58%
controls:1.13%
cases:2.62%
controls:0.62%
cases:0.47%
controls:0.16%
cases:0.34%
controls:0.00%
cases:0.87%
controls:0.18%
cases:3.14%
controls:0.71%
cases:5.56%
controls:1.39%
38
164
1437
14387
39
91
1449
14580
7
23
1481
14648
5
0
1483
14671
13
26
1474
14602
45
100
1388
14041
62
154
1053
10909
Atypical anorexia nervosa
F50.1 [45586245]
1.4e+00
2.3e+00
—
—
—
2.7e+00
1.8e+00
cases:0.54%
controls:0.13%
cases:0.74%
controls:0.07%
—
—
—
—
—
—
cases:0.77%
controls:0.05%
cases:0.90%
controls:0.15%
8
19
1467
14532
11
11
1477
14660
—
—
—
11
7
1422
14134
10
17
1105
11046
Cannabinoids [Presence] in Urine
3427-2 [3028300]
8.5e-01
1.7e+00
1.9e+00
—
1.7e+00
3.7e-01
6.4e-01
cases:6.37%
controls:2.84%
cases:5.44%
controls:1.09%
cases:0.81%
controls:0.12%
—
—
cases:0.54%
controls:0.10%
cases:1.88%
controls:1.31%
cases:6.82%
controls:3.72%
94
413
1381
14138
81
160
1407
14511
12
17
1476
14654
—
8
14
1479
14614
27
185
1406
13956
76
412
1039
10651
Opiates [Presence] in Urine
3879-4 [3027008]
8.5e-01
1.6e+00
1.9e+00
—
1.7e+00
3.8e-01
6.4e-01
cases:6.37%
controls:2.84%
cases:5.38%
controls:1.09%
cases:0.81%
controls:0.12%
—
—
cases:0.54%
controls:0.10%
cases:1.88%
controls:1.30%
cases:6.82%
controls:3.70%
94
413
1381
14138
80
160
1408
14511
12
17
1476
14654
—
8
14
1479
14614
27
184
1406
13957
76
409
1039
10654
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
9.2e-01
9.1e-01
1.8e+00
—
1.4e+00
1.1e+00
6.8e-01
cases:7.73%
controls:3.23%
cases:2.28%
controls:0.93%
cases:0.94%
controls:0.16%
—
—
cases:0.67%
controls:0.16%
cases:2.30%
controls:0.81%
cases:5.29%
controls:2.77%
114
470
1361
14081
34
137
1454
14534
14
23
1474
14648
—
10
24
1477
14604
33
115
1400
14026
59
306
1056
10757
Psychological sympt/compl other
P29 [2002000823]
1.3e+00
1.5e+00
1.5e+00
—
1.1e+00
1.3e+00
1.1e+00
cases:6.03%
controls:1.72%
cases:4.37%
controls:1.00%
cases:0.87%
controls:0.20%
—
—
cases:0.61%
controls:0.21%
cases:3.35%
controls:0.93%
cases:7.89%
controls:2.69%
89
250
1386
14301
65
147
1423
14524
13
29
1475
14642
—
9
31
1478
14597
48
132
1385
14009
88
298
1027
10765
Medical doctor
Z2221 [2001311556]
6.1e-01
1.0e+00
9.4e-01
—
1.9e+00
1.6e+00
1.6e+00
cases:7.39%
controls:4.17%
cases:2.76%
controls:1.02%
cases:0.47%
controls:0.18%
—
—
cases:0.87%
controls:0.14%
cases:3.56%
controls:0.74%
cases:9.60%
controls:2.02%
109
607
1366
13944
41
149
1447
14522
7
27
1481
14644
—
13
20
1474
14608
51
105
1382
14036
107
224
1008
10839
Other healthcare associate professional
Z3229 [2001311561]
2.4e-01
1.3e+00
2.5e+00
—
—
1.7e+00
1.2e+00
cases:1.69%
controls:1.34%
cases:1.01%
controls:0.28%
cases:0.40%
controls:0.03%
—
—
—
—
cases:1.19%
controls:0.21%
cases:2.15%
controls:0.65%
25
195
1450
14356
15
41
1473
14630
6
5
1482
14666
—
—
17
30
1416
14111
24
72
1091
10991
Psychiatric treatment plan, extended/prolonged
ICB02 [2001304099]
1.1e+00
1.7e+00
—
1.0e+50
—
2.0e+00
1.9e+00
cases:1.08%
controls:0.38%
cases:0.87%
controls:0.16%
—
—
cases:0.67%
controls:0.00%
—
—
cases:0.91%
controls:0.12%
cases:2.42%
controls:0.36%
16
55
1459
14496
13
24
1475
14647
—
10
0
1478
14671
—
13
17
1420
14124
27
40
1088
11023
Recurrent depressive disorder, current episode moderate
F33.1 [45576543]
1.8e+00
1.7e+00
—
—
-1.0e+50
1.7e+00
1.5e+00
cases:2.31%
controls:0.41%
cases:1.41%
controls:0.26%
—
—
—
—
cases:0.00%
controls:0.05%
cases:1.12%
controls:0.21%
cases:2.42%
controls:0.56%
34
59
1441
14492
21
38
1467
14633
—
—
0
7
1487
14621
16
30
1417
14111
27
62
1088
11001
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
1.2e+00
1.9e+00
—
—
—
1.9e+00
1.6e+00
cases:1.56%
controls:0.49%
cases:0.74%
controls:0.12%
—
—
—
—
—
—
cases:1.05%
controls:0.16%
cases:2.24%
controls:0.44%
23
71
1452
14480
11
17
1477
14654
—
—
—
15
22
1418
14119
25
49
1090
11014
Other developmental disorders of speech and language
F80.8 [45566856]
1.5e+00
1.7e+00
—
—
—
1.7e+00
1.7e+00
cases:0.68%
controls:0.16%
cases:0.60%
controls:0.11%
—
—
—
—
—
—
cases:0.63%
controls:0.11%
cases:0.90%
controls:0.17%
10
23
1465
14528
9
16
1479
14655
—
—
—
9
16
1424
14125
10
19
1105
11044
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
1.1e+00
1.2e+00
9.9e-01
—
1.4e+00
1.3e+00
1.5e+00
cases:5.08%
controls:1.81%
cases:2.62%
controls:0.78%
cases:0.60%
controls:0.22%
—
—
cases:0.81%
controls:0.19%
cases:2.93%
controls:0.82%
cases:6.73%
controls:1.55%
75
264
1400
14287
39
115
1449
14556
9
33
1479
14638
—
12
28
1475
14600
42
116
1391
14025
75
172
1040
10891
Unspecified mood [affective] disorder
F39 [45591137]
1.6e+00
1.7e+00
—
—
—
1.8e+00
1.5e+00
cases:1.76%
controls:0.35%
cases:0.94%
controls:0.18%
—
—
—
—
—
—
cases:0.70%
controls:0.12%
cases:1.52%
controls:0.35%
26
51
1449
14500
14
26
1474
14645
—
—
—
10
17
1423
14124
17
39
1098
11024
gabapentin; oral
N02BF01 [955005]
8.5e-01
1.2e+00
1.4e+00
—
1.3e+00
1.0e+00
7.2e-01
cases:3.25%
controls:1.42%
cases:2.08%
controls:0.61%
cases:1.08%
controls:0.27%
—
—
cases:0.74%
controls:0.21%
cases:2.02%
controls:0.76%
cases:3.77%
controls:1.86%
48
207
1427
14344
31
90
1457
14581
16
39
1472
14632
—
11
30
1476
14598
29
107
1404
14034
42
206
1073
10857
Supplier / Service Provider
OMOP5117446 [33004]
-3.3e-01
-6.4e-01
-3.6e-01
-1.0e+50
2.5e+00
2.3e+00
2.7e+00
cases:21.76%
controls:27.87%
cases:4.97%
controls:9.00%
cases:0.67%
controls:0.96%
cases:0.00%
controls:0.05%
cases:0.67%
controls:0.05%
cases:4.61%
controls:0.50%
cases:14.62%
controls:1.17%
321
4056
1154
10495
74
1320
1414
13351
10
141
1478
14530
0
7
1488
14664
10
8
1477
14620
66
70
1367
14071
163
129
952
10934
Emergency Medicine
93 [38004510]
3.3e-01
4.4e-01
8.3e-01
3.0e+00
1.0e+00
5.6e-01
3.3e-01
cases:23.19%
controls:17.86%
cases:12.50%
controls:8.45%
cases:2.35%
controls:1.04%
cases:0.81%
controls:0.04%
cases:2.69%
controls:1.00%
cases:13.68%
controls:8.27%
cases:25.83%
controls:20.02%
342
2599
1133
11952
186
1240
1302
13431
35
153
1453
14518
12
6
1476
14665
40
146
1447
14482
196
1169
1237
12972
288
2215
827
8848
Other recurrent depressive disorders
F33.8 [45600740]
2.0e+00
1.9e+00
—
1.0e+50
—
—
2.5e+00
cases:0.68%
controls:0.10%
cases:0.47%
controls:0.07%
—
—
cases:0.47%
controls:0.00%
—
—
—
—
cases:1.26%
controls:0.10%
10
14
1465
14537
7
10
1481
14661
—
7
0
1481
14671
—
—
14
11
1101
11052
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
1.0e+00
2.1e+00
—
—
—
1.8e+00
1.3e+00
cases:1.29%
controls:0.47%
cases:0.67%
controls:0.08%
—
—
—
—
—
—
cases:0.77%
controls:0.13%
cases:1.35%
controls:0.35%
19
68
1456
14483
10
12
1478
14659
—
—
—
11
18
1422
14123
15
39
1100
11024
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
1.3e+00
1.5e+00
—
—
—
1.4e+00
2.1e+00
cases:1.90%
controls:0.54%
cases:1.28%
controls:0.28%
—
—
—
—
—
—
cases:1.19%
controls:0.30%
cases:4.13%
controls:0.54%
28
79
1447
14472
19
41
1469
14630
—
—
—
17
43
1416
14098
46
60
1069
11003
pregabalin; oral
N02BF02 [955152]
1.2e+00
1.2e+00
9.8e-01
—
1.4e+00
1.3e+00
1.1e+00
cases:5.08%
controls:1.66%
cases:3.16%
controls:0.95%
cases:0.94%
controls:0.35%
—
—
cases:1.41%
controls:0.36%
cases:3.14%
controls:0.92%
cases:5.02%
controls:1.74%
75
241
1400
14310
47
139
1441
14532
14
52
1474
14619
—
21
52
1466
14576
45
130
1388
14011
56
193
1059
10870
zolpidem; oral
N05CF02 [21604655]
9.0e-01
1.3e+00
1.6e+00
—
1.0e+00
1.2e+00
9.6e-01
cases:3.66%
controls:1.52%
cases:2.15%
controls:0.59%
cases:0.87%
controls:0.17%
—
—
cases:0.40%
controls:0.14%
cases:2.23%
controls:0.65%
cases:3.50%
controls:1.37%
54
221
1421
14330
32
87
1456
14584
13
25
1475
14646
—
6
21
1481
14607
32
92
1401
14049
39
152
1076
10911
Hospital inpatient
ZY000 [2001311598]
1.0e+00
1.0e+00
—
1.0e+50
—
2.4e+00
2.6e+00
cases:0.95%
controls:0.34%
cases:0.34%
controls:0.12%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.84%
controls:0.08%
cases:1.35%
controls:0.10%
14
50
1461
14501
5
18
1483
14653
—
5
0
1483
14671
—
12
11
1421
14130
15
11
1100
11052
Case Management Agency
251B00000X [38004193]
7.2e-02
2.7e-01
7.5e-01
3.7e+00
7.1e-01
2.7e-01
2.8e-01
cases:71.05%
controls:69.56%
cases:69.83%
controls:63.84%
cases:44.69%
controls:27.56%
cases:42.07%
controls:1.72%
cases:44.52%
controls:28.19%
cases:71.32%
controls:65.46%
cases:82.69%
controls:78.33%
1048
10121
427
4430
1039
9366
449
5305
665
4043
823
10628
626
252
862
14419
662
4124
825
10504
1022
9257
411
4884
922
8666
193
2397
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
1.2e+00
1.5e+00
—
—
—
1.7e+00
1.5e+00
cases:1.36%
controls:0.41%
cases:0.60%
controls:0.14%
—
—
—
—
—
—
cases:0.84%
controls:0.15%
cases:2.42%
controls:0.53%
20
59
1455
14492
9
20
1479
14651
—
—
—
12
21
1421
14120
27
59
1088
11004
Clinic/Center
261Q00000X [38004207]
8.8e-01
1.6e+00
—
—
—
1.6e+00
1.8e+00
cases:1.42%
controls:0.60%
cases:0.74%
controls:0.14%
—
—
—
—
—
—
cases:0.63%
controls:0.13%
cases:1.70%
controls:0.28%
21
87
1454
14464
11
21
1477
14650
—
—
—
9
18
1424
14123
19
31
1096
11032
Child-centred family therapy
IEP02 [2001304194]
1.5e+00
1.4e+00
—
—
—
1.5e+00
1.5e+00
cases:1.42%
controls:0.32%
cases:0.94%
controls:0.23%
—
—
—
—
—
—
cases:0.70%
controls:0.16%
cases:1.17%
controls:0.25%
21
47
1454
14504
14
34
1474
14637
—
—
—
10
23
1423
14118
13
28
1102
11035
Emotionally unstable personality disorder
F60.3 [45566852]
2.0e+00
1.9e+00
—
—
—
—
1.9e+00
cases:1.63%
controls:0.22%
cases:0.74%
controls:0.11%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.12%
24
32
1451
14519
11
16
1477
14655
—
—
—
—
9
13
1106
11050
Poisoning by systemic antibiotics
T36 [45756588]
1.0e+00
1.7e+00
—
—
—
1.7e+00
1.4e+00
cases:1.90%
controls:0.71%
cases:1.01%
controls:0.18%
—
—
—
—
—
—
cases:1.19%
controls:0.21%
cases:2.60%
controls:0.67%
28
103
1447
14448
15
26
1473
14645
—
—
—
17
30
1416
14111
29
74
1086
10989
Assessment of need for psychiatric treatment
IAA01 [2001304011]
8.4e-01
1.4e+00
—
—
2.4e+00
9.4e-01
1.2e+00
cases:2.17%
controls:0.95%
cases:1.61%
controls:0.40%
—
—
—
—
cases:0.54%
controls:0.05%
cases:1.12%
controls:0.44%
cases:3.50%
controls:1.11%
32
138
1443
14413
24
59
1464
14612
—
—
8
7
1479
14621
16
62
1417
14079
39
123
1076
10940
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
5.1e-01
7.1e-01
7.0e-01
1.7e+00
9.5e-01
6.4e-01
5.6e-01
cases:40.27%
controls:28.75%
cases:28.43%
controls:16.27%
cases:5.58%
controls:2.84%
cases:0.74%
controls:0.13%
cases:6.72%
controls:2.71%
cases:25.47%
controls:15.28%
cases:43.32%
controls:30.41%
594
4184
881
10367
423
2387
1065
12284
83
417
1405
14254
11
19
1477
14652
100
397
1387
14231
365
2161
1068
11980
483
3364
632
7699
Sleep apnoea
G47.3 [45562094]
1.2e+00
1.2e+00
1.1e+00
—
1.6e+00
1.2e+00
6.8e-01
cases:4.88%
controls:1.55%
cases:3.63%
controls:1.12%
cases:0.74%
controls:0.25%
—
—
cases:1.34%
controls:0.29%
cases:3.98%
controls:1.27%
cases:5.11%
controls:2.65%
72
226
1403
14325
54
164
1434
14507
11
36
1477
14635
—
20
42
1467
14586
57
180
1376
13961
57
293
1058
10770
Other mixed disorders of conduct and emotions
F92.8 [45605519]
2.7e+00
3.1e+00
—
—
—
—
—
cases:1.02%
controls:0.07%
cases:0.87%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
15
10
1460
14541
13
6
1475
14665
—
—
—
—
—
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
5.1e-01
7.2e-01
7.3e-01
1.6e+00
9.6e-01
6.4e-01
5.5e-01
cases:40.27%
controls:28.75%
cases:28.49%
controls:16.22%
cases:5.71%
controls:2.84%
cases:0.74%
controls:0.14%
cases:6.79%
controls:2.71%
cases:25.54%
controls:15.28%
cases:43.14%
controls:30.44%
594
4184
881
10367
424
2379
1064
12292
85
416
1403
14255
11
21
1477
14650
101
397
1386
14231
366
2161
1067
11980
481
3368
634
7695
Remote contact by video link
ZYC02 [2001311580]
2.7e+00
—
—
—
—
—
3.1e+00
cases:0.68%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.05%
10
7
1465
14544
—
—
—
—
—
11
5
1104
11058
Extensive health certificate
SPAT1284 [2001700385]
1.6e+00
2.5e+00
—
—
—
1.4e+00
1.6e+00
cases:2.10%
controls:0.43%
cases:0.87%
controls:0.07%
—
—
—
—
—
—
cases:0.35%
controls:0.08%
cases:1.43%
controls:0.28%
31
62
1444
14489
13
11
1475
14660
—
—
—
5
12
1428
14129
16
31
1099
11032
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
8.9e-01
1.4e+00
1.2e+00
—
1.7e+00
1.0e+00
7.4e-01
cases:5.02%
controls:2.12%
cases:4.84%
controls:1.29%
cases:0.54%
controls:0.16%
—
—
cases:0.74%
controls:0.14%
cases:3.63%
controls:1.33%
cases:8.16%
controls:4.08%
74
308
1401
14243
72
189
1416
14482
8
24
1480
14647
—
11
20
1476
14608
52
188
1381
13953
91
451
1024
10612
Psychoeducation, group
IER01 [2001304205]
1.4e+00
1.5e+00
—
—
—
3.0e+00
1.2e+00
cases:0.95%
controls:0.23%
cases:0.47%
controls:0.11%
—
—
—
—
—
—
cases:1.74%
controls:0.08%
cases:1.08%
controls:0.32%
14
33
1461
14518
7
16
1481
14655
—
—
—
25
12
1408
14129
12
35
1103
11028
Bipolar affective disorder, unspecified
F31.9 [45571758]
1.5e+00
1.1e+00
1.7e+00
—
1.3e+00
1.4e+00
1.7e+00
cases:2.31%
controls:0.51%
cases:0.87%
controls:0.30%
cases:0.40%
controls:0.07%
—
—
cases:0.34%
controls:0.09%
cases:1.12%
controls:0.28%
cases:2.51%
controls:0.47%
34
74
1441
14477
13
44
1475
14627
6
11
1482
14660
—
5
13
1482
14615
16
39
1417
14102
28
52
1087
11011
Home Visit
OMOP4822459 [581476]
3.7e-01
7.5e-01
1.6e+00
—
1.3e+00
9.1e-01
7.0e-01
cases:8.68%
controls:6.16%
cases:3.97%
controls:1.92%
cases:1.55%
controls:0.31%
—
—
cases:1.34%
controls:0.36%
cases:4.68%
controls:1.94%
cases:9.69%
controls:5.05%
128
896
1347
13655
59
282
1429
14389
23
46
1465
14625
—
20
53
1467
14575
67
275
1366
13866
108
559
1007
10504
Bipolar affective disorder
F31 [45595902]
1.9e+00
2.2e+00
—
—
—
1.6e+00
1.6e+00
cases:1.76%
controls:0.27%
cases:0.87%
controls:0.10%
—
—
—
—
—
—
cases:0.42%
controls:0.08%
cases:1.08%
controls:0.22%
26
40
1449
14511
13
15
1475
14656
—
—
—
6
12
1427
14129
12
24
1103
11039
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
1.7e+00
2.6e+00
—
—
—
1.5e+00
1.2e+00
cases:1.63%
controls:0.30%
cases:1.21%
controls:0.09%
—
—
—
—
—
—
cases:0.56%
controls:0.12%
cases:1.26%
controls:0.37%
24
43
1451
14508
18
13
1470
14658
—
—
—
8
17
1425
14124
14
41
1101
11022
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
2.0e+00
1.8e+00
—
—
—
1.8e+00
6.3e-01
cases:1.76%
controls:0.25%
cases:0.60%
controls:0.10%
—
—
—
—
—
—
cases:0.63%
controls:0.11%
cases:0.63%
controls:0.33%
26
37
1449
14514
9
15
1479
14656
—
—
—
9
15
1424
14126
7
37
1108
11026
Other internal psychiatric consultation
IAZ98 [2001304039]
—
3.2e+00
—
—
—
—
2.3e+00
—
—
cases:0.81%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.11%
—
12
5
1476
14666
—
—
—
—
12
12
1103
11051
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
6.5e-01
9.3e-01
1.1e+00
—
1.4e+00
7.4e-01
6.3e-01
cases:32.54%
controls:20.13%
cases:20.30%
controls:9.13%
cases:2.69%
controls:0.95%
—
—
cases:3.43%
controls:0.90%
cases:16.54%
controls:8.61%
cases:34.80%
controls:22.18%
480
2929
995
11622
302
1340
1186
13331
40
140
1448
14531
—
51
132
1436
14496
237
1218
1196
12923
388
2454
727
8609
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
9.9e-01
1.3e+00
9.9e-01
—
1.6e+00
6.7e-01
7.7e-01
cases:11.66%
controls:4.69%
cases:7.66%
controls:2.28%
cases:0.60%
controls:0.22%
—
—
cases:1.34%
controls:0.27%
cases:4.26%
controls:2.22%
cases:12.74%
controls:6.30%
172
683
1303
13868
114
334
1374
14337
9
33
1479
14638
—
20
39
1467
14589
61
314
1372
13827
142
697
973
10366
Functional capacity evaluation
443351003 [40481051]
1.2e+00
1.4e+00
—
—
2.8e+00
9.5e-01
7.7e-01
cases:2.92%
controls:0.91%
cases:1.08%
controls:0.28%
—
—
—
—
cases:0.54%
controls:0.03%
cases:0.77%
controls:0.30%
cases:1.79%
controls:0.84%
43
133
1432
14418
16
41
1472
14630
—
—
8
5
1479
14623
11
42
1422
14099
20
93
1095
10970
citalopram; oral, parenteral
N06AB04 [21604712]
1.2e+00
1.1e+00
1.3e+00
—
1.0e+00
1.6e+00
1.4e+00
cases:5.02%
controls:1.60%
cases:2.62%
controls:0.87%
cases:0.67%
controls:0.19%
—
—
cases:0.67%
controls:0.25%
cases:3.70%
controls:0.78%
cases:5.11%
controls:1.36%
74
233
1401
14318
39
127
1449
14544
10
28
1478
14643
—
10
36
1477
14592
53
111
1380
14030
57
150
1058
10913
Education problem
Z07 [2002001463]
1.2e+00
1.9e+00
—
—
—
—
2.2e+00
cases:1.02%
controls:0.31%
cases:0.54%
controls:0.08%
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.20%
15
45
1460
14506
8
12
1480
14659
—
—
—
—
19
22
1096
11041
Pharmacy visit
OMOP4822462 [581458]
2.8e-01
6.0e-01
7.3e-01
1.8e+00
8.7e-01
6.9e-01
5.0e-01
cases:93.02%
controls:90.96%
cases:83.20%
controls:73.01%
cases:46.84%
controls:29.81%
cases:8.87%
controls:1.55%
cases:49.97%
controls:29.55%
cases:84.65%
controls:73.35%
cases:94.35%
controls:90.99%
1372
13235
103
1316
1238
10711
250
3960
697
4373
791
10298
132
227
1356
14444
743
4322
744
10306
1213
10372
220
3769
1052
10066
63
997
Extensive initial psychiatric evaluation
IBA04 [2001304046]
1.3e+00
2.8e+00
—
1.0e+50
—
9.6e-01
1.2e+00
cases:2.85%
controls:0.81%
cases:3.09%
controls:0.20%
—
—
cases:0.60%
controls:0.00%
—
—
cases:0.63%
controls:0.24%
cases:2.42%
controls:0.78%
42
118
1433
14433
46
29
1442
14642
—
9
0
1479
14671
—
9
34
1424
14107
27
86
1088
10977
olanzapine and samidorphan
N05AH53 [955100]
1.6e+00
1.3e+00
—
—
—
1.5e+00
2.0e+00
cases:1.29%
controls:0.25%
cases:0.54%
controls:0.14%
—
—
—
—
—
—
cases:0.63%
controls:0.14%
cases:2.24%
controls:0.30%
19
37
1456
14514
8
21
1480
14650
—
—
—
9
20
1424
14121
25
33
1090
11030
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
1.0e+00
1.5e+00
1.8e+00
—
—
1.5e+00
1.1e+00
cases:2.98%
controls:1.09%
cases:1.01%
controls:0.23%
cases:0.34%
controls:0.05%
—
—
—
—
cases:1.19%
controls:0.27%
cases:2.60%
controls:0.85%
44
159
1431
14392
15
34
1473
14637
5
8
1483
14663
—
—
17
38
1416
14103
29
94
1086
10969
Rehabilitative psychiatric group intervention, functional
IER04 [2001304208]
1.5e+00
1.3e+00
—
—
—
1.6e+00
2.0e+00
cases:0.75%
controls:0.17%
cases:0.34%
controls:0.09%
—
—
—
—
—
—
cases:0.56%
controls:0.11%
cases:1.35%
controls:0.18%
11
25
1464
14526
5
13
1483
14658
—
—
—
8
16
1425
14125
15
20
1100
11043
moclobemide; oral
N06AG02 [21604727]
2.9e+00
2.1e+00
—
—
—
—
1.6e+00
cases:1.15%
controls:0.06%
cases:0.40%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.09%
17
9
1458
14542
6
7
1482
14664
—
—
—
—
5
10
1110
11053
clonazepam; oral, parenteral
N03AE01 [21604415]
1.2e+00
1.3e+00
—
—
—
1.2e+00
1.3e+00
cases:1.36%
controls:0.40%
cases:0.81%
controls:0.22%
—
—
—
—
—
—
cases:0.91%
controls:0.27%
cases:1.26%
controls:0.35%
20
58
1455
14493
12
32
1476
14639
—
—
—
13
38
1420
14103
14
39
1101
11024
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
6.6e-01
1.4e+00
—
—
—
1.8e+00
1.2e+00
cases:2.58%
controls:1.35%
cases:1.34%
controls:0.35%
—
—
—
—
—
—
cases:1.47%
controls:0.24%
cases:2.24%
controls:0.69%
38
196
1437
14355
20
51
1468
14620
—
—
—
21
34
1412
14107
25
76
1090
10987
Recurrent depressive disorder
F33 [45576542]
1.6e+00
1.7e+00
—
—
—
4.3e-01
1.7e+00
cases:1.56%
controls:0.31%
cases:1.01%
controls:0.19%
—
—
—
—
—
—
cases:0.35%
controls:0.23%
cases:1.70%
controls:0.31%
23
45
1452
14506
15
28
1473
14643
—
—
—
5
32
1428
14109
19
34
1096
11029
Office Visit
OMOP4822458 [581477]
3.2e-01
5.4e-01
1.2e+00
—
1.5e+00
7.6e-01
6.1e-01
cases:14.31%
controls:10.81%
cases:6.25%
controls:3.74%
cases:2.02%
controls:0.59%
—
—
cases:2.82%
controls:0.62%
cases:7.40%
controls:3.60%
cases:14.53%
controls:8.48%
211
1573
1264
12978
93
549
1395
14122
30
86
1458
14585
—
42
90
1445
14538
106
509
1327
13632
162
938
953
10125
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
3.7e-01
6.2e-01
6.0e-01
1.6e+00
8.3e-01
4.9e-01
4.1e-01
cases:41.15%
controls:32.58%
cases:32.06%
controls:20.32%
cases:6.79%
controls:3.84%
cases:0.81%
controls:0.16%
cases:7.80%
controls:3.54%
cases:29.10%
controls:20.05%
cases:46.28%
controls:36.44%
607
4740
868
9811
477
2981
1011
11690
101
563
1387
14108
12
23
1476
14648
116
518
1371
14110
417
2835
1016
11306
516
4031
599
7032
zopiclone; oral
N05CF01 [21604654]
8.3e-01
8.0e-01
1.4e+00
—
1.2e+00
1.0e+00
8.8e-01
cases:5.56%
controls:2.50%
cases:2.28%
controls:1.04%
cases:0.87%
controls:0.21%
—
—
cases:0.67%
controls:0.21%
cases:2.79%
controls:1.02%
cases:5.83%
controls:2.50%
82
364
1393
14187
34
153
1454
14518
13
31
1475
14640
—
10
31
1477
14597
40
144
1393
13997
65
277
1050
10786
Psychologist in multidisciplinary team
ZXY81 [2001311550]
2.0e+00
—
—
—
—
1.8e+00
2.9e+00
cases:0.95%
controls:0.12%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.06%
cases:0.81%
controls:0.05%
14
18
1461
14533
—
—
—
—
5
8
1428
14133
9
5
1106
11058
Visit based on need for special support
SPAT1389 [2001700489]
1.1e+00
1.2e+00
—
—
—
1.0e+00
1.6e+00
cases:6.58%
controls:2.33%
cases:2.15%
controls:0.63%
—
—
—
—
—
—
cases:0.98%
controls:0.35%
cases:3.32%
controls:0.70%
97
339
1378
14212
32
93
1456
14578
—
—
—
14
50
1419
14091
37
77
1078
10986
Other chronic pain
R52.2 [45568139]
1.5e+00
1.6e+00
—
—
—
2.0e+00
1.4e+00
cases:0.88%
controls:0.20%
cases:0.34%
controls:0.07%
—
—
—
—
—
—
cases:0.42%
controls:0.06%
cases:1.08%
controls:0.27%
13
29
1462
14522
5
10
1483
14661
—
—
—
6
8
1427
14133
12
30
1103
11033
Delayed milestone
R62.0 [45597195]
1.0e+00
1.6e+00
2.3e+00
—
—
7.7e-01
1.2e+00
cases:1.83%
controls:0.66%
cases:1.28%
controls:0.27%
cases:0.40%
controls:0.04%
—
—
—
—
cases:0.35%
controls:0.16%
cases:0.81%
controls:0.24%
27
96
1448
14455
19
40
1469
14631
6
6
1482
14665
—
—
5
23
1428
14118
9
27
1106
11036
Physical Medicine And Rehabilitation
25 [38004468]
8.8e-01
1.0e+00
8.9e-01
—
1.5e+00
9.2e-01
4.9e-01
cases:9.69%
controls:4.26%
cases:4.70%
controls:1.72%
cases:0.94%
controls:0.39%
—
—
cases:1.34%
controls:0.29%
cases:4.61%
controls:1.90%
cases:7.89%
controls:4.97%
143
620
1332
13931
70
252
1418
14419
14
57
1474
14614
—
20
43
1467
14585
66
268
1367
13873
88
550
1027
10513
propranolol; oral, parenteral
C07AA05 [21601670]
8.7e-01
1.0e+00
1.0e+00
—
9.4e-01
9.5e-01
9.4e-01
cases:10.98%
controls:4.89%
cases:6.18%
controls:2.31%
cases:1.21%
controls:0.43%
—
—
cases:1.08%
controls:0.42%
cases:5.93%
controls:2.38%
cases:11.84%
controls:5.00%
162
712
1313
13839
92
339
1396
14332
18
63
1470
14608
—
16
62
1471
14566
85
337
1348
13804
132
553
983
10510
Outreach service in patient’s home or everyday environment
ZYB04 [2001311573]
1.9e+00
—
—
—
—
—
2.9e+00
cases:0.81%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.05%
12
18
1463
14533
—
—
—
—
—
9
5
1106
11058
Occupational therapist
ZXY03 [2001311513]
2.0e+00
—
—
—
—
—
2.8e+00
cases:0.61%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.05%
9
12
1466
14539
—
—
—
—
—
8
5
1107
11058
Assessment of vocational rehabilitation needs in a mental health context
IBB03 [2001304050]
—
—
—
—
—
2.8e+00
2.0e+00
—
—
—
—
—
—
—
—
—
—
cases:0.56%
controls:0.04%
cases:0.54%
controls:0.07%
—
—
—
—
—
8
5
1425
14136
6
8
1109
11055
CBC panel - Blood by Automated count
58410-2 [40761511]
2.7e-01
5.1e-01
5.6e-01
1.8e+00
9.6e-01
4.8e-01
2.3e-01
cases:41.42%
controls:35.04%
cases:27.55%
controls:18.66%
cases:4.77%
controls:2.79%
cases:0.60%
controls:0.10%
cases:6.12%
controls:2.44%
cases:24.91%
controls:17.09%
cases:39.64%
controls:34.37%
611
5099
864
9452
410
2738
1078
11933
71
410
1417
14261
9
15
1479
14656
91
357
1396
14271
357
2417
1076
11724
442
3802
673
7261
Macroprolactin [Units/volume] in Serum or Plasma
74953-1 [44816844]
1.0e+00
1.1e+00
—
—
—
1.9e+00
1.8e+00
cases:1.90%
controls:0.68%
cases:0.60%
controls:0.20%
—
—
—
—
—
—
cases:0.63%
controls:0.09%
cases:1.79%
controls:0.30%
28
99
1447
14452
9
30
1479
14641
—
—
—
9
13
1424
14128
20
33
1095
11030
Hyperkinetic disorder
P81 [2002000875]
1.6e+00
1.9e+00
—
—
—
1.2e+00
1.3e+00
cases:1.36%
controls:0.27%
cases:1.28%
controls:0.20%
—
—
—
—
—
—
cases:0.63%
controls:0.20%
cases:1.88%
controls:0.54%
20
39
1455
14512
19
29
1469
14642
—
—
—
9
28
1424
14113
21
60
1094
11003
Moderate depressive episode
F32.1 [45552478]
1.4e+00
1.3e+00
1.7e+00
1.0e+50
—
1.1e+00
9.3e-01
cases:4.20%
controls:1.08%
cases:1.81%
controls:0.50%
cases:0.47%
controls:0.09%
cases:0.47%
controls:0.00%
—
—
cases:1.33%
controls:0.43%
cases:3.23%
controls:1.30%
62
157
1413
14394
27
73
1461
14598
7
13
1481
14658
7
0
1481
14671
—
19
61
1414
14080
36
144
1079
10919
Recurrent depression, severe episode without somatic syndrome
F33.30 [2000501986]
1.7e+00
—
—
—
—
—
3.0e+00
cases:0.75%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.08%
controls:0.05%
11
19
1464
14532
—
—
—
—
—
12
6
1103
11057
Occupational therapy
R4120 [2001310234]
9.1e-01
1.1e+00
—
1.0e+50
—
1.5e+00
1.1e+00
cases:1.76%
controls:0.71%
cases:0.87%
controls:0.29%
—
—
cases:0.34%
controls:0.00%
—
—
cases:1.54%
controls:0.33%
cases:2.78%
controls:0.91%
26
104
1449
14447
13
43
1475
14628
—
5
0
1483
14671
—
22
47
1411
14094
31
101
1084
10962
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
6.3e-01
8.9e-01
6.8e-01
2.3e+00
1.2e+00
6.7e-01
5.9e-01
cases:36.00%
controls:23.05%
cases:23.92%
controls:11.42%
cases:3.16%
controls:1.62%
cases:0.34%
controls:0.03%
cases:4.84%
controls:1.48%
cases:19.47%
controls:10.96%
cases:35.52%
controls:23.46%
531
3354
944
11197
356
1675
1132
12996
47
238
1441
14433
5
5
1483
14666
72
217
1415
14411
279
1550
1154
12591
396
2595
719
8468
Monitoring the use of the aid
R5140 [2001310249]
1.7e+00
1.5e+00
—
—
—
1.5e+00
8.5e-01
cases:2.24%
controls:0.43%
cases:1.01%
controls:0.23%
—
—
—
—
—
—
cases:1.12%
controls:0.25%
cases:1.61%
controls:0.70%
33
62
1442
14489
15
34
1473
14637
—
—
—
16
36
1417
14105
18
77
1097
10986
Chief Physician, Head of Department or Deputy Chief Physician
ZXY01 [2001311511]
1.6e+00
—
—
—
—
—
3.0e+00
cases:0.81%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:0.90%
controls:0.05%
12
23
1463
14528
—
—
—
—
—
10
5
1105
11058
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
4.6e-01
9.5e-01
9.7e-01
—
1.3e+00
5.1e-01
4.3e-01
cases:23.53%
controls:16.30%
cases:17.07%
controls:7.36%
cases:2.55%
controls:0.98%
—
—
cases:3.23%
controls:0.89%
cases:11.51%
controls:7.22%
cases:25.47%
controls:18.21%
347
2372
1128
12179
254
1080
1234
13591
38
144
1450
14527
—
48
130
1439
14498
165
1021
1268
13120
284
2015
831
9048
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
1.0e+00
1.2e+00
9.0e-01
—
1.3e+00
1.1e+00
1.3e+00
cases:1.29%
controls:0.46%
cases:1.28%
controls:0.37%
cases:0.40%
controls:0.16%
—
—
cases:0.34%
controls:0.09%
cases:1.19%
controls:0.40%
cases:1.97%
controls:0.57%
19
67
1456
14484
19
55
1469
14616
6
24
1482
14647
—
5
13
1482
14615
17
56
1416
14085
22
63
1093
11000
Amphetamines [Presence] in Urine
3349-8 [3027944]
8.6e-01
1.6e+00
1.6e+00
—
1.7e+00
2.6e-01
5.4e-01
cases:6.37%
controls:2.80%
cases:4.97%
controls:1.06%
cases:0.54%
controls:0.11%
—
—
cases:0.47%
controls:0.09%
cases:1.67%
controls:1.29%
cases:6.19%
controls:3.69%
94
408
1381
14143
74
155
1414
14516
8
16
1480
14655
—
7
13
1480
14615
24
183
1409
13958
69
408
1046
10655
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
6.1e-01
8.5e-01
7.2e-01
2.1e+00
1.3e+00
6.1e-01
5.6e-01
cases:40.88%
controls:27.38%
cases:27.89%
controls:14.23%
cases:3.97%
controls:1.97%
cases:0.34%
controls:0.04%
cases:6.12%
controls:1.83%
cases:23.24%
controls:14.17%
cases:42.06%
controls:29.39%
603
3984
872
10567
415
2087
1073
12584
59
289
1429
14382
5
6
1483
14665
91
267
1396
14361
333
2004
1100
12137
469
3251
646
7812
temazepam; oral
N05CD07 [21604642]
1.1e+00
1.1e+00
1.2e+00
—
1.3e+00
1.2e+00
1.2e+00
cases:3.59%
controls:1.22%
cases:1.88%
controls:0.65%
cases:0.54%
controls:0.16%
—
—
cases:0.61%
controls:0.17%
cases:2.09%
controls:0.67%
cases:4.48%
controls:1.41%
53
178
1422
14373
28
95
1460
14576
8
23
1480
14648
—
9
25
1478
14603
30
95
1403
14046
50
156
1065
10907
flupentixol; oral, parenteral
N05AF01 [21604531]
2.3e+00
—
—
—
—
—
2.2e+00
cases:0.68%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.99%
controls:0.11%
10
10
1465
14541
—
—
—
—
—
11
12
1104
11051
pramipexole; oral
N04BC05 [21604477]
1.3e+00
1.7e+00
—
—
—
1.5e+00
1.2e+00
cases:1.08%
controls:0.30%
cases:0.74%
controls:0.14%
—
—
—
—
—
—
cases:0.70%
controls:0.16%
cases:0.90%
controls:0.27%
16
43
1459
14508
11
20
1477
14651
—
—
—
10
22
1423
14119
10
30
1105
11033
Psychosocial counselling and guidance
SPAT1307 [2001700408]
1.3e+00
1.4e+00
1.7e+00
—
—
9.6e-01
8.2e-01
cases:8.14%
controls:2.32%
cases:2.28%
controls:0.57%
cases:0.34%
controls:0.06%
—
—
—
—
cases:1.19%
controls:0.46%
cases:3.32%
controls:1.48%
120
337
1355
14214
34
84
1454
14587
5
9
1483
14662
—
—
17
65
1416
14076
37
164
1078
10899
Depressive disorder
P76 [2002000870]
1.2e+00
1.1e+00
—
—
—
1.2e+00
9.2e-01
cases:4.88%
controls:1.46%
cases:1.68%
controls:0.55%
—
—
—
—
—
—
cases:1.33%
controls:0.40%
cases:4.04%
controls:1.65%
72
213
1403
14338
25
80
1463
14591
—
—
—
19
57
1414
14084
45
183
1070
10880
Child behaviour symptom/complaint
P22 [2002000817]
1.3e+00
1.5e+00
1.7e+00
—
1.7e+00
3.3e-01
-2.7e-01
cases:2.85%
controls:0.80%
cases:1.88%
controls:0.44%
cases:0.60%
controls:0.11%
—
—
cases:0.34%
controls:0.06%
cases:0.56%
controls:0.40%
cases:0.54%
controls:0.71%
42
116
1433
14435
28
64
1460
14607
9
16
1479
14655
—
5
9
1482
14619
8
57
1425
14084
6
78
1109
10985
Internal Medicine
11 [38004456]
2.6e-01
4.9e-01
7.8e-01
2.7e+00
8.6e-01
3.9e-01
3.8e-01
cases:13.49%
controls:10.71%
cases:6.18%
controls:3.89%
cases:1.48%
controls:0.68%
cases:0.74%
controls:0.05%
cases:1.61%
controls:0.69%
cases:5.37%
controls:3.72%
cases:14.80%
controls:10.61%
199
1558
1276
12993
92
571
1396
14100
22
100
1466
14571
11
7
1477
14664
24
101
1463
14527
77
526
1356
13615
165
1174
950
9889
Agoraphobia with concomitant panic disorder
F40.01 [2000501993]
1.9e+00
1.6e+00
—
1.0e+50
—
2.5e+00
1.7e+00
cases:0.61%
controls:0.09%
cases:0.34%
controls:0.07%
—
—
cases:0.40%
controls:0.00%
—
—
cases:0.63%
controls:0.05%
cases:0.54%
controls:0.10%
9
13
1466
14538
5
10
1483
14661
—
6
0
1482
14671
—
9
7
1424
14134
6
11
1109
11052
Psychological examination of need and possibilities to rehabilitation
R1220 [2001310175]
9.3e-01
2.3e+00
—
—
—
2.2e+00
5.5e-01
cases:0.88%
controls:0.35%
cases:0.67%
controls:0.07%
—
—
—
—
—
—
cases:0.49%
controls:0.06%
cases:0.63%
controls:0.36%
13
51
1462
14500
10
10
1478
14661
—
—
—
7
8
1426
14133
7
40
1108
11023
Other child protection assessment
IBC98 [2001304073]
2.0e+00
—
—
—
—
—
2.4e+00
cases:0.54%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.07%
8
11
1467
14540
—
—
—
—
—
9
8
1106
11055
Malaise and fatigue
R53 [45553741]
9.0e-01
7.1e-01
1.5e+00
—
5.0e-01
7.6e-01
5.3e-01
cases:7.25%
controls:3.07%
cases:2.69%
controls:1.34%
cases:0.74%
controls:0.17%
—
—
cases:0.34%
controls:0.21%
cases:2.93%
controls:1.39%
cases:7.09%
controls:4.28%
107
447
1368
14104
40
196
1448
14475
11
25
1477
14646
—
5
30
1482
14598
42
196
1391
13945
79
473
1036
10590
12 lead EKG panel
34534-8 [3044889]
5.4e-01
7.4e-01
9.6e-01
—
1.1e+00
4.5e-01
5.6e-01
cases:18.31%
controls:11.54%
cases:9.41%
controls:4.71%
cases:1.48%
controls:0.57%
—
—
cases:1.61%
controls:0.53%
cases:7.19%
controls:4.71%
cases:19.64%
controls:12.24%
270
1679
1205
12872
140
691
1348
13980
22
84
1466
14587
—
24
77
1463
14551
103
666
1330
13475
219
1354
896
9709
Assessment of need for medical rehabilitation
SPAT1215 [2001700316]
1.5e+00
1.9e+00
—
—
—
—
1.0e+00
cases:1.90%
controls:0.45%
cases:0.67%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.45%
28
65
1447
14486
10
15
1478
14656
—
—
—
—
14
50
1101
11013
Other negative life events in childhood
Z61.8 [45585844]
1.8e+00
—
—
—
—
2.5e+00
1.9e+00
cases:0.47%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.04%
cases:0.90%
controls:0.14%
7
12
1468
14539
—
—
—
—
6
5
1427
14136
10
15
1105
11048
Other depressive episodes
F32.8 [45571759]
1.8e+00
1.8e+00
—
—
—
1.3e+00
2.6e+00
cases:0.88%
controls:0.15%
cases:0.40%
controls:0.07%
—
—
—
—
—
—
cases:0.42%
controls:0.12%
cases:1.61%
controls:0.13%
13
22
1462
14529
6
10
1482
14661
—
—
—
6
17
1427
14124
18
14
1097
11049
levomepromazine; oral, parenteral
N05AA02 [21604493]
1.2e+00
1.2e+00
—
—
—
1.3e+00
1.8e+00
cases:1.36%
controls:0.40%
cases:0.81%
controls:0.25%
—
—
—
—
—
—
cases:1.05%
controls:0.29%
cases:2.78%
controls:0.48%
20
58
1455
14493
12
37
1476
14634
—
—
—
15
41
1418
14100
31
53
1084
11010
Social worker in multidisciplinary team
ZXY83 [2001311552]
1.9e+00
—
—
—
—
—
2.5e+00
cases:0.61%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.05%
9
14
1466
14537
—
—
—
—
—
7
6
1108
11057
Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14685-2 [3009035]
9.5e-01
1.3e+00
1.3e+00
—
1.8e+00
1.2e+00
8.8e-01
cases:6.03%
controls:2.42%
cases:2.82%
controls:0.80%
cases:0.40%
controls:0.11%
—
—
cases:0.40%
controls:0.07%
cases:2.37%
controls:0.74%
cases:5.74%
controls:2.47%
89
352
1386
14199
42
117
1446
14554
6
16
1482
14655
—
6
10
1481
14618
34
104
1399
14037
64
273
1051
10790
paroxetine; oral
N06AB05 [21604713]
1.4e+00
1.3e+00
1.4e+00
—
1.8e+00
1.1e+00
1.6e+00
cases:1.83%
controls:0.45%
cases:0.81%
controls:0.22%
cases:0.34%
controls:0.08%
—
—
cases:0.34%
controls:0.05%
cases:0.84%
controls:0.29%
cases:2.15%
controls:0.46%
27
66
1448
14485
12
32
1476
14639
5
12
1483
14659
—
5
8
1482
14620
12
41
1421
14100
24
51
1091
11012
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
5.5e-01
8.7e-01
8.2e-01
—
2.1e+00
5.7e-01
7.8e-01
cases:6.71%
controls:3.97%
cases:3.09%
controls:1.32%
cases:0.40%
controls:0.18%
—
—
cases:1.01%
controls:0.13%
cases:2.23%
controls:1.28%
cases:7.00%
controls:3.33%
99
578
1376
13973
46
194
1442
14477
6
26
1482
14645
—
15
19
1472
14609
32
181
1401
13960
78
368
1037
10695
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
9.8e-01
1.1e+00
8.3e-01
—
9.9e-01
9.7e-01
1.2e+00
cases:3.93%
controls:1.52%
cases:3.43%
controls:1.20%
cases:1.01%
controls:0.44%
—
—
cases:0.81%
controls:0.30%
cases:3.07%
controls:1.18%
cases:4.75%
controls:1.46%
58
221
1417
14330
51
176
1437
14495
15
65
1473
14606
—
12
44
1475
14584
44
167
1389
13974
53
161
1062
10902
modafinil; oral
N06BA07 [21604760]
2.2e+00
2.0e+00
—
—
—
1.9e+00
—
cases:0.61%
controls:0.07%
cases:0.40%
controls:0.05%
—
—
—
—
—
—
cases:0.42%
controls:0.06%
—
—
9
10
1466
14541
6
8
1482
14663
—
—
—
6
9
1427
14132
—
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
6.5e-01
8.1e-01
4.2e-01
—
1.4e+00
6.6e-01
6.3e-01
cases:15.39%
controls:8.65%
cases:10.35%
controls:4.89%
cases:0.94%
controls:0.62%
—
—
cases:2.62%
controls:0.64%
cases:8.72%
controls:4.69%
cases:19.10%
controls:11.13%
227
1259
1248
13292
154
718
1334
13953
14
91
1474
14580
—
39
94
1448
14534
125
663
1308
13478
213
1231
902
9832
calcium (different salts in combination); oral
A12AA20 [21600872]
6.2e-01
6.8e-01
2.8e-01
—
1.3e+00
7.1e-01
8.1e-01
cases:4.14%
controls:2.26%
cases:2.69%
controls:1.38%
cases:0.47%
controls:0.35%
—
—
cases:0.94%
controls:0.25%
cases:2.72%
controls:1.36%
cases:4.84%
controls:2.21%
61
329
1414
14222
40
203
1448
14468
7
52
1481
14619
—
14
36
1473
14592
39
192
1394
13949
54
245
1061
10818
Other function in accordance with nutritional therapy nomenclature
SPAT1298 [2001700399]
2.1e+00
—
—
—
—
—
2.0e+00
cases:0.61%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.08%
9
11
1466
14540
—
—
—
—
—
7
9
1108
11054
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
1.3e+00
1.5e+00
—
—
—
1.3e+00
7.1e-01
cases:5.08%
controls:1.50%
cases:2.02%
controls:0.44%
—
—
—
—
—
—
cases:1.54%
controls:0.41%
cases:2.24%
controls:1.11%
75
218
1400
14333
30
64
1458
14607
—
—
—
22
58
1411
14083
25
123
1090
10940
More than five and less than seven hours
ZXE30 [2001311411]
-4.7e-02
1.1e+00
—
—
—
2.4e+00
1.7e+00
cases:0.61%
controls:0.64%
cases:0.47%
controls:0.15%
—
—
—
—
—
—
cases:0.49%
controls:0.04%
cases:0.72%
controls:0.14%
9
93
1466
14458
7
22
1481
14649
—
—
—
7
6
1426
14135
8
15
1107
11048
Psychoeducation, family
IEP01 [2001304193]
1.7e+00
—
—
—
1.0e+50
—
2.4e+00
cases:0.61%
controls:0.11%
—
—
—
—
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.99%
controls:0.09%
9
16
1466
14535
—
—
—
5
0
1482
14628
—
11
10
1104
11053
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.2e-01
8.4e-01
3.7e-01
—
1.4e+00
6.5e-01
5.6e-01
cases:9.02%
controls:5.06%
cases:4.17%
controls:1.85%
cases:0.34%
controls:0.23%
—
—
cases:0.74%
controls:0.18%
cases:3.14%
controls:1.67%
cases:8.25%
controls:4.89%
133
737
1342
13814
62
271
1426
14400
5
34
1483
14637
—
11
27
1476
14601
45
236
1388
13905
92
541
1023
10522
pantoprazole; oral, parenteral
A02BC02 [21600097]
4.6e-01
5.9e-01
1.1e+00
—
8.5e-01
6.1e-01
3.9e-01
cases:13.69%
controls:9.06%
cases:6.79%
controls:3.89%
cases:1.68%
controls:0.55%
—
—
cases:1.48%
controls:0.64%
cases:7.05%
controls:3.97%
cases:13.45%
controls:9.50%
202
1319
1273
13232
101
571
1387
14100
25
81
1463
14590
—
22
93
1465
14535
101
561
1332
13580
150
1051
965
10012
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
1.1e+00
6.8e-01
—
—
—
1.5e+00
1.3e+00
cases:2.85%
controls:0.97%
cases:0.54%
controls:0.27%
—
—
—
—
—
—
cases:1.19%
controls:0.25%
cases:2.69%
controls:0.77%
42
141
1433
14410
8
40
1480
14631
—
—
—
17
36
1416
14105
30
85
1085
10978
lurasidone; oral
N05AE05 [43534827]
2.2e+00
—
—
—
—
—
1.7e+00
cases:0.54%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.13%
8
9
1467
14542
—
—
—
—
—
8
14
1107
11049
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
7.9e-01
7.8e-01
5.4e-01
—
1.6e+00
4.6e-01
7.9e-01
cases:10.85%
controls:5.21%
cases:4.77%
controls:2.24%
cases:0.54%
controls:0.31%
—
—
cases:1.34%
controls:0.29%
cases:3.21%
controls:2.04%
cases:9.96%
controls:4.80%
160
758
1315
13793
71
329
1417
14342
8
46
1480
14625
—
20
42
1467
14586
46
289
1387
13852
111
531
1004
10532
Developmental disorder of scholastic skills, unspecified
F81.9 [45581474]
1.6e+00
2.3e+00
—
—
—
—
1.5e+00
cases:0.75%
controls:0.15%
cases:0.54%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.45%
controls:0.10%
11
22
1464
14529
8
8
1480
14663
—
—
—
—
5
11
1110
11052
Observation for suspected nervous system disorder
Z03.3 [45609903]
1.0e+00
1.4e+00
—
—
—
1.4e+00
8.1e-01
cases:1.97%
controls:0.71%
cases:1.01%
controls:0.24%
—
—
—
—
—
—
cases:0.84%
controls:0.21%
cases:1.52%
controls:0.69%
29
104
1446
14447
15
35
1473
14636
—
—
—
12
29
1421
14112
17
76
1098
10987
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
1.1e+00
5.2e-01
—
—
—
1.3e+00
1.4e+00
cases:1.22%
controls:0.39%
cases:0.47%
controls:0.28%
—
—
—
—
—
—
cases:1.05%
controls:0.28%
cases:1.70%
controls:0.42%
18
57
1457
14494
7
41
1481
14630
—
—
—
15
40
1418
14101
19
46
1096
11017
Extensive assessment of psychosocial situation
SPAT1241 [2001700342]
1.6e+00
2.3e+00
—
—
—
—
1.4e+00
cases:1.02%
controls:0.21%
cases:0.40%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.14%
15
31
1460
14520
6
6
1482
14665
—
—
—
—
6
15
1109
11048
Therapeutic discussion
SPAT1240 [2001700341]
1.3e+00
1.7e+00
1.3e+00
—
8.7e-01
7.3e-01
8.5e-01
cases:10.44%
controls:3.12%
cases:4.23%
controls:0.82%
cases:0.74%
controls:0.21%
—
—
cases:0.54%
controls:0.23%
cases:1.47%
controls:0.71%
cases:4.93%
controls:2.17%
154
454
1321
14097
63
121
1425
14550
11
31
1477
14640
—
8
33
1479
14595
21
101
1412
14040
55
240
1060
10823
Evaluation of need for psychiatric rehabilitation
IBA02 [2001304044]
7.5e-01
1.8e+00
—
—
—
1.3e+00
2.0e+00
cases:0.81%
controls:0.38%
cases:0.74%
controls:0.12%
—
—
—
—
—
—
cases:0.49%
controls:0.13%
cases:1.52%
controls:0.22%
12
56
1463
14495
11
18
1477
14653
—
—
—
7
19
1426
14122
17
24
1098
11039
Audiology
64 [38004489]
6.2e-01
8.9e-01
1.5e+00
—
1.2e+00
7.7e-01
5.2e-01
cases:3.53%
controls:1.93%
cases:2.35%
controls:0.97%
cases:0.74%
controls:0.17%
—
—
cases:0.40%
controls:0.12%
cases:2.09%
controls:0.98%
cases:3.32%
controls:2.00%
52
281
1423
14270
35
143
1453
14528
11
25
1477
14646
—
6
17
1481
14611
30
138
1403
14003
37
221
1078
10842
Other specific personality disorders
F60.8 [45600756]
1.9e+00
—
—
—
—
2.3e+00
1.9e+00
cases:0.61%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.04%
cases:0.72%
controls:0.11%
9
14
1466
14537
—
—
—
—
5
5
1428
14136
8
12
1107
11051
2-person team, nurses
ZXY60 [2001311534]
1.4e+00
—
—
—
—
—
2.3e+00
cases:1.02%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:0.54%
controls:0.05%
15
36
1460
14515
—
—
—
—
—
6
6
1109
11057
Phosphatidylethanol [Mass/volume] in Blood
74661-0 [44816559]
9.4e-01
1.9e+00
—
—
—
8.6e-01
9.0e-01
cases:1.42%
controls:0.56%
cases:2.28%
controls:0.35%
—
—
—
—
—
—
cases:0.98%
controls:0.42%
cases:3.50%
controls:1.46%
21
82
1454
14469
34
52
1454
14619
—
—
—
14
59
1419
14082
39
161
1076
10902
Psychiatric functioning capacity evaluation
IBB01 [2001304048]
1.9e+00
—
—
—
—
—
1.8e+00
cases:0.61%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.63%
controls:0.10%
9
14
1466
14537
—
—
—
—
—
7
11
1108
11052
Psychiatric evaluation of working capacity and rehabilitation
IBB02 [2001304049]
9.0e-01
1.8e+00
—
—
—
2.0e+00
1.7e+00
cases:0.34%
controls:0.14%
cases:0.47%
controls:0.08%
—
—
—
—
—
—
cases:0.63%
controls:0.08%
cases:1.35%
controls:0.25%
5
20
1470
14531
7
12
1481
14659
—
—
—
9
12
1424
14129
15
28
1100
11035
Electroconvulsive Therapy (ECT)
IFB01 [2001304301]
1.9e+00
—
—
—
—
2.3e+00
1.7e+00
cases:0.61%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.35%
controls:0.04%
cases:0.72%
controls:0.13%
9
13
1466
14538
—
—
—
—
5
5
1428
14136
8
14
1107
11049
Depressive episode
F32 [45595904]
1.4e+00
1.3e+00
1.8e+00
—
—
7.3e-01
9.7e-01
cases:3.05%
controls:0.80%
cases:1.14%
controls:0.31%
cases:0.40%
controls:0.07%
—
—
—
—
cases:0.63%
controls:0.30%
cases:1.97%
controls:0.76%
45
116
1430
14435
17
45
1471
14626
6
10
1482
14661
—
—
9
43
1424
14098
22
84
1093
10979
topiramate; oral
N03AX11 [21604433]
8.8e-01
1.1e+00
1.7e+00
—
1.3e+00
9.9e-01
7.1e-01
cases:1.42%
controls:0.60%
cases:0.94%
controls:0.31%
cases:0.54%
controls:0.10%
—
—
cases:0.34%
controls:0.09%
cases:0.91%
controls:0.34%
cases:1.26%
controls:0.62%
21
87
1454
14464
14
46
1474
14625
8
15
1480
14656
—
5
13
1482
14615
13
48
1420
14093
14
69
1101
10994
Epilepsy, unspecified
G40.9 [45562083]
1.1e+00
1.1e+00
—
—
—
6.0e-01
1.4e+00
cases:1.36%
controls:0.45%
cases:0.87%
controls:0.29%
—
—
—
—
—
—
cases:0.49%
controls:0.27%
cases:2.06%
controls:0.52%
20
65
1455
14486
13
42
1475
14629
—
—
—
7
38
1426
14103
23
58
1092
11005
amitriptyline; oral, parenteral
N06AA09 [21604696]
7.7e-01
7.9e-01
8.8e-01
—
1.3e+00
7.6e-01
4.0e-01
cases:6.03%
controls:2.89%
cases:2.96%
controls:1.36%
cases:0.74%
controls:0.31%
—
—
cases:0.87%
controls:0.24%
cases:2.93%
controls:1.39%
cases:4.13%
controls:2.79%
89
420
1386
14131
44
200
1444
14471
11
45
1477
14626
—
13
35
1474
14593
42
197
1391
13944
46
309
1069
10754
Feeding problem of adult
T05 [2002001069]
1.8e+00
1.8e+00
—
—
—
—
1.8e+00
cases:0.81%
controls:0.13%
cases:0.40%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.26%
controls:0.22%
12
19
1463
14532
6
10
1482
14661
—
—
—
—
14
24
1101
11039
Psychiatric/psychological examination
SPAT1243 [2001700344]
1.4e+00
2.2e+00
—
—
—
1.1e+00
8.4e-01
cases:3.05%
controls:0.75%
cases:1.41%
controls:0.16%
—
—
—
—
—
—
cases:0.42%
controls:0.13%
cases:1.43%
controls:0.62%
45
109
1430
14442
21
24
1467
14647
—
—
—
6
19
1427
14122
16
69
1099
10994
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
3.8e-01
6.7e-01
7.7e-01
—
1.3e+00
5.9e-01
6.6e-01
cases:10.51%
controls:7.45%
cases:6.12%
controls:3.22%
cases:1.01%
controls:0.47%
—
—
cases:1.55%
controls:0.43%
cases:5.23%
controls:2.98%
cases:13.09%
controls:7.23%
155
1084
1320
13467
91
472
1397
14199
15
69
1473
14602
—
23
63
1464
14565
75
422
1358
13719
146
800
969
10263
Obesity
T82 [2002001125]
9.9e-01
1.5e+00
—
—
2.3e+00
1.1e+00
1.1e+00
cases:1.15%
controls:0.43%
cases:0.67%
controls:0.15%
—
—
—
—
cases:0.34%
controls:0.03%
cases:0.84%
controls:0.27%
cases:1.52%
controls:0.53%
17
63
1458
14488
10
22
1478
14649
—
—
5
5
1482
14623
12
38
1421
14103
17
59
1098
11004
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
4.4e-01
7.0e-01
4.8e-01
1.5e+00
9.2e-01
5.4e-01
4.3e-01
cases:41.22%
controls:31.15%
cases:32.46%
controls:19.21%
cases:5.85%
controls:3.71%
cases:0.47%
controls:0.11%
cases:8.07%
controls:3.37%
cases:28.96%
controls:19.14%
cases:45.92%
controls:35.64%
608
4532
867
10019
483
2819
1005
11852
87
544
1401
14127
7
16
1481
14655
120
493
1367
14135
415
2707
1018
11434
512
3943
603
7120
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
8.9e-01
5.7e-01
1.4e+00
—
1.7e+00
3.9e-01
8.5e-01
cases:6.24%
controls:2.67%
cases:1.88%
controls:1.07%
cases:0.47%
controls:0.12%
—
—
cases:0.54%
controls:0.10%
cases:1.40%
controls:0.95%
cases:4.75%
controls:2.09%
92
388
1383
14163
28
157
1460
14514
7
17
1481
14654
—
8
14
1479
14614
20
134
1413
14007
53
231
1062
10832
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
6.2e-01
7.0e-01
3.3e-01
—
9.7e-01
5.6e-01
6.2e-01
cases:17.56%
controls:10.29%
cases:9.54%
controls:4.99%
cases:1.14%
controls:0.82%
—
—
cases:2.35%
controls:0.91%
cases:6.98%
controls:4.12%
cases:15.16%
controls:8.74%
259
1498
1216
13053
142
732
1346
13939
17
121
1471
14550
—
35
133
1452
14495
100
583
1333
13558
169
967
946
10096
Observation for other suspected diseases and conditions
Z03.80 [2000503756]
1.5e+00
1.6e+00
—
—
—
1.6e+00
2.0e+00
cases:1.49%
controls:0.34%
cases:0.47%
controls:0.10%
—
—
—
—
—
—
cases:0.49%
controls:0.10%
cases:1.61%
controls:0.23%
22
50
1453
14501
7
14
1481
14657
—
—
—
7
14
1426
14127
18
25
1097
11038
Sleep disorder, unspecified
G47.9 [45595948]
1.5e+00
1.3e+00
—
—
—
1.9e+00
7.2e-01
cases:0.88%
controls:0.19%
cases:0.40%
controls:0.11%
—
—
—
—
—
—
cases:0.70%
controls:0.11%
cases:0.63%
controls:0.31%
13
28
1462
14523
6
16
1482
14655
—
—
—
10
15
1423
14126
7
34
1108
11029
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
1.3e+00
1.5e+00
—
1.0e+50
—
2.1e+00
1.2e+00
cases:0.95%
controls:0.25%
cases:0.47%
controls:0.11%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.63%
controls:0.08%
cases:0.81%
controls:0.24%
14
37
1461
14514
7
16
1481
14655
—
5
0
1483
14671
—
9
11
1424
14130
9
26
1106
11037
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
2.1e-01
4.4e-01
3.4e-01
1.1e+00
7.0e-01
3.7e-01
2.2e-01
cases:48.20%
controls:43.07%
cases:39.99%
controls:29.94%
cases:8.33%
controls:6.06%
cases:0.94%
controls:0.31%
cases:10.69%
controls:5.63%
cases:36.85%
controls:28.72%
cases:52.83%
controls:47.25%
711
6267
764
8284
595
4393
893
10278
124
889
1364
13782
14
45
1474
14626
159
824
1328
13804
528
4062
905
10079
589
5227
526
5836
Other specified special examinations
Z01.8 [45581003]
6.9e-01
1.2e+00
1.3e+00
—
1.3e+00
9.7e-01
5.8e-01
cases:5.76%
controls:2.98%
cases:3.02%
controls:0.95%
cases:0.67%
controls:0.18%
—
—
cases:0.54%
controls:0.15%
cases:2.65%
controls:1.03%
cases:5.20%
controls:2.98%
85
433
1390
14118
45
140
1443
14531
10
26
1478
14645
—
8
22
1479
14606
38
145
1395
13996
58
330
1057
10733
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
6.1e-01
7.1e-01
3.1e-01
—
8.6e-01
5.6e-01
6.4e-01
cases:16.54%
controls:9.73%
cases:8.74%
controls:4.51%
cases:1.01%
controls:0.74%
—
—
cases:1.95%
controls:0.83%
cases:6.28%
controls:3.68%
cases:13.99%
controls:7.87%
244
1416
1231
13135
130
661
1358
14010
15
109
1473
14562
—
29
122
1458
14506
90
521
1343
13620
156
871
959
10192
Psychoeducation, individual
IEY01 [2001304220]
1.4e+00
1.9e+00
—
—
—
1.9e+00
1.3e+00
cases:0.75%
controls:0.18%
cases:0.40%
controls:0.06%
—
—
—
—
—
—
cases:0.49%
controls:0.07%
cases:0.90%
controls:0.24%
11
26
1464
14525
6
9
1482
14662
—
—
—
7
10
1426
14131
10
27
1105
11036
Fear of mental disorder
P27 [2002000821]
1.2e+00
2.1e+00
—
—
—
—
9.4e-01
cases:0.88%
controls:0.26%
cases:0.40%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.72%
controls:0.28%
13
38
1462
14513
6
7
1482
14664
—
—
—
—
8
31
1107
11032
Internal hemorrhoids without complication
I84.2 [45596267]
1.2e+00
—
—
—
—
2.2e+00
—
cases:0.95%
controls:0.29%
—
—
—
—
—
—
—
—
cases:0.49%
controls:0.06%
—
—
14
42
1461
14509
—
—
—
—
7
8
1426
14133
—
Prolactin [Units/volume] in Serum or Plasma
15081-3 [3021387]
4.4e-01
1.2e+00
—
—
2.1e+00
1.1e+00
1.0e+00
cases:3.05%
controls:1.98%
cases:1.75%
controls:0.55%
—
—
—
—
cases:0.34%
controls:0.04%
cases:1.67%
controls:0.57%
cases:4.22%
controls:1.52%
45
288
1430
14263
26
81
1462
14590
—
—
5
6
1482
14622
24
80
1409
14061
47
168
1068
10895

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
290
909
3.67
77.49
3.0
3.2
—
—
—
0
0
290
937
3.55
73.77
1.7
1.5
1129.99
1127.72
nmol/l
0.01
225
738
787
4488
2.50
68.02
5.6
9.8
1.23
1.22
mmol/l
1.71
735
4259
482
2231
2.66
64.03
1.7
1.4
17.91
19.09
nmol/l
1.09
435
2025
833
4984
2.42
63.24
6.2
9.1
1.22
1.22
mmol/l
0.90
732
4499
669
3650
2.44
62.27
2.0
1.7
98.53
97.71
pmol/l
0.18
410
2063
362
1493
2.84
59.77
1.6
1.5
423.45
30632398.56
pmol/l
1.54
306
1345
1328
10014
3.10
59.44
5.4
4.0
14.48
14.47
pmol/l
0.05
1237
9268
572
3098
2.32
52.05
2.6
2.8
2.36
2.37
mmol/l
0.54
530
2898
115
248
4.90
50.06
6.3
5.8
393.91
382.77
umol/l
0.31
99
229
1106
7926
2.32
49.62
6.4
6.8
89.62
86.06
u/l
0.96
1037
7562
828
5307
2.17
48.81
3.1
3.0
66.66
68.40
nmol/l
1.17
784
5076
345
1548
2.56
47.10
3.4
3.0
—
—
—
0
0
1412
11464
3.29
46.67
6.6
4.6
1.86
1.78
mu/l
2.41
1361
10975
1437
11822
3.53
45.68
13.1
11.0
139.79
139.53
mmol/l
5.92
1403
11531
1436
11845
3.48
44.68
13.1
11.1
3.87
3.91
mmol/l
7.73
1397
11503
1274
10031
2.41
40.84
4.7
3.0
5.56
5.50
mmol/l
0.86
1203
9483
662
4135
2.03
39.12
3.7
3.8
29.01
31.03
u/l
0.95
630
3952
77
145
5.51
39.01
11.3
12.6
0.58
0.59
mmol/l
0.15
67
137
177
625
3.05
37.76
3.3
3.3
7.38
7.33
ph
3.88
137
474
352
1772
2.26
36.16
2.7
2.3
—
—
—
0
0
545
3354
1.95
32.09
3.8
4.0
8.62
9.22
mmol/l
1.38
464
3084
512
3091
1.96
31.86
2.3
2.7
2.51
2.51
mg/l
0.00
442
2739
208
878
2.57
31.40
1.6
1.7
0.15
0.23
mg/l
2.60
74
402
619
4004
1.89
31.12
4.7
6.3
38.64
38.25
g/l
1.08
563
3800
443
2570
2.00
30.74
3.1
4.1
7.39
7.39
ph
0.31
307
1722
287
1419
2.24
30.32
2.2
2.3
355.74
370.73
nmol/l
0.65
274
1343
45
65
7.07
29.61
2.0
2.1
17.31
13.57
umol/l
0.96
45
65
493
3013
1.92
29.08
2.7
2.8
53.96
57.02
u/l
0.84
441
2835
418
2418
1.98
28.99
2.9
2.4
288.81
290.49
u/l
0.01
401
2337
713
4972
1.78
26.95
4.7
6.4
13.02
13.77
umol/l
0.31
645
4674
365
2071
1.98
26.45
2.8
2.2
—
—
—
0
0
233
1144
2.21
24.71
2.0
1.7
392.67
303.68
mu/l
2.52
200
1035
843
6318
1.71
23.50
4.8
6.1
6.06
6.16
mmol/l
0.63
779
5780
374
2220
1.89
23.34
2.9
2.2
—
—
—
0
0
374
2231
1.88
22.94
2.8
2.2
—
—
—
0
0
374
2238
1.87
22.68
2.8
2.2
—
—
—
0
0
1114
9072
1.77
22.46
4.4
3.5
32.73
31.95
u/l
0.23
1070
8791
60
1892
0.29
22.04
1.2
1.2
—
—
—
0
0
1469
13207
2.72
21.55
13.7
10.9
67.28
68.72
umol/l
2.25
1454
13037
43
82
5.34
21.48
4.9
4.2
264.22
207.95
umol/l
0.33
23
42
1461
13161
2.56
20.23
10.8
9.0
29.52
27.93
u/l
1.67
1430
12869
72
1930
0.34
19.05
1.5
1.6
1041.82
966.08
mu/l
0.19
61
1692
86
310
2.86
17.53
1.9
1.6
427.53
377.16
mu/l
0.48
73
253
351
2208
1.75
17.49
2.4
2.1
—
—
—
0
0
639
4739
1.58
16.48
1.6
1.6
1.61
2.08
u/ml
0.39
152
1140
66
213
3.18
16.32
1.9
2.5
—
—
—
0
0
27
45
6.06
15.52
1.7
2.5
—
—
—
0
0
897
7240
1.55
15.49
7.6
8.0
2.16
2.13
e9/l
0.52
790
6403
894
7220
1.54
15.32
8.2
8.6
0.18
0.20
e9/l
1.97
771
6318
91
2010
0.42
15.29
1.6
1.6
3.50
3.54
ratio
0.09
61
1415
123
563
2.28
15.27
3.3
4.3
1.22
1.23
mmol/l
0.98
104
488
465
3256
1.60
15.02
5.7
6.2
1.06
1.10
inr
1.24
410
2719
869
6997
1.53
14.94
7.6
8.1
0.04
0.04
e9/l
0.71
743
6025
868
6991
1.53
14.87
7.6
8.1
0.53
0.55
e9/l
2.09
744
6021
934
7644
1.54
14.84
12.5
10.3
3.68
3.81
e9/l
1.26
815
6539
1124
9598
1.59
14.66
4.8
3.7
35.85
36.09
mmol/mol
0.37
1046
9272
560
4112
1.55
14.64
1.9
1.8
1.49
1.35
mmol/l
1.35
477
3781
162
846
2.01
14.33
2.9
3.4
4.97
4.84
pmol/l
0.96
145
773
814
6504
1.51
14.21
7.9
8.2
0.66
0.66
%
0.00
756
6198
813
6538
1.49
13.47
7.9
8.2
8.14
8.41
%
2.69
756
6232
433
5822
0.64
13.41
2.6
2.4
—
—
—
0
0
795
6375
1.49
13.29
10.8
10.3
0.00
0.00
e9/l
0.69
649
5076
268
1678
1.71
13.24
5.2
9.8
1.18
1.22
mmol/l
1.61
252
1593
809
6520
1.49
13.12
7.8
8.1
2.73
2.95
%
2.17
749
6211
839
6857
1.47
12.39
7.7
8.0
33.08
32.25
%
1.50
789
6603
188
1083
1.83
12.34
2.8
3.8
0.23
0.22
g/l
0.72
174
1031
522
3886
1.51
12.32
6.1
7.2
—
—
—
0
0
1224
10818
1.58
12.24
4.4
3.5
2.81
2.77
mmol/l
0.94
1153
10401
879
7267
1.47
12.11
3.5
3.4
64.14
69.72
ug/l
0.77
814
6969
1223
10823
1.57
11.99
4.2
3.4
4.55
4.56
mmol/l
0.16
1157
10455
72
1590
0.42
11.89
1.6
1.5
3.39
3.36
mmol/l
0.06
47
1011
822
6729
1.45
11.79
7.7
7.8
52.86
53.34
%
0.59
778
6513
273
3972
0.62
11.59
2.3
2.0
—
—
—
0
0
217
1341
1.71
11.15
2.1
2.2
2.38
2.40
mmol/l
2.51
189
1177
1209
10744
1.53
10.90
4.2
3.3
1.31
1.39
mmol/l
11.50
1141
10334
1136
9977
1.49
10.75
3.5
3.0
1.33
1.20
mmol/l
5.11
1064
9561
247
1596
1.64
10.69
5.3
7.5
0.82
0.82
mmol/l
0.23
232
1539
264
1742
1.61
10.49
2.3
2.8
15.01
14.86
umol/l
0.11
244
1642
313
2155
1.56
10.36
2.6
2.8
573.19
575.40
mosm/kgh2o
0.05
278
1913
244
1593
1.62
10.10
2.2
2.8
2.61
2.51
g/l
2.03
217
1484
163
955
1.78
10.08
5.7
5.4
0.03
0.04
%
0.20
40
226
233
1506
1.63
10.04
2.4
2.3
10.42
12.63
nmol/l
2.71
201
1414
210
1322
1.67
10.03
5.5
8.3
5.15
5.04
kpa
1.18
199
1282
21
777
0.26
9.98
1.3
1.5
—
—
—
0
0
208
1310
1.67
9.91
5.5
8.4
7.40
7.41
ph
1.29
175
1085
57
226
2.57
9.76
2.7
4.6
—
—
—
0
0
51
193
2.69
9.58
4.0
4.9
1.92
2.01
mmol/l
0.10
32
112
23
789
0.28
9.58
1.5
1.6
—
—
—
0
0
21
758
0.27
9.57
1.3
1.5
1.17
1.27
mm
0.47
13
553
66
285
2.36
9.43
2.1
3.9
32.66
34.77
umol/l
0.48
58
275
156
926
1.75
9.22
4.5
4.8
0.20
0.53
%
2.24
45
249
61
261
2.38
8.91
1.5
1.4
12.41
12.61
u/l
0.02
47
229
219
1434
1.61
8.91
2.2
2.9
24.48
23.78
%
0.26
201
1356
24
762
0.30
8.68
1.0
1.1
—
0.61
—
0
51
28
821
0.33
8.67
1.4
1.5
—
—
—
0
0
365
2683
1.46
8.67
3.1
2.4
12.84
136.75
ng/l
0.65
167
1084
540
4269
1.40
8.53
1.6
1.6
1.83
1.92
g/l
0.88
301
2641
157
963
1.69
8.24
5.6
5.1
0.61
0.70
%
0.17
41
261
153
938
1.69
8.05
5.7
5.2
0.00
0.07
%
2.30
38
236
199
1310
1.59
7.89
1.3
1.2
93.63
139.55
u/ml
0.85
63
464
318
2344
1.44
7.32
2.6
3.0
8.08
7.90
e6/l
0.06
288
2118
252
1783
1.49
7.16
3.3
4.0
140.83
72.51
mg/l
0.36
156
1326
265
1899
1.47
7.05
1.4
1.5
282.93
504.95
titre
3.01
41
311
252
1791
1.48
6.99
4.1
4.8
4.31
19.74
mg/mmol
1.12
151
1314
343
4395
0.71
6.87
1.8
1.8
—
—
—
0
0
1185
12652
0.72
6.67
17.6
13.8
334.60
335.11
g/l
1.09
1176
12568
249
1783
1.46
6.63
1.3
1.2
—
—
—
0
0
452
3619
1.34
6.20
3.6
3.6
83.92
47.28
e6/l
0.30
354
2656
1423
13471
1.56
6.10
11.8
8.7
—
—
—
0
0
159
1059
1.55
5.99
1.9
1.9
7.26
6.76
u/l
0.26
122
772
218
1561
1.45
5.79
4.3
8.6
7.37
7.37
ph
0.03
142
1023
219
1572
1.45
5.74
4.3
8.5
5.87
5.84
kpa
0.25
214
1532
205
1453
1.47
5.74
4.2
8.5
4.87
5.07
kpa
0.85
200
1418
216
1547
1.45
5.73
4.3
8.6
1.35
1.17
mmol/l
0.40
181
1277
411
3284
1.33
5.64
3.3
3.3
0.00
0.00
estimate
1.23
172
1231
389
4736
0.76
5.23
1.6
1.8
—
—
—
0
0
34
144
2.38
5.20
1.1
1.1
—
—
—
0
0
151
1033
1.50
5.04
2.9
3.4
—
—
—
0
0
1524
14766
2.01
5.00
21.7
16.5
271.07
262.10
e9/l
6.61
1484
14415
115
747
1.58
4.86
4.8
7.3
53.01
63.84
ng/l
2.17
101
716
1524
14779
1.97
4.77
21.5
16.4
87.80
88.18
fl
2.39
1505
14661
1524
14780
1.97
4.76
21.9
17.1
41.20
41.88
%
0.77
1506
14656
1524
14781
1.97
4.74
21.5
16.4
29.47
29.64
pg
3.20
1505
14663
1524
14782
1.97
4.72
21.6
16.4
4.72
4.68
e12/l
3.11
1483
14411
53
279
1.92
4.71
1.6
1.4
343.08
347.93
ug/g
0.05
24
144
73
425
1.74
4.71
1.8
1.6
0.28
0.35
nmol/l
0.79
59
342
1524
14787
1.95
4.64
21.8
16.6
138.66
138.16
g/l
0.74
1506
14671
190
1385
1.42
4.57
2.1
5.1
6.51
6.30
umol/l
0.09
157
1172
27
110
2.47
4.51
1.1
1.4
—
—
nmol/l
—
0
0
1524
14795
1.93
4.50
21.7
16.5
6.75
6.77
e9/l
0.16
1484
14415
329
2627
1.31
4.42
2.4
3.2
122.89
108.45
ug/g
0.22
222
2147
46
237
1.96
4.37
1.5
1.6
0.51
0.52
e9/l
0.08
46
237
383
3126
1.29
4.37
3.3
3.0
1.02
2.08
kg/l
0.80
257
1921
261
2021
1.34
4.34
1.4
1.3
20.69
23.08
iu/ml
0.13
46
474
190
1399
1.40
4.32
3.8
2.7
3.92
4.88
e9/l
1.37
160
1268
10
16
6.26
4.28
2.4
1.4
33.74
33.80
nmol/l
—
10
16
398
3273
1.28
4.27
5.4
4.7
—
—
—
0
0
68
402
1.72
4.19
1.9
2.1
2.27
3.75
iu/l
2.15
31
182
15
39
3.86
4.17
1.6
1.2
78.87
79.15
nmol/24h
0.00
15
39
177
1297
1.40
4.14
3.2
4.7
548.32
801.48
ng/l
0.40
125
996
392
3231
1.28
4.11
3.5
3.5
0.30
0.26
e6/l
0.18
294
2284
152
1095
1.42
3.92
6.3
8.5
—
—
—
0
0
25
532
0.46
3.82
1.1
1.2
—
—
—
0
0
25
530
0.46
3.79
1.1
1.2
—
—
—
0
0
159
1163
1.40
3.77
1.2
1.3
—
—
—
0
0
137
1864
0.71
3.71
1.5
1.5
—
—
—
0
0
128
908
1.44
3.61
2.3
2.2
12.12
15.66
au/ml
—
10
114
31
149
2.09
3.60
1.6
1.4
1.11
1.43
promille
0.61
22
112
234
1834
1.32
3.57
1.3
1.3
7.11
6.11
u/ml
0.10
85
707
448
5171
0.81
3.55
2.7
3.0
—
—
estimate
—
0
0
283
2279
1.29
3.53
3.5
4.1
—
—
—
0
0
337
2780
1.26
3.46
2.5
2.3
—
—
—
0
0
21
87
2.42
3.44
1.0
1.2
—
—
—
0
0
1366
13068
1.32
3.31
12.0
10.9
19.75
21.29
mg/l
1.04
994
9981
298
3574
0.79
3.30
2.3
2.6
—
—
—
0
0
13
38
3.43
3.29
3.6
2.7
—
—
—
0
0
51
301
1.71
3.23
2.1
3.0
124.63
288.33
ug/l
2.64
44
283
75
491
1.55
3.16
1.9
1.8
0.00
0.01
estimate
0.50
34
182
6
8
7.49
3.04
1.5
2.6
—
—
—
0
0
69
1026
0.65
3.02
1.3
1.3
243.45
245.40
miu/ml
0.01
20
502
142
1065
1.36
2.94
6.7
9.1
9.62
9.73
kpa
0.32
135
1036
892
8213
1.19
2.88
4.3
4.0
—
3.79
—
0
7
185
1447
1.31
2.88
5.8
11.9
—
—
—
0
0
15
58
2.59
2.85
1.7
2.7
—
—
—
0
0
61
914
0.65
2.78
1.9
2.0
6.13
6.30
ph
0.67
43
555
7
14
5.00
2.72
1.3
1.5
59.86
55.79
ug/l
—
7
14
445
5034
0.83
2.72
2.5
2.2
—
—
—
0
0
23
111
2.08
2.70
1.3
1.2
60.92
33.59
u/l
0.21
23
103
13
49
2.66
2.60
1.0
1.2
—
—
—
0
0
121
905
1.36
2.57
1.9
1.9
0.00
0.02
estimate
0.78
37
235
11
36
3.06
2.55
1.1
1.3
—
—
—
0
0
168
1320
1.30
2.55
1.4
1.4
194.24
354.54
u/ml
1.31
157
1224
49
307
1.61
2.54
2.9
10.7
64.19
67.94
%
0.65
49
301
105
774
1.38
2.45
1.2
1.2
—
—
—
0
0
5
8
6.24
2.36
1.0
1.3
592.38
351.76
nmol/l
—
5
8
104
1370
0.74
2.35
1.7
1.4
—
—
—
0
0
176
1408
1.28
2.34
2.1
1.6
—
—
—
0
0
62
420
1.49
2.30
1.2
1.7
81.43
80.74
titre
—
7
54
152
1198
1.29
2.27
1.3
1.2
62.00
168.90
titre
—
5
40
70
488
1.45
2.26
1.5
1.7
4.75
8.71
u/ml
0.78
17
138
42
648
0.64
2.24
1.2
1.2
—
—
—
0
0
30
173
1.74
2.15
3.0
5.8
5.01
6.16
pmol/l
0.92
30
173
822
7632
1.15
2.09
4.4
3.9
256.93
965.76
e6/l
0.66
14
88
63
438
1.45
2.08
1.4
2.6
67.33
66.83
g/l
0.19
58
419
148
1177
1.28
2.08
1.9
1.8
11.24
12.41
iu/l
0.28
115
890
506
4538
1.16
2.06
4.6
4.2
54.75
58.30
e6/l
0.05
366
2900
5
10
4.99
2.06
2.2
2.5
—
—
—
0
0
325
3697
0.84
2.03
1.8
1.8
—
—
—
0
0
142
1129
1.28
2.01
2.1
2.5
25.93
75.74
u/l
0.61
114
942
23
126
1.83
1.96
1.1
1.3
0.17
0.15
nmol/l
0.69
16
100
94
710
1.34
1.93
1.8
1.8
33.13
37.05
nmol/l
1.03
94
700
38
241
1.58
1.93
1.2
1.7
—
—
—
0
0
231
1951
1.21
1.90
3.5
3.2
3.36
2.78
e6/l
0.36
119
915
21
114
1.85
1.85
1.2
1.2
109.81
118.98
pmol/l
0.41
21
114
11
46
2.39
1.83
1.4
1.5
127.91
142.12
nmol/l
0.50
11
46
35
531
0.65
1.78
1.5
1.4
2.82
4.63
ug/l
2.33
30
502
152
1243
1.24
1.72
2.5
3.4
10.30
9.92
g/l
0.66
139
1170
7
24
2.91
1.71
1.6
4.2
38.70
141.04
ng/l
—
7
24
7
24
2.91
1.71
1.0
1.3
—
—
—
0
0
20
110
1.82
1.71
1.2
1.2
1.50
1.83
mmol/l
2.07
20
102
123
986
1.26
1.66
1.6
2.0
1.13
1.11
g/l
0.11
110
932
154
1267
1.23
1.66
2.5
2.7
1.05
1.12
ug/l
0.23
131
1156
47
326
1.45
1.63
2.3
2.2
—
—
—
0
0
97
760
1.29
1.58
3.4
4.5
66.71
68.33
e9/l
0.18
70
474
20
114
1.76
1.54
1.4
1.3
—
—
—
0
0
0
42
0.00
1.52
0.0
2.2
—
97.38
—
0
42
56
408
1.38
1.50
3.0
4.1
65.37
131.96
ng/l
2.27
46
342
45
321
1.41
1.38
1.0
1.1
—
—
—
0
0
14
74
1.89
1.37
1.0
1.7
31.93
32.30
pg
0.15
14
74
35
241
1.46
1.30
2.5
3.9
3.43
3.66
e9/l
0.37
35
241
29
424
0.67
1.30
1.0
1.2
—
—
—
0
0
41
292
1.41
1.28
4.0
6.0
—
—
—
0
0
23
145
1.59
1.27
1.1
1.3
99.87
189.32
pmol/l
2.54
23
145
45
328
1.38
1.24
1.1
1.1
—
—
—
0
0
184
1588
1.17
1.24
2.7
2.6
8890.96
7760.80
u/l
0.08
43
600
95
769
1.24
1.24
6.1
13.1
0.74
0.15
mmol/l
0.75
71
634
6
25
2.39
1.23
1.0
1.1
—
—
—
0
0
18
108
1.67
1.20
1.5
1.5
—
—
—
0
0
66
513
1.29
1.20
1.1
1.1
1.57
5.67
eliau/ml
—
7
80
40
540
0.73
1.17
1.8
1.9
—
—
—
0
0
15
247
0.60
1.16
1.7
1.7
7.11
7.54
mmol/l
0.51
15
239
43
316
1.36
1.15
2.3
3.2
33.82
21.88
mu/l
0.44
37
298
37
265
1.40
1.14
1.1
1.1
—
—
—
0
0
39
526
0.73
1.14
3.2
3.5
15.07
7.37
umol/l
0.35
26
425
181
1575
1.16
1.11
3.0
3.2
181.29
968.53
ng/l
3.70
86
820
11
58
1.89
1.11
1.5
1.4
162.89
165.83
mmol/24h
0.02
11
58
8
41
1.95
1.08
1.0
1.2
—
—
—
0
0
51
390
1.31
1.07
1.4
2.9
3.35
3.47
mmol/l
0.88
51
371
16
252
0.63
1.05
1.2
1.9
—
—
—
0
0
49
629
0.77
1.04
1.6
1.5
—
—
—
0
0
122
1036
1.19
1.02
1.4
1.6
—
—
—
0
0
29
400
0.72
0.99
1.3
1.1
—
—
—
0
0
17
259
0.65
0.98
1.1
1.4
—
—
—
0
0
225
2013
1.13
0.95
3.5
3.1
1.15
0.88
e6/l
0.31
115
981
24
339
0.70
0.95
1.0
1.1
3.97
2.34
eliau/ml
0.31
11
146
12
197
0.60
0.95
2.2
3.5
0.77
0.34
e9/l
—
7
115
131
1128
1.17
0.95
4.5
5.6
1.48
1.52
%
0.18
114
1046
93
778
1.20
0.93
6.3
13.1
7.40
7.41
ph
0.19
48
339
16
101
1.58
0.92
7.5
9.8
12.69
11.72
mmol/l
0.61
16
86
16
102
1.57
0.89
7.5
9.7
108.13
104.92
mmol/l
1.35
16
87
19
276
0.68
0.89
2.4
2.7
—
36.78
—
0
10
573
5402
1.09
0.88
3.5
3.1
6.42
6.27
ph
2.36
319
2920
10
168
0.59
0.88
1.5
1.2
—
—
—
0
0
41
522
0.78
0.85
1.8
1.9
143.00
115.94
au/ml
—
5
173
52
414
1.26
0.84
1.7
2.0
3.36
7.97
ug/l
3.38
42
360
53
424
1.25
0.83
1.5
2.9
370.96
425.78
mg/l
0.59
53
408
8
46
1.74
0.82
4.1
4.8
56.38
168.58
ug/l
—
8
46
1243
12125
1.10
0.82
18.2
14.1
13.13
13.10
%
0.51
1221
11978
97
1121
0.85
0.80
2.2
2.0
—
—
—
0
0
8
47
1.70
0.80
1.0
1.6
—
—
—
0
0
7
124
0.56
0.77
1.0
1.1
2295.14
1418.19
miu/ml
—
7
124
17
242
0.70
0.74
3.9
4.5
4.45
16.61
u/ml
1.57
17
237
183
2005
0.90
0.70
2.9
3.0
317.81
321.35
umol/l
0.20
148
1883
128
1131
1.14
0.70
1.1
1.2
—
—
—
0
0
29
220
1.32
0.70
1.4
2.9
—
—
—
0
0
5
27
1.85
0.68
1.8
4.3
—
—
—
0
0
7
42
1.66
0.68
1.1
1.1
—
—
—
0
0
41
329
1.25
0.66
3.7
2.9
1.08
4.96
index
2.51
24
197
55
653
0.83
0.65
1.4
1.3
—
—
—
0
0
60
704
0.84
0.63
1.6
1.7
243.43
199.12
u/ml
0.43
14
400
17
233
0.72
0.62
2.1
3.6
40.02
39.21
%
0.13
17
233
264
2446
1.09
0.62
2.0
2.8
0.72
1.22
mg/l
3.09
182
1706
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
75.64
—
0
22
34
272
1.25
0.58
2.4
2.3
11.09
9.86
mg/l
0.69
34
258
47
390
1.21
0.58
1.4
1.5
—
—
—
0
0
21
157
1.34
0.58
1.5
1.4
6.56
10.64
u/ml
0.57
13
108
52
436
1.19
0.57
8.1
16.5
17.02
16.39
%
1.01
52
419
45
372
1.21
0.57
1.5
3.1
—
—
—
0
0
6
37
1.62
0.55
1.2
2.3
—
—
—
0
0
23
176
1.31
0.55
4.5
16.1
12.47
11.82
%
0.38
23
176
10
65
1.54
0.54
1.2
3.0
261.10
148.32
ug/g
—
10
59
8
124
0.64
0.54
1.3
1.2
—
—
—
0
0
10
146
0.68
0.53
1.1
1.2
—
—
—
0
0
674
6501
1.06
0.50
3.5
3.3
0.00
4.93
estimate
1.33
175
1273
676
6522
1.06
0.50
3.6
3.3
0.00
0.00
estimate
-0.00
169
1247
7
110
0.63
0.48
1.3
1.2
—
1023.81
—
0
21
10
142
0.70
0.47
1.1
1.2
—
—
—
0
0
8
117
0.68
0.46
2.0
2.0
—
—
—
0
0
35
292
1.20
0.44
1.1
1.4
1.35
3.30
u/ml
0.95
23
164
499
4791
1.05
0.43
3.2
2.9
0.18
0.01
estimate
0.45
138
1103
46
395
1.16
0.42
1.5
3.0
318.54
628.82
e6/l
0.28
37
290
0
15
0.00
0.41
0.0
1.2
—
43.80
—
0
15
0
16
0.00
0.41
0.0
2.4
—
0.27
—
0
16
0
17
0.00
0.40
0.0
1.9
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
38521.36
—
0
11
7
104
0.67
0.39
1.6
1.6
—
—
—
0
0
666
6457
1.05
0.39
3.5
3.3
0.00
0.00
estimate
0.50
176
1300
276
2883
0.94
0.38
1.8
1.7
—
—
—
0
0
11
80
1.37
0.37
1.4
1.3
70.00
72.41
umol/l
0.15
11
80
17
133
1.28
0.37
1.6
2.3
—
—
—
0
0
21
255
0.82
0.36
1.3
1.2
—
—
—
0
0
89
810
1.10
0.35
1.3
1.4
—
—
—
0
0
45
393
1.14
0.35
1.5
3.0
7.21
15.75
e6/l
0.88
34
274
128
1368
0.93
0.35
1.5
1.5
—
—
—
0
0
6
44
1.36
0.34
1.2
1.2
—
—
—
0
0
77
841
0.91
0.34
1.1
1.2
1.48
2.89
u/ml
1.63
49
542
6
45
1.33
0.33
2.5
2.7
21.67
29.24
%
—
6
45
6
45
1.33
0.33
1.3
1.4
0.00
0.00
estimate
—
6
45
31
264
1.17
0.33
6.7
7.7
—
—
—
0
0
20
163
1.22
0.33
1.7
2.4
2.98
4.81
u/ml
—
6
69
61
548
1.11
0.32
2.2
1.9
8.37
4.98
iu/ml
0.27
14
110
309
2959
1.05
0.31
3.9
6.0
93.16
90.50
%
1.22
298
2904
7
98
0.71
0.30
1.7
2.1
—
—
—
0
0
7
55
1.27
0.30
1.0
1.1
—
4.50
iu/ml
—
0
8
29
250
1.16
0.28
1.2
1.3
5.00
3.87
u/ml
0.20
14
123
16
130
1.23
0.28
1.8
1.6
—
—
—
0
0
23
195
1.18
0.27
1.5
1.4
—
—
—
0
0
5
72
0.69
0.26
5.4
3.8
21.11
24.23
ug/l
—
5
72
35
309
1.13
0.25
1.1
1.2
160.00
221.26
iu/ml
—
10
92
19
223
0.85
0.25
3.7
2.9
18.26
25.40
mg/l
—
8
155
10
126
0.79
0.25
1.2
1.2
—
—
—
0
0
23
197
1.16
0.25
1.4
1.4
0.27
0.39
g/l
2.94
16
155
23
197
1.16
0.25
1.4
1.4
5.14
6.04
g/l
1.19
16
157
23
197
1.16
0.25
1.4
1.4
2.36
2.58
g/l
0.25
16
158
66
710
0.92
0.24
1.9
2.1
0.45
0.57
ug/l
0.84
32
270
126
1323
0.94
0.23
1.6
2.0
—
—
—
0
0
36
398
0.90
0.22
2.1
1.9
—
15.50
—
0
8
34
304
1.12
0.21
1.4
1.6
0.51
0.67
g/l
1.11
23
252
55
505
1.09
0.21
5.3
6.1
259.38
346.41
mg/l
0.44
34
346
0
10
0.00
0.21
0.0
1.0
—
21.20
—
0
5
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
7.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
3.6
—
0.47
—
0
11
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
3.2
—
139.85
—
0
13
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
45
410
1.10
0.20
2.5
3.0
52.58
54.96
%
0.66
45
410
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
11.9
—
76.00
—
0
7
27
239
1.13
0.20
2.1
1.9
—
—
—
0
0
27
239
1.13
0.20
2.1
1.9
—
—
—
0
0
27
239
1.13
0.20
2.1
1.9
—
—
—
0
0
27
239
1.13
0.20
2.1
1.9
—
—
—
0
0
135
1405
0.95
0.19
2.0
2.0
—
—
—
0
0
6
50
1.20
0.19
1.3
1.2
—
—
—
0
0
16
136
1.17
0.19
1.1
1.1
—
—
—
0
0
20
174
1.15
0.19
1.1
1.2
2.18
21.62
u/ml
0.78
13
136
35
382
0.91
0.18
1.0
1.1
—
—
—
0
0
22
246
0.89
0.17
1.1
1.1
0.20
2.82
u/ml
1.19
14
119
12
141
0.85
0.17
3.7
8.8
12.46
9.02
mg/l
0.56
12
131
31
338
0.91
0.16
1.2
1.5
—
6.87
—
0
6
46
426
1.08
0.16
2.3
2.2
1.02
1.02
ratio
0.32
39
366
21
186
1.13
0.16
2.0
2.4
—
—
—
0
0
14
161
0.86
0.16
1.0
1.3
—
217.00
—
0
30
14
161
0.86
0.16
1.0
1.3
—
242.86
—
0
7
6
77
0.77
0.15
1.3
1.4
—
—
—
0
0
24
215
1.11
0.15
1.3
1.2
—
—
—
0
0
6
78
0.76
0.15
2.5
4.1
—
—
—
0
0
8
98
0.81
0.13
1.3
1.1
12.00
41.83
iu/ml
—
8
98
165
1595
1.03
0.13
1.7
1.7
—
—
—
0
0
56
589
0.94
0.13
1.1
1.1
0.24
0.75
u/ml
0.83
29
256
88
841
1.04
0.12
1.3
1.2
—
—
—
0
0
15
168
0.89
0.12
1.5
1.3
22.02
14.95
u/ml
—
9
131
13
147
0.88
0.12
1.1
1.2
—
—
—
0
0
26
238
1.09
0.12
1.6
4.2
—
—
—
0
0
19
171
1.11
0.11
1.5
1.6
1244.38
15316.82
e6/l
1.77
13
126
27
290
0.93
0.11
1.3
1.4
1.24
12.29
u/ml
1.02
17
148
64
666
0.95
0.11
2.1
5.4
20.75
21.69
s
0.56
57
612
14
124
1.13
0.10
1.6
1.5
10.27
9.76
umol/l
0.15
14
119
15
134
1.12
0.10
3.4
6.2
10.88
9.83
mg/l
—
9
114
5
48
1.04
0.09
2.2
2.0
—
—
—
0
0
64
617
1.03
0.07
1.1
1.1
3.72
9.38
u/ml
3.27
38
350
9
85
1.05
0.07
1.6
1.7
7.49
5.59
mmol/l
—
9
71
9
86
1.04
0.07
3.1
2.7
20.60
297.68
ug/l
—
9
77
8
90
0.88
0.06
1.5
2.1
34.88
108.73
mg/l
—
8
81
79
807
0.97
0.06
1.1
1.1
—
—
—
0
0
154
1558
0.98
0.06
2.3
4.6
29.72
30.05
s
0.35
149
1534
67
651
1.03
0.05
1.1
1.1
—
—
—
0
0
17
179
0.95
0.03
1.0
1.0
—
—
—
0
0
65
658
0.98
0.02
1.1
1.1
2.44
5.85
u/ml
1.76
41
405
32
327
0.97
0.02
2.4
4.3
2.04
5.54
ug/l
1.52
21
227
42
410
1.02
0.01
1.3
1.2
—
—
—
0
0
11
103
1.06
0.01
1.1
2.0
—
—
—
0
0
87
858
1.01
0.01
1.1
1.2
3.88
6.57
u/ml
1.15
54
586
84
843
0.99
0.00
1.1
1.2
0.80
1.10
u/ml
0.35
46
503
375
3741
1.00
0.00
2.9
2.6
0.34
0.01
estimate
0.48
148
1077
12
124
0.96
0.00
1.0
1.1
—
—
—
0
0
19
185
1.02
0.00
1.1
1.0
—
—
—
0
0
11
113
0.97
0.00
7.3
4.0
0.82
0.74
index
0.08
11
113
42
418
1.00
0.00
1.1
1.4
—
—
—
0
0
13
133
0.97
0.00
1.2
1.2
0.85
10.70
u/ml
1.26
13
128
94
934
1.00
0.00
1.2
1.2
2.52
2.70
u/ml
0.08
60
597
24
244
0.98
0.00
1.3
1.1
—
—
—
0
0
13
130
1.00
0.00
1.5
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
2.34
—
0
5
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
77
0.90
0.00
22.9
5.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.0
—
—
—
0
0
8
81
0.98
-0.00
1.0
1.1
218.99
221.93
iu/ml
—
8
81
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.4
—
15.90
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
0.07
—
0
6
7
73
0.95
-0.00
1.0
1.1
—
—
—
0
0
9
90
1.00
-0.00
1.6
2.1
30.62
29.84
mg/l
—
9
80
0
8
0.00
-0.00
0.0
1.0
—
28.40
—
0
8
5
55
0.90
-0.00
2.2
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
66
0.90
-0.00
4.7
7.6
2.06
2.41
mg/l
—
6
55
0
6
0.00
-0.00
0.0
3.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_DEVWIDE – Wide developmental disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).